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Abstract 
Piscine francisellosis in an infectious emerging bacterial disease that affects several 
marine and fresh water fish species worldwide, including farmed salmon, wild and 
farmed cod, farmed tilapia and several ornamental species, for which no commercial 
treatment or vaccine exists. During 2011 and the first semester of 2012, chronic episodes 
of moderate to high levels of mortality with nonspecific clinical signs, and widespread 
multifocal white nodules as the most consistent gross pathological lesion were 
experienced by farmed tilapia fingerlings at two different locations in Northern Europe. 
In this study such outbreaks of granulomatous disease were diagnosed as francisellosis 
with a genus-specific PCR, and 10 new isolates of the bacterium including the one named 
STIR-GUS-F2f7, were recovered on a new selective “cysteine blood-tilapia” agar and 
cysteine heart agar with bovine haemoglobin. Ultrastructural observations of the 
pathogen in Nile tilapia (O. niloticus) tissues suggested the secretion of outer membrane 
vesicles (OMVs) by the bacterial cells during infection in these fish. This represented the 
first documented report of isolation of pathogenic Francisella strains from tilapia in 
Europe. The phenotypic characterisation indicated that isolates recovered were able to 
metabolise dextrin, N-acetyl-D glucosamine, D-fructose, α-D-glucose, D-mannose, 
methyl pyruvate, acetic acid, α-keto butyric acid, L-alaninamide, L-alanine, L-
alanylglycine, L-asparagine, L-glutamic acid, L-proline, L-serine, L-threonine, inosine, 
uridine, glycerol, D L-α-glycerol phosphate, glucose-1-phosphate and glucose-6-
phosphate. The predominant structural fatty acids of the isolates were 24:1 (20.3%), 
18:1n-9 (16.9%), 24:0 (13.1%) 14:0 (10.9%), 22:0 (7.8%), 16:0 (7.6%) and 18:0 (5.5%). 
Anti-microbial resistance analyses indicated that STIR-GUS-F2f7 was susceptible to 
neomycin, novobiocin, amikacin, ciprofloxacin, imipenem, gatifloxacin, meropenem, 
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tobramycin, nitrofurantoin, and levofloxacin using the quantitative broth micro-dilution 
method, while the qualitative disc diffusion method indicated susceptibility to 
enrofloxacin, kanamycin, gentamicin, tetracycline, oxytetracycline, florfenicol, oxolinic 
acid and streptomycin. The use of the following housekeeping genes: mdh, dnaA, mutS, 
16SrRNA-ITS-23SrRNA, prfB putA rpoA, rpoB and tpiA indicated 100% similarity 
with other isolates belonging to the subspecies F. noatunensis orientalis (Fno). Koch’s 
postulates were successfully fulfilled by establishing an intraperitoneal injection (IP) 
challenge model with STIR-GUS-F2f7 in Nile tilapia. Moreover, the challenge model 
was used to investigate the susceptibility of 3 genetic groups of tilapia to STIR-GUS-
F2f7. The lowest amount of bacteria required to cause mortality was 12 CFU/ml and this 
was seen as early as only 24 hours post infection in the red Nile tilapia and in the wild 
type after 26 days, no mortalities were seen in the species O. mossambicus with this dose. 
The mortality in red O. niloticus was significantly higher than that of the other two tilapia 
groups when 12 and 120 CFU/fish were injected. It was also observed that when a dose 
of 1200 CFU/ml was used, the mortality in O. niloticus wild type was significantly lower 
than that of the other two tilapia groups and no differences were seen among the 3 groups 
when the highest dose (1.2 x105 CFU/fish) was used.  The median lethal dose (LD50) of 
O. niloticus wild type was the most stable during the experiment (values around 104 
CFU/ml) and the highest of the three groups after day 25 post infection. At the end of the 
experiment (day 45) the LD50 was 30 CFU/ml in the red Nile tilapia, 2.3x104 CFU/ml for 
the wild type and 3.3x102 CFU/ml for O. mossambicus. This pattern, where the LD50 of 
the red tilapia was lower than that of the other two groups, was observed during the whole 
experiment. The outcomes of these experiments suggested that the red Nile tilapia family 
appeared to be the most susceptible while the wild type Nile tilapia family the most 
Abstract 
 
VIII 
 
resistant. The complete genome of STIR-GUS-F2f7 was sequenced using next generation 
sequencing (NGS) Illumina Hi-Seq platform™, and the annotation of the assembled 
genome predicted 1970 protein coding sequences and 63 non-coding rRNA sequences 
distributed in 328 sub-systems. The taxonomy of the species Francisella noatunensis was 
revised using genomic-derived parameters form STIR-GUS-F2f7 and other strains in 
combination with a polyphasic approach that included ecologic, chemotaxonomic and 
phenotypic analyses. The results indicated that STIR-GUS-F2f7 and all the other strains 
from warm water fish represent a new bacterial species for which the name Francisella 
orientalis was assigned. Moreover the description of F. noatunensis was emended and 
the creation of a new subspecies within this taxon i.e. Francisella noatunensis subsp. 
chilense was proposed. The results of this study led to the development of a highly 
efficacious vaccine to protect tilapia against francisellosis.  
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Chapter One 
General introduction and aims of this study.  
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1.1 Introduction 
1.1.1 World aquaculture and farmed fish production 
Fish for food production (fisheries and aquaculture) has kept growing steadily worldwide 
during the last 50 years at an average rate of 3.2% overtaking world population growth 
by 1.6%. Thanks to this, the global fish consumption per capita has increased worldwide 
from 9.9kg in the 1960s to 19.2kg in 2012 (FAO, 2014).   
The aquaculture sector itself continues to grow at an incredible pace and now provides 
almost half of all fish for human consumption, in fact the worldwide “food fish” 
production from aquaculture, where the term  refers to finfishes, crustaceans, molluscs, 
amphibians, freshwater turtles and other aquatic animals (such as sea cucumbers, sea 
urchins, sea squirts and edible jellyfish) produced for the intended use as food for 
humans,  has expanded from 32.4 million tonnes in 2000 to 66.6 million tonnes in 2012 
(average annual rate of 6.2%) making of aquaculture one of the fastest-growing food-
producing sectors in the world and one of the most important sources of high quality 
protein for human consumption (FAO, 2014; Tidwell and Allan, 2001).  
According to FAO (2014) it is estimated that a portion of 150g of fish can provide about 
50–60 percent of an adult’s daily protein requirements and that in 2010, fish accounted 
for 16.7% of the global population’s intake of animal protein and 6.5% of all protein 
consumed. Within the group of finfishes the farming of tilapias is the most widespread 
type of aquaculture in the world with official statistics from 135 countries and territories 
on all continents, however it is estimated that the true number of producer countries is 
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higher because commercially farmed tilapias are yet to be reflected separately in national 
statistics in Canada and some European countries (FAO, 2014) 
1.1.2 Tilapia aquaculture 
The term tilapia refers to a group of cichlids from Africa that comprises more than 100 
species from 3 genera: Oreochromis, Tilapia and Sarotherodon (Fitzsimmons and 
Watanabe, 2010). In aquaculture, tilapia is the second largest production in volume after 
carps and is also the most extensively farmed group of fish in the world (Norman-López 
and Bjørndal, 2009).  
Thanks to their great adaptability to different farming systems tilapia is becoming one of 
the most successful sectors in aquaculture, with figures from the last decade indicating 
that tilapia production has increased from 2.6 million tons in 2005 to 4.5 million tonnes 
in 2012 (FAO, 2014) and according to Fitzsimmons et al. (2014) it is expected that it will 
reach the 4.8 or 5 million tonnes between 2014 and 2015.  
Nile tilapia (Oreochromis niloticus) is recognised as the most commercially important 
tilapia species, as its production accounts for ~80% of the total, tilapia production 
worldwide. Other important tilapia species in aquaculture are: Mozambique tilapia (O. 
mossambicus), blue tilapia (O. aureus) and a variety of hybrids produced by the crossing 
of these species (FAO, 2010).  
Particular significance have the red tilapia hybrids, produced and cultured in several 
countries in Asia and Latin America to extend the production into brackish and sea water 
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and to satisfy the demand of consumers that relate the red tilapia with marine and reef 
fishes of similar hue (Castillo-Campo, 2013; Ramírez-Paredes et al., 2012a). 
In Europe, Nile tilapia production can be found in, France, Germany, the Netherlands 
Great Britain, which has the biggest market for this industry, Sweden, Latvia, Norway 
and Poland. To cope with the climate of these regions and to satisfy the high demand of 
consumers, farmers are using recirculating systems with hyper intensive culture 
conditions (high stocking densities, poor water quality and excessive handling).  
Unfortunately the use of these intensive culture systems without adequate biosecurity has 
brought several drawbacks to this industry and one of the main problems is the 
occurrence of infectious diseases, particularly those caused by bacterial pathogens, which 
usually led to massive financial losses (Bebak, 1998). 
Disease-related financial losses in aquaculture are divided in market and direct losses. 
The market losses are associated with a reduction in the quality of survivors (i.e. resulting 
from reduced growth rates or reduced product quality) and poor market assessments due 
to a decrease in the facility’s reputation. This last one is takes and added importance in 
cases or regions where the farming of a specific species is incipient like the case of tilapia 
in Europe. The direct losses relate to mortalities (sometimes the loos of the whole 
productive cycle), facility closure, restriction of fish movement and inability to replace 
stock especially in cases where intracellular pathogens with vertical transmissions are 
presented (Bebak, 1998). 
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In tilapia aquaculture, bacterial diseases are considered to be a major cause of losses to 
the industry and they occur when rearing or farming conditions are poor as it frequently 
happens in highly or hyper intensive farming (Plumb and Larry, 2010). 
1.1.3 Bacterial diseases of tilapia  
Tilapia are in general considered to be resistant to infectious diseases, especially when 
they are farmed under extensive conditions in their natural ecosystem; however as the 
production intensifies their susceptibility to pathogenic microorganisms increases 
(Fitzsimmons and Watanabe, 2010; Plumb and Larry, 2010). 
Several bacterial diseases can affect tilapia including streptococcosis, caused by 
Streptococcus agalactiae and S. iniae; francisellosis caused by the facultative 
intracellular bacterium Francisella noatunensis orientalis; edwardsiellosis by 
Edwardsiella tarda and E. ictaluri; vibriosis resulting from different Vibrio spp.; 
columnaris disease caused by Flavobacterium columnare and motile aeromonas 
septicemia (MAS) associated with several opportunistic Aeromonas spp. including A. 
hydrophila (Austin, 2011; Austin, 2012; Plumb and Larry, 2010). 
Of these diseases, streptococcosis and francisellosis have been reported as the most 
economically important, with both having a worldwide distribution and affecting fish at 
a range of sizes, in fresh, brackish and sea water. However, while streptococcosis has 
been studied in tilapia since the 1970s and there are commercial treatments for its 
prevention, francisellosis is still considered an emergent disease in several countries and 
no treatments are available for its prevention or cure. 
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Francisellosis does not only affect the tilapia industry worldwide, but also affects other 
important aquaculture sectors such as ornamental fish (Camus et al., 2013; Hsieh et al., 
2007; Lewis et al., 2014; Soto et al., 2014a), the salmon industry in Chile (Birkbeck et 
al., 2007; Birkbeck, 2011; Bohle et al., 2009; Ibieta et al., 2011), cod farming in Norway 
(Birkbeck et al., 2011; Colquhoun and Doudu, 2011; Nylund et al., 2006; Ottem et al., 
2008) and abalone production in Japan (Brevik et al., 2011; Kamaishi et al., 2010). 
1.1.4 Francisellosis in tilapia and other aquatic organisms 
1.1.4.1 Aetiological agents (host specificity and reservoirs) 
The Francisella species that have been identified as causative agents of natural or 
experimental disease in aquatic organisms include the following species: 
Francisella noatunensis noatunensis (Fnn), in Europe it has been found in wild and 
farmed Atlantic cod (Gadus morhua) in Sweden, Denmark, Norway and Ireland 
(Birkbeck et al., 2011; Colquhoun and Doudu, 2011) and farmed Atlantic salmon (Salmo 
salar) in Norway (Ottem et al., 2008). Experimental infections have been successfully 
reproduced in cod (Ellingsen et al., 2011; Gjessing et al., 2011; Inami, 2011) and 
zebrafish (Danio rerio) (Brudal et al., 2014a). Additionally it has been retrospectively 
detected by quantitative real time PCR (qPCR) in wild cod sampled from the coasts of 
the UK and in Norway in wild fish: saithe (Pollachius virens), pollock (Pollachius 
pollachius), poor cod (Trisopterus minutes), mackerel (Scomber scombrus), European 
plaice (Pleuronectes platessa), megrim (Lepidorhombus whiffiagonis), angler-fish 
(Lophius piscatorius) and flounder (Platichthys flesus), as well as in invertebrates such 
as blue mussel (Mytilus edulis) and edible crab (Cancer pagurus) (Ottem et al., 2008; 
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Wangen, 2009; Wangen et al., 2012). In Chile natural outbreaks in farmed Atlantic 
salmon and and common galaxias or jollytail (Galaxias maculatus) (Birkbeck et al., 
2007; Birkbeck et al., 2011;  Bohle et al., 2009; Cvitanich et al., 1995; Enríquez et al., 
1998; Pharmaq Norway, 2006).  
Successful experimental infections in Chile with Fnn have been reported in Atlantic 
salmon and to a less extent in coho salmon (Oncorhynchus kisutch) (Brossard-Andrade, 
1999; Cárdenas-Villaroel, 1998; Gacitúa-Sandoval, 1999; Hausdorf-Volke, 2009; 
Schulze-Barrientos, 2010; Thibaut-Páez, 2009; Urra-Sáez, 2010) and according to 
Cárdenas-Villaroel (1998) experimental infections in rainbow trout (Onchorhyncus 
mykiss) were not successful. 
Francisella noatunensis orientalis (Fno) is associated with natural outbreaks in farmed 
tilapia (Oreochromis spp., Sarotherodon melanotheron, Tilapia spp. and hybrids of these 
species) (Colquhoun and Doudu, 2011); Three line grunt or Isaki fish (Parapristipoma 
trilineatum) (Kamaishi et al., 2005); Hybrid striped bass (Morone chrysops x M. 
saxatilis) (Ostland et al., 2006); Indo-Pacific reef fish species (fairy wrasses including 
orangeback, (Cirrhilabrus aurantidorsalis), solor (C. solorensis), exquisite (C. 
exquisitus), Lubbock’s (C. lubbocki) and blue-green damselfish (Chromis viridis) 
(Camus et al., 2013); Ornamental marine grunts (French grunt Haemulon flavolineatum 
and Caesar grunt Haemulon carbonarium) (Soto et al., 2014a); Ornamental Malawi 
cichlids: Nimbochromis venustus, N. linni, Aulonocara stuartgranti “maleri”, 
Placidochromis sp. “blue hongi”, Protomelas sp., Naevochromis chryosogaster, 
Copadichromis mloto and Otopharynx tetrastigama (Lewish et al., 2014).  
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It has been possible to experimentally infect Isaki fish, tilapia and zebra fish with Fno 
(Brudal et al., 2014; Kamaishi et al., 2005; Soto et al., 2009a; Vojtech et al., 2009; 
Vojtech et al., 2012).  
Additionally, Fno has been detected by conventional polymerase chain reaction (PCR) 
and real time quantitate PCR (RT q-PCR) in wild guapote tigre (Parachromis 
managuensis); ornamental cichlids: firebird (Aulonocara rubescens), elegans 
(Pseudotropheus elegans), zebra cichlid (Pseudotropheus zebra), Rhodes’s chilo 
(Chilotilapia rhoadesii), Malawi eyebiter (Dimidiochromis compressiceps), brown 
discus (Symphysodon aequifasciatus), deep-water hap (Haplochromis electra), electric 
blue hap (Sciaenochromis fryeri), blue-white labido (Labidochromis caeruleus), 
Placidochromis milomo, Frontosa cichlid (Cyphotilapia frontosa), barracuda (Sphyraena 
barracuda), farmed Hawaiian Chinese catfish (Clarias fuscus) and barramundi (Lates 
calcarifer) farmed in Hawaii (Colquhoun and Duodu, 2011; Camus et al., 2013; Hsieh, 
et al., 2007; Kamaishi et al. 2005; Klinger-Bowen et al., 2015; Lewisch et al., 2014; 
Ostland et al., 2006; Soto et al., 2012a; Soto et al., 2014a).  
Francisella halioticida (Fh) is associated with natural outbreaks in Japanese farmed 
giant abalone Haliotis gigantea and experimental infections in Japanese black abalone 
Haliotis discus discus and H. gigantea (Brevik et al., 2011; Kamaishi et al., 2010). 
Francisella tularensis novicida (Ftn): experimental infections were successfully 
established with the strain U112 in zebrafish (Brudal et al., 2014a). Unsuccessful 
experimental infections via intraperitoneal injection were reported in rainbow trout, 
northern pike (Esox Lucius), black bullhead (Ameirus melas), black crappie (Pomoxis 
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nigromaculatus), largemouth bass (Huro salmoides) and yellow perch (Perca flavescens) 
with Francisella tularensis tularensis (Ftt) more than 70 years ago where no mortalities 
or clinical signs of francisellosis were observed in the fish (Morgan, 1947). 
1.1.4.2 History and taxonomy  
The first report of disease outbreaks in fish involving Francisella sp. was from Japan in 
2005 (Kamaishi et al., 2005). Previous to this study, there were several cases of 
granulomatous infections where no isolation or molecular methods were used to confirm 
the identity of the causative agents.  
Most of these outbreaks occurred between 1981 and 2005 affecting the following fish 
species: wild Atlantic cod captured around the English costs of the UK during 1981-1983 
(Van Banning, 1987); wild dragonets (Callionymus lyra) from Welsh coasts of the UK 
in 1986 (Davies, 1986); farmed tilapia in Taiwan, Hawaii, Jamaica, Indonesia and 
continental USA (southern California, Florida and South Carolina) during the 1990s 
(Chern and Chao, 1993; Chen et al., 1994; Mauel et al., 2003; Mauel and Miller, 2002); 
ornamental blue-eyed plecostomus (Panaque suttoni) from Colombia in 1995 (Khoo et 
al., 1995); imported three-line grunt  from China into Japan from 1999-2001(Fukuda et 
al., 2002); hatchery-reared juvenile white seabass (Atractoscion nobilis) in southern 
California USA (Chen et al., 2000); farmed grouper (Epinephelus melanostigma) in 
Taiwan in 2000 (Chen et al., 2000); snakehead fish (Ophiocephalus argus) in China 
between 2001-2002 (Guo et al., 2004), tilapia farmed in the USA (Florida, California 
and South Carolina) during 2001-2003 (Mauel et al., 2005) and  farmed Atlantic salmon 
and common galaxias or jollytail fish in Chile (Birkbeck et al., 2007; Birkbeck et al., 
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2011;  Bohle et al., 2009; Cvitanich et al., 1995; Enríquez et al., 1998; Pharmaq Norway, 
2006). 
In most of these reports the presence of intracellular bacteria Piscirickettsia salmonis 
and/or Mycobacterium spp. was discarded by molecular methods and the authors 
assigned the terms rickettsia like organisms (RLOs), Piscirickettsia-like organisms 
(PRLOs) to the possible causative agents and mycobacteriosis-like or piscirickettsiosis-
like disease to the pathogeny. 
The first report confirming Francisella sp. as the causative agent of mortalities in farmed 
fish was presented in 2005 (Kamaishi et al., 2005). After that, researchers started to use 
conventional and quantitative PCR, and selective synthetic media to investigate cases of 
granulomatous disease in aquatic organisms and a number cases in tilapia (Soto et al., 
2009a), Atlantic salmon (Birkbeck et al., 2007), Atlantic cod (Olsen et al., 2006), 
ornamental fish (Camus et al., 2013; Lewisch et al., 2014; Soto et al. 2014a) and hybrid 
striped bass (Ostland et al., 2006) were reported. Additionally with the use of these 
techniques it was also possible to retrospectively confirm some of the cases previously 
reported as mycobacteriosis-like or piscirickettsiosis-like disease as piscine 
francisellosis. (Hsieh et al., 2007; Mauel et al., 2007; Mauel et al. 2003; Soto et al., 
2011a; Zerihun et al., 2011) 
It was not until 2007 that the first attempt to taxonomically classify the Francisella spp. 
recovered from fish was published (Ottem et al., 2007b). In that study the comparative 
characterisation of one strain recovered from farmed Norwegian Atlantic cod and the 
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type strain of Francisella philomiragia indicated that the first should constitute a new 
species, for which the authors gave the name Francisella piscicida. 
Later the same year, Mikalsen et al. (2007) compared seven cod isolates against four 
strains of F. philomiragia and classified the cod isolates as a subspecies of the latter and 
named it as F. philomiragia subsp. noatunensis. 
The name F. piscicida was published as valid in January 2008 (Euzeby, 2008). In that 
report, it was suggested that the bacterium could constitute a heterotypic synonym of F. 
philomiragia subsp. noatunensis thus according to the rule of priority, if the later had to 
later be elevated to the rank of species the epithet “noatunensis” should remain over 
“piscicida”. Some months later in 2008, the type strains of F. piscicida and F. 
philomiragia noatunensis were compared against five isolates of F. philomiragia 
including the type strain. Additionally, one strain from diseased fish farmed in warm 
water environment “Ehime-1” and DNA from one isolate recovered from Indonesian 
tilapia were included (Ottem et al., 2009).  
As a result of these comparisons F. piscicida was proved to be a heterotypic synonym of 
F. philomiragia noatunensis and both were elevated to the rank of species as F. 
noatunensis, while the single isolate Ehime-1 was described as the type strain of the 
subspecies F. noatunensis orientalis on the basis of a few phenotypic traits (Ottem et al. 
2009). These results appeared to elucidate the new name for the various isolates, but were 
not considered as valid until finally were published in the “list of new names and new 
combinations previously effectively, but not validly, published” in 2009 (Euzeby, 2009a; 
Euzeby, 2009b). 
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In September 2009, an “ahead of print electronic publication” of the International Journal 
of Systematic and Evolutionary Microbiology (IJSEB) appeared online. In this study a 
Chilean strain named “PQ1106”, DNA from the Japanese strain Ehime-1 and a strain 
from tilapia farmed in Costa Rica were analysed. The result of this study also elevated 
the rank F. philomiragia noatunensis to the species level as F. noatunensis and 
additionally described the Costa Rican and Japanese strains as a new species for which 
the authors gave the name F. asiatica  (Mikalsen and Colquhoun, 2009). 
Since F. noatunensis had already been published as a valid name, this electronic version 
of this paper was later withdrawn by the IJSEB and the name F. asiatica was never 
considered as valid or even effectively published. After this no other investigations took 
place to clarify the taxonomic rank F. noatunensis orientalis. 
1.1.4.3 Morphological and biochemical characteristics 
All the fish pathogenic Francisella strains are Gram negative, non-motile highly 
pleomorphic coccobacilli cells, with a size ranging from 0.2 to 0.4µm in width and 0.4 
to 1.9µm in length, catalase positive, oxidase negative, with requirement of cysteine to 
grow and agglutinate with polyclonal antiserum against Fnn (strains GM2212 and NVI 
5330) but not with monoclonal or polyclonal antiserum against F. tularensis.  
Micrographs in Figure 1.1 show the ultrastructure of Fno in tilapia tissues. The 
biochemical characteristics of fish pathogenic Francisella strains is summarised in Table 
1.1. The table is adapted from the results presented by (Ottem, 2011; Birkbeck et al., 
2011).  
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Figure 1.1 Micrograph of F. noatunensis orientalis in tilapia tissues. The shape and size 
of the cell varies according to life cycle stage and localisation in the host. A Bacterial 
cell size is 344.59nm (red line) X 264.23nm (green line). Scale bar=100nm. B Bacterial 
cell size is 609.14nm (red line) X 345.86nm (green line). Scale bar=200nm.
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Table 1.1. Biochemical and physiological characteristics of fish pathogenic Francisella spp. and the F. philomiragia type strain 
Characteristic Fno Fnn from Europe Fnn from Chile F. philomiragia
Optimal temperature °C 28.5 22 22 15-37
Cysteine required for growth + + + -
Motility - - - -
Oxidase - - - -
Catalseⱡ + + + +
Indoleⱡ + + + +
Alkaline phosphatase + + + +
Esterase C4 + + + +
Esterase lipase C8 + + + +
acid phosphatase + + + +
H2S-production + + + +
β-Lactamase + + + +
Naphtol-AS-BI phosphohydrolase + - w+ +
Proline arylamidase + + - +
Phenylalanine arylamidase + - - +
Tyrosine arylamidase - w+ w+ +
Alanine arylamidase w+ + w+ +
Histidine arylamidase - w+ w+ +
InDoxyl phosphate (IDP) + - - +
Arginine arylamidase  +w  +w  +w +
D-Glucose [+] + + +
Mannose - - - +
Data presented are based on combined results published by Birkbeck et al . (2011) and Ottem (2011); W=weakly positive;
In green: differences between Fno and Fnn ;   In orange the differences between Fnn from Chile and Fnn from continetal Europe;
The result in [ ] is shown as negative and ⱡ as weekly positive  in  Birkbeck et  al . (2011);
Chapter One 
 
15 
 
There are minor differences between the results shown in Table 1.2 and those stated in 
the valid description of F. noatunensis (Ottem et al., 2009) (previously F. philomiragia 
noatunensis (Mikalsen and Colquhoun, 2009)). In both reports API Kits were used to 
characterise the strains, however in the description of the species it is stated that F. 
noatunensis is positive for Naphtol-AS-BI phosphohydrolase and degradation of 
mannose, and negative for tyrosine arylamidase, histidine arylamidase and arginine 
arylamidase.  
According to the currently valid description (Ottem et al., 2009) there are only four 
differences between Fnn and Fno and they are presented in Table 1.2. 
Table 1.2. Phenotypic differences between Fno and Fnn according to their 
currently valid description. 
Characteristic Fno Fnn 
Phenylalanine arylamidase + - 
InDoxyl phosphate + - 
Arginine arylamidase + - 
Mannose - + 
 
The few differences between strains that have such a dissimilar geographical and 
ecological niche (i.e. farmed tilapia in Central America and wild cod caught in 
Scandinavia) and the inconsistencies between studies indicate that the API Kits are not a 
good option to biochemically and phenotypically analyse fish pathogenic Francisella 
strains or any other members of this genus. These results also highlight the need of 
reliable methodologies to characterise these bacteria and eventually establish minimal 
standards for the delineation of species and subspecies within this genus. 
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1.1.4.4 Clinical signs and gross pathology in tilapia 
The clinical signs of francisellosis in tilapia can be variable and are not considered 
specific for the disease. The most frequently found include enlargement of the abdominal 
cavity due to ascites and swollen organs, pale/darkened skin colour, pale gills, skin 
haemorrhages (petechial on the sides), ulcers/excess of mucus in the skin, lethargic 
behaviour, frayed fins, exophthalmia and abnormal swimming (fish may float at the 
surface and/or show vertical or circular movements) (Chern and Chao, 1993; Chen et al., 
1994; Colquhoun and Doudu, 2011; Mauel et al., 2003; Mauel et al., 2007; Mauel and 
Miller, 2002; Soto et al., 2009a; Soto et al., 2011a).  
At necropsy, the organs in the abdominal cavity are enlarged and haemorrhagic, white 
nodules can be found mainly in the spleen and kidney, but also in the liver, gills, stomach, 
intestine and mesenteric fat (Chern and Chao, 1993; Chen et al., 1994; Mauel et al., 2003; 
Mauel et al., 2007; Mauel and Miller, 2002; Soto et al., 2009a; Soto et al., 2011a).  
A transparent fluid can be extracted from moribund fish with advanced degrees of ascites 
and centrifugation of the fluid reveals the presence of bacteria in extracellular phase 
(personal observation).  
Figure 1.2 and 1.3 show clinical signs and lesions of experimentally infected 
Mozambique tilapia via intraperitoneal injection.
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Figure 1.2 Clinical signs and gross pathology of experimentally induced francisellosis in Mozambique tilapia. A Anaemic gills and pale skin. B 
Bilateral exophthalmia. C Varying degrees of ascites. D Extraction of transparent fluid from ascites. E Haemorrhagic gills and enlargement of 
liver and intestines. 
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Figure 1.3 Kidney and spleen of Mozambique tilapia with experimentally induced 
francisellosis. A White arrow points to the enlarged head kidney, black arrows point 
multiple white nodules in posterior and middle kidney. B The enlarged spleen with 
parenchyma covered by multiple coalescent white nodules.  The fish is the same 
individual shown in Figure 1.2.
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1.1.3.5 Haematology and histopathology in tilapia 
According to Chen et al. (1994) the haematocrit value (percentage of the packed cell-
volume) in infected fish was around 66% less (10.5 ± 5.2) than that of the healthy fish 
(31.5 ± 2.8). In that study blood smears stained of infected fish stained with Giemsa, 
Gram stain and periodic acid-Schiffs showed apparent neutrophilia and 36 to 42% less 
protein and monocytes than the healthy fished. The authors also found basophilic 
granules within the cytoplasmic vacuoles of macrophages stained in the blood smears. 
Large amounts of Gram-negative coccobacilli with polymorphic shapes were found 
intracellularly in organ smears stained with Liu's stain and Gram stain. 
In haematoxylin and eosin (H&E) sections, severe granulomatous formation can be 
systemically seen with fibrin or thrombi in the small blood vessels of organs (larger blood 
vessels are involved in the kidney and liver) and perivascular necrosis with disseminated 
intravascular coagulation. The granulomas consist of large vacuolated macrophages 
encircled by thin fibrous capsules and small cuffs of lymphocytes. Melanomacrophages 
are frequently found associated with the infiltrates. Infected macrophages often have 
obliterated and the nucleus displaced to the periphery, while the vacuoles contain 
enlarged and numerous, pleomorphic, basophilic intracytoplasmic coccobacilli cells. The 
centre of the granuloma can be necrotic or with small areas of necrosis associated with 
individual or small clusters of the pleomorphic coccobacilli cells. (Birkbeck et al., 2011).  
According to Hsieh et al. (2006), who histologically examined 120 tilapias, the most 
affected organs with granuloma formation were the spleen (100%), kidneys (100%), liver 
(85.8%), gills (72.5%), gonads (63.3%), gastrointestinal tract (56.7%), heart (47.5%), 
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swim bladder (40%) and eyes (30.8%). The brain and the muscle tissue can also present 
granulomatous lesions with necrosis and chronic inflammatory cell infiltration and this 
is linked with the abnormal swimming behaviour observed (Birkbeck et al., 2011; Mauel 
et al., 2005) 
Some of the histopathological findings reported in specific tissues include necrosis and 
ulcers in the intestine and stomach (found in the muscular layer) and focal chronic 
inflammation in the submucosa, lamina propria or serosa; in advanced cases generalised 
coagulation and necrosis invading from serosa through the mucosa can also be observed. 
In gills some fish may show epithelial hyperplasia with consolidation or fusion of 
secondary lamellae or “loss” of intralamellar spaces. Granulomatous proliferative 
response can also be presented at the base of the gill arch. In the heart, epicarditis, 
endocarditis and myocarditis can be observed with fragmentation of myocardial fibres, 
and granulomas can also be detected. In kidney, necrosis and degeneration of renal 
tubules can be seen indicating the formation of hyaline droplets. Invasion of 
inflammatory cells in anterior and posterior kidney is commonly observed replacing the 
renal tissue. The nonreplaced renal epithelium generally shows degeneration. The spleen 
generally shows multi-granulomatous formation, and replacement of normal lymphoid 
tissues by diffuse chronic inflammatory cells. The replacement can be found in almost 
the entire normal splenic architecture depending on the severity of the infection. In liver 
degeneration of hepatocytes within macrophages containing bacteria in cytoplasmic 
vacuoles and hepatic lipidosis are frequently noted (Chen et al., 1994; Chern and Chao 
1993; Mauel et al., 2005; Soto et al., 2009a). Typical histopathological findings in 
kidney, spleen and heart of tilapia are shown in Figures 1.4 to 1.6. 
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Figure 1.4 Histological sections stained with H&E of the kidney of tilapia experimentally infected with francisellosis. A The arrows indicate the 
granuloma formation. Scale bar=100µm. B Zoom to one of the granulomas 100X. 
Chapter One 
 
22 
 
 
Figure 1.5 Histological sections stained with H&E of the heart of tilapia experimentally infected with francisellosis. A The square indicates the 
granuloma formation and fragmentation of myocardial fibres. Scale bar=100µm. B Zoom to the granuloma 200X.
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Figure 1.6 Histological sections stained with H&E of the spleen and kidney of tilapia experimentally infected with francisellosis. A Spleen. Arrows 
point coalescent granulomas replacing haematopoietic tissue. Scale bar=100µm. B Kidney. The arrows indicate formation of granulomas. Scale 
bar=100µm. 
Chapter One 
 
24 
 
1.1.4.6 Pathogenesis of Francisella noatunensis orientalis 
Soto et al. (2011b) showed that Fno replicates in the skin mucus and enters the fish via 
gills and skin lesions. According to Chen et al. (1994) the bacterium then spreads to the 
endothelial cells of capillary beds via the blood where acute vasculitis occurs. This is 
followed by perivascular leucocytic inflammatory infiltration and these lesions lead to 
focal necrosis and chronic infiltration of inflammatory cells.  
Some of the genes associated with the ability of Fno to survive and replicate within the 
phagocytic cells of the fish have been identified as homologues of those previously 
reported in F. tularensis like the intracellular growth ABCD operon (iglABCD) (Soto et 
al., 2009b). According to the authors the iglC gene is necessary for intra-macrophage 
survival in tilapia, but plays no role in the resistance to normal and heat inactivated tilapia 
serum (Soto et al., 2010a).  
In adult zebrafish intraperitoneally infected with F. noatunensis orientalis a pro-
inflammatory response with up regulation of inter-leukin-1β (IL-1β), gamma interferon 
(IFN-γ) and tumour necrosis factor alpha (TNF-α) was detected in the gills 6h post 
infection and it lasted for up to 7 days (Vojtech et al., 2009).  
In another experiment the same researchers used Fno to show that during experimental 
infections primary leukocytes from adult zebrafish display caspase-1-like activity that 
results in IL-1β processing demonstrating for the first time the processing and secretion 
of this interleukin in zebrafish (Vojtech et al., 2012).  
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A different research group also found a robust proinflammatory immune response, 
dominated by increased transcription of TNF-α and IL-1 β in zebrafish embryos injected 
with Fno (Brudal et al., 2014a). In this study authors also found the induction of the anti-
inflammatory cytokine IL-10. According to the authors, a lack of IL-10 production in 
systemic infections can result in higher levels of pro-inflammatory cytokines, more tissue 
damage, and earlier death, while excessive production causes decreased ability to clear 
pathogens, resulting in chronic or lethal infections. 
A recent study has demonstrated that temperature plays a key role on the pathogenesis of 
the disease in tilapia during experimental infections. When fish are kept at 25°C 
mortalities and spleen bacterial loads were significantly higher than those observed when 
the fish was maintained at 28°C. This study also demonstrated that water salinity has no 
effect on the course of the disease (Soto et al., 2012c). In contrast to tilapia, all the 
experimental infections in zebrafish have been successfully achieved when the fish is 
maintained at 28°C. 
1.1.4.7 Diagnosis and culture 
The clinical signs, lesions and histopathological findings described in Section 1.3.4 are 
valuable as a first approach to the diagnosis of piscine francisellosis. However, since 
many other disease like mycobacteriosis and piscirickettsiosis develop similar patterns 
other techniques preferably molecular approaches should be used to confirm the presence 
of the pathogen in disease outbreaks.  
Among the different options for molecular diagnosis of piscine francisellosis, the 
conventional genus specific PCR developed by Forsman et al. (1994) is a useful, 
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inexpensive tool that allows the identification of Francisella spp. in the fish tissues 
without the need of DNA sequencing. Since quantification of the bacterium is limited 
using this technique a number of real time quantitative PCR assays have been published 
in the last ten years.  
In 2008, Ottem et al. (2008) published a multiplex assay that combined two real time 
PCR assays to detect low levels of Fnn, although the sensitivity of these assays was good 
it was not capable of differentiating between Fnn and other Francisella spp. without 
multiplexing or combining different genes. A year later Soto et al. (2010b) published a 
quantitative PCR assays for diagnosis of Fno in tilapia, this protocol had a lower (better) 
power of detection but like the previous assays this was not considered specific for 
bacteria belonging to the taxon Fno.  
In 2012 Doudu et al. (2012) published two highly sensitive real time PCRs. These assays 
were developed with specific Fnn and Fno gene sequences, and therefore are considered 
subspecies specific, but could not distinguish between Fnn strains. The limit of detection 
of the assays was only of 10 genome equivalents. This assay is supposed to have the 
lowest limit of detection for the diagnosis of piscine francisellosis however it would be 
recommended to develop a comparative study, such as that recently presented by 
Monaghan et al. (2015) for viral detection in carp (Cyprinus carpio), to analyse its real 
sensitivity and specificity in comparison with all the other PCR assays. 
The main drawback of conventional and real time PCRs is that they require the use of 
specialised lab equipment and cannot be performed at the farm side. A solution to these 
problem were addressed by Caipang et al. (2010), who proposed a loop-mediated 
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isothermal amplification (LAMP) reaction to identify Fnn in cod tissues. According to 
the authors, the method was 100 times more sensitive than the conventional PCR and 
highly specific for Fnn.  
The LAMP approach has not been attempted for detection of Fno in tilapia aquaculture 
and further research is required to develop non-lethal diagnostic methods that can be 
performed at the farm site.   
Prior to the first identification of Francisella spp. in fish, the isolation of these pathogens 
had only been achieved using cell culture. The cell lines that were successfully used to 
recover Fnn were: salmon head kidney (SHK-1), Atlantic salmon kidney cells (ASK) 
and rainbow trout gonad cell line RTG-2, (Bohle et al., 2009; Cvitanich et al., 1995; 
Nylund et al., 2006) while Fno was isolated using Chinook salmon embryo (CHSE-214) 
cells lines (Hsieh et al., 2006). 
After the confirmation of Francisella spp. in the fish outbreaks, several synthetic 
selective media haven used to isolate Fnn and Fno. The formulation of these agars is 
based on media used to isolate F. tularensis and environmental Francisella spp. Soto et 
al. (2009a) reported the following agars as suitable for secondary passages of pure Fno: 
chocolate Agar/Improved Thayer-Martin biplate, Chocolate II Agar, and the Mueller Hinton 
base supplemented with 3% foetal bovine serum, 1% glucose and 0.1% cysteine. Table 1.3, 
adapted from (Colquhoun and Duodu, 2011), shows a summary of the agars that have been 
successfully used to recover Fnn and Fno. The broth or liquid media that have been 
successfully used to grow purified Fnn and Fno are: Bacto Eugon Broth with 
FeCl3·6H2O, Growth medium B1817 and modified Mueller-Hinton II cation adjusted 
broth supplemented with 2% IsoVitaleX (Ottem et al., 2007a; Soto et al., 2009a).  
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Table 1.3 Media used for primary isolation of Francisella spp. from diseased fish 
 
Bacterium             Fish species            Media type             Reference
Fnn Atlantic cod cysteine heart agar + 5% ovine blood Olsen et al.  (2006)
blood agar + 0.1% cysteine + 1% glucose (BCG-plates) Nylund et al.  (2006)
MacConkey agar Ottem et al .  (2006)
growth medium B1817 in agar Ottem et  al .  (2007)
cysteine heart agar + 5% ovine blood+10% vancomycin Ruane et  al . (2015)
Atlantic salmon cysteine heart agar + 5% ovine blood Birkbeck et al . (2007)
agar Eugon + 0.1% L-cysteine, 1% glucose 6% (v/v) yeastolate and 10% (v/v) bovine foetal serum Bohle et al . (2009)
Fno Isaki cysteine heart agar + 1% bovine haemoglobin Kamaishi et al.  (2005)
Tilapia Thayer-Martin agar Hsieh et al . (2006)
modified Thayer-Martin agar Soto et al.  (2009a)
cysteine heart agar + 2% bovine haemoglobin Soto et al.  (2009a)
cysteine heart agar + 2% bovine haemoglobin + polymixin B (100 units/ml) and ampicillin (50 μg/ml) Soto et al.  (2009a)
cysteine heart agar + 5% rabbit blood Soto et al.  (2009a)
French and Caesar grunts modified Thayer-Martin agar Soto et al.  (2014a)
Malawi cichlids cysteine heart agar + 2% laked horse blood + ampicillin (50 μg/ml) Lewisch et al . (2014)
Chapter One 
 
29 
 
1.1.4.8 Treatment of piscine francisellosis 
In 1994, Chen et al. (1994) reported on the effectiveness of using oxytetracycline (OTC) 
to treat 75g Mozambique tilapia at a dose of 30mg/kg given for a period of 10-14 days 
when the fish were held at 30°C.  
In 2003, Mauel et al. (2003) also reported effectiveness of OTC in 10g Nile tilapia when 
it was mixed with the food at a dose of 4g/2.2kg and Ostland et al. (2006) had good 
results with OTC in hybrid striped bass, but with a dose of 3.8g per 0.5kg of food when 
feeding at 3% of the body weight for 10 days. 
Nylund et al. (2006) and Ottem et al. (2007a) were the first to report on the susceptibility 
of Francisella spp. against a variety of antibiotics in vitro with the strains showing 
resistance to erythromycin, sulfamethoxazole/trimethoprim, penicillin, ampicillin, 
cefuroxime erythromycin and susceptibility to ceftazidime tetracycline gentamicin 
ciprofloxacin and oxolonic acid.  
Bohle et al. (2009) reported the following minimum inhibitory concentrations (MIC) for 
Francisella spp. obtained from Atlantic salmon in Chile: florfenicol 1.0 µg/ml; 
flumequine 0.25 0 µg/ml; oxolonic acid 0.25 0 µg/ml; oxytetracycline 0.5 0 µg/ml; 
amoxicillin >64.00 µg/ml.   
Also using isolates collected from Chile, Muller et al. (2011) reported on the 
effectiveness of a commercial product Duplalim (quaternary ammonium and glutaric 
aldehydes) (Veterquimica, Santiago, Chile) used at a dilution of 1:50 for 5 min to 
disinfect facilities that had problems with francisellosis in salmon. 
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In 2010, Soto et al. (2010c) investigated the in vitro and in vivo efficacy of florfenicol to 
control francisellosis in tilapia, determining the MIC values for Fno with this antibiotic 
using the broth dilution method. They also examined the susceptibility of the bacterium 
to antibiotics in vitro in tilapia head kidney macrophages and the efficacy of using 
medicated-feed against experimental infections using immersion challenges. The results 
indicated that florfenicol administered during early stages of infection had the potential 
to treat the disease by penetrating the fish cells and clearing the bacteria. 
Soto et al. (2012b) examined the susceptibility of Fno to a variety of antibiotics in vitro 
and reported it to be susceptible to enrofloxacin, gentamycin, neomycin, oxytetracycline 
(0.25 µg/ml), tetracycline, florfenicol, streptomycin, novobiocin, amikacin, ciprofloxacin 
(0.5 1.0 µg/ml), imipenem, atifloxacin, meropenem, tobramycin, nitrofurantoin, oxolinic 
acid, and levofloxacin; and resistant to penicillin, amoxicillin, ampicillin, piperacillin, 
oxacillin, erythromycin, novobiocin, tylosin tartrate, clyndamycin, sulphathiazole, 
sulphadimethoxine, trimethropin/sulfamethoxazole, piperacillin/tazobactam constant 4, 
ticarcillin/clavulanic acid constant 2, ampicillin/sulbactam 2:1 ratio, aztreonam, 
ceftiofur, cefazolin, cefepime, cefotetan Na, ceftriaxone, ceftazidime, cefoxitin, 
cefuroxime and vancomycin. 
Shortly after Isachsen et al. (2012) analysed Fnn from cod and determined the following 
MIC values to these antibiotics: oxytetracycline 64μg/ml, trimethoprim/sulfadiazine 64-
128μg/ml, erythromycin 16μg/ml, ciprofloxacin 8μg/ml and streptomycin 32-128μg/ml, 
florfenicol0.5μg/ml oxolinic acid 0.25µg/ml, flumequine 0.25µg/ml and rifampin 0.25-
1.0µg/ml. 
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Soto et al. (2013a) subsequently determined the most efficacious concentration of 
florfenicol administered in feed to control experimentally induced infections of Fno in 
Nile tilapia. Their results indicated that doses of 15 and 20 mg/kg body weight per day 
for 10 days significantly reduced mortalities.  
Taking into account all the in vitro and in vivo studies performed so far, florfenicol and 
oxytetracycline seem to be the most appropriate antibiotics to fish in farms with piscine 
francisellosis as they have provided positive results in preliminary trials and are 
authorised antibiotics for use in food fish in Europe and the USA.  
1.1.4.9 Prevention (vaccine development) 
There are currently no commercial products to prevent piscine francisellosis. The first 
attempt to develop an autologous vaccine against piscine francisellosis were performed 
in Norway and the results were presented in 2007 (Krossøy et al., 2007). On that study 
different oil-adjuvants were tested to prepare whole cell inactivated vaccines with Fnn 
isolates from Cod and the possible side effects at different time points post vaccination 
were assessed.  
Two years later, also in Norway, Schrøder et al. (2009) performed a similar experiment 
to study the mechanisms of the adaptive immune response of cod, immunising the fish 
against Fnn, Vibrio anguillinarum and Aeromonas salmonicida and subsequently 
experimentally infecting the fish to assess the efficacy of the vaccine preparations.  In 
2011 results of the immune gene expression analysed by microarray technique in Cod 
immunised with these formulations were presented by Müller et al. (2011).  
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Soto et al. (2009b, 2011b) developed a live attenuated strain, with a deletion mutation at 
the intracellular growth locus C gene (iglC), which was shown to confer a relative 
percentage survival (RPS) of 87.5% in Nile tilapia after experimental infection by 
immersion. Later on, it was demonstrated that temperature and size at vaccination are 
important factors when implementing immunization prophylaxis in cultured tilapia under 
laboratory conditions (Soto et al., 2014) with this vaccine. 
More recently Brudal et al., (2014b) developed a vaccine based on “outer membrane 
vesicles” (OMVs), which contain similar structures to those found on Gram negative 
bacteria that contain virulence factors and which have been shown to protect zebrafish 
embryos against Fnn. The challenges with high doses of live pathogenic Fnn indicated 
that the vesicles have potential for further research in vaccine development against 
piscine francisellosis. 
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1.2 Aims of this study: 
- To diagnose outbreaks of piscine francisellosis and isolate new strains of fish 
pathogenic Francisella spp. from diseased Nile tilapia farmed in Europe. 
 
- To develop a methodology for the phenotypic and genetic analyses of fish 
pathogenic Francisella spp. strains and integrate a polyphasic approach for their 
characterisation. 
 
- To sequence the complete genome of the novel isolates using next generation 
sequencing technology. 
 
- To clarify the taxonomic status of the novel strains and other Francisella spp. 
from fish using genomic derived parameters and the polyphasic approach 
proposed. 
 
- To establish an in vivo challenge model via intraperitoneal injection in different 
species of tilapia with one of the novel isolates. 
 
- To investigate the in vivo susceptibility/resistance of difference genetic groups of 
tilapia to one of the novel isolates using the in vivo challenge model proposed. 
 
- To develop an autologous vaccine against piscine francisellosis with one of the 
novel isolates and assess its efficacy in red Nile tilapia.
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Chapter Two 
First isolation and characterisation of Francisella noatunensis orientalis from red 
Nile tilapia (Oreochromis niloticus L.) farmed in Europe.
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2.1 Introduction 
Francisella noatunensis (Fn), (genus Francisella family Francisellaceae) is a Gram 
negative, non-motile, non-sporulating, aerobic, coccobacillar, facultative intracellular 
bacterium and the causative agent of the emerging disease “piscine francisellosis”, 
reported to affect several farmed and wild (marine and fresh water) fish species 
worldwide. (Colquhoun et al., 2014) 
Currently Fn is divided into two subspecies: noatunensis (Fnn) and orientalis (Fno) 
(Euzeby, 2009a; Euzeby, 2009b; Ottem et al., 2009). Fnn is responsible for causing the 
disease in cold water fish species, mainly farmed and wild Atlantic Cod (Gadus morhua) 
(Birkbeck et al., 2011; Colquhoun and Duodu, 2011) and farmed Atlantic salmon (Salmo 
salar) in fresh and sea water (Birkbeck et al., 2007; Ottem et al., 2008).  
Fno is the causative agent of the disease in a range of warm, marine and freshwater fish 
including: guapote tigre (Parachromis managuensis), Hawaiian Chinese catfish, 
barramundi, three line grunt or Isaki fish (Parapristipoma trilineatum), hybrid striped 
bass (Morone chrysops x M. saxatilis), tilapia (Oreochromis spp.) and a number of 
ornamental species belonging to more than 18 different genera (Camus et al., 2013; 
Colquhoun and Duodu, 2011; Hsieh et al., 2007; Kamaishi et al., 2005; Lewisch et al., 
2014; Ostland et al., 2006; Soto et al., 2012a; Soto, et al., 2014a). 
In farmed fish, francisellosis occurs as an acute or chronic disease, with non-specific 
clinical signs such as erratic swimming, lethargy, frayed fins, pale or dark skin, 
exophthalmia, ascites, emaciation, pale or haemorrhagic gills, and haemorrhagic or white 
skin nodules, with levels of mortality ranging from 5% up to 95%.  Disease progression, 
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mortality rates and clinical signs presented, vary depending on the fish species, water 
temperature and rearing system (Colquhoun and Duodu, 2011). 
As facultative intracellular pathogens, Fno and Fnn are capable of avoiding the immune 
system of their hosts by entering macrophages and other phagocytic cells, to eventually 
form granulomas (white nodules), which are the most frequent finding at necropsy. These 
structures are regularly found in the splenic and renal (haematopoietic) tissues of diseased 
fish, but they can also be systemically distributed (Soto et al., 2011a).  F. noatunensis 
ssp. are highly fastidious pathogens that grow slowly (up to 5 days) and require the use 
of cell lines or artificial media enhanced with supplements and enrichments for their 
isolation from diseased fish. Moreover, they are able to enter into a viable but not 
culturable (VBNC) state (similar to the Gram positive bacterial spores) that allows them 
to persist in the environment and fish tissues causing clinical signs, without being isolated 
on culture media (Duodu and Colquhoun, 2010). Additionally the antagonism of 
secondary bacterial infections and the use of antibiotics to kill them, frequently 
contributes to complicate the recovery of Fn from the fish. At present there are no reports 
of Fn isolation from sources other than diseased fish i.e. from environmental samples or 
plants. 
Due to these difficulties, the isolation and characterisation of Francisella pathogens from 
fish has historically represented a challenge for researchers. Several non-cultured and 
therefore uncharacterised Francisella spp. and Francisella-like bacteria (FLB) have been 
reported based only on molecular diagnosis such as conventional polymerase chain 
reaction (PCR) (Jeffery and Stone, 2010; Krajangwong et al., 2011;Ostland et al., 2006; 
Ramírez-Paredes et al., 2012b).  
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In Europe the presence of Fnn affecting fish has been reported in cod and salmon  in: 
Norway (Mikalsen et al., 2007), Sweden (Ottem et al., 2008), United Kingdom (UK) 
(Zerihun et al., 2011), Denmark (Ottem et al., 2007a) and Ireland (Ruane et al., 2013), 
with reports of successful isolation in Denmark, Sweden, Norway, and Ireland, whereas 
Fno has been diagnosed in tilapia in the UK (Jeffery and Stone, 2010) and isolated from 
ornamental Malawi cichlids in Austria (Lewisch et al., 2014).   
Consistent with their fastidious nature, the Fn strains are biochemically unreactive, a 
condition that complicates the use of methodologies that rely on bacterial growth like 
standardised biochemical test kits, to assess their physiological response to different 
metabolites and environments (phenotypic characterisation). Recent reports document 
isolation of novel Fn strains, particularly Fno  using commercial Thayer-Martin agar and 
5% sheep blood or 2% bovine haemoglobin enriched cysteine heart agar (CHA) (Leal et 
al., 2014; Lewisch et al., 2014; Nguyen et al., 2014). However, these studies lack in-
depth methodology for the integrated characterisation of novel isolates and their 
descriptions are based only on a few primary phenotypic and genetic characteristics.  
The present study describes the diagnosis of francisellosis in farmed tilapia and the 
isolation of Fno strains using a novel selective (5%) tilapia blood enriched CHA and the 
development of a comprehensive methodology (based on a polyphasic approach) for the 
phenotypic and genetic characterisation of this highly fastidious bacterium. Additionally, 
an experimental infection model was established in Nile tilapia to fulfil Koch’s postulates 
and to investigate pathogenesis in this species. This study is thought to constitute the first 
documented report of isolation and characterisation of Fno from Nile tilapia in Europe. 
Chapter One 
 
38 
 
2.2 Materials and methods 
2.2.1 Presumptive diagnosis  
2.2.1.1 Diseased fish history 
During 2011 and early semester of 2012, chronic disease episodes with non-specific 
clinical signs and mortalities of up to 60% were experienced in farmed tilapia fingerlings 
at two different farms in Northern Europe.  
In July 2012, five individual fish from different sections of each farm (ten fish in total) 
were euthanized with a lethal overdose of Tricaine Pharmaq 1000mg/g (TPQ) anaesthetic 
(Pharmaq, Hampshire, UK) i.e. 3x the normal dose for anaesthesia (300mg/l) and 
sampled for diagnosis.  
The gills, heart, kidney, liver and spleen were fixed for at least 24h at 4 °C in 10% neutral 
buffered formalin for histologic analyses, 2.5% (v/v) glutaraldehyde in 100mM sodium 
cacodylate buffer (pH 7.2) for electron microscopy and 96% ethanol for molecular 
diagnosis.  
Views of the production systems in the farms and pictures of the sampled fish are shown 
in Figure 2.1.
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Figure 2.1 European tilapia farms with francisellosis outbreaks.  A and B Facilities and fish sampled at Farm 1; C and D Recirculating systems at 
the second farm. 
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2.2.1.2 Histopathological analyses 
Formalin fixed tissues were processed using standard histological methods, stained with 
haematoxylin and eosin (H&E) and examined under light microscopy. 
2.2.1.3 Transmission scanning and electron microscopy analyses  
The spleen and head kidney, previously fixed in 2.5% glutaraldehyde in 100mM sodium 
cacodylate buffer, were cut to obtain 2mm samples that were then post-fixed in 1% 
osmium tetroxide in cacodylate buffer and rinsed three times in distilled water 10 minutes 
each time to remove excess fixative. 
For TEM the tissues were dehydrated in a gradient cold acetone series (50–100%), 
embedded in Epon812, and cut into ultra-thin sections. The sections were observed under 
an FEI Tecnai Spirit G2 Bio Twin transmission electron microscope. For SEM the tissues 
were dehydrated in an ethanol series and critical point dried using a Bal-Tec 030 critical 
point drier. Samples were then attached to aluminium stubs, which were gold sputter 
coated using an Edwards S150B sputter coater, and visualised using a Jeol JSM6460LV 
scanning electron microscope.  
2.2.1.4 Molecular diagnosis using a genus specific PCR  
A PCR able to amplify a specific DNA sequence from bacteria belonging to the genus 
Francisella (Forsman et al., 1994) was performed using genomic DNA (gDNA) 
extracted from the fish tissues as a template. The gDNA was extracted from the ethanol 
fixed samples using a Nucleo Spin Tissue® kit (Macherey&Nagel, Düren, Germany), 
according to the manufacturer’s instructions.  
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A negative control was included using gDNA from tilapia reared at the Tropical 
Aquarium (TA) IoA UoS a source confirmed in this study to be free of francisellosis after 
sampling 25 fish for biological (culture in plates) and molecular (PCR) diagnosis.  
The PCR was performed using Illustra PuReTaq Ready-To-Go Beads™ (200 μM each 
dNTP in 10 mM Tris-HCl, pH 9.0, 50 mM KCl, and 1.5 mM MgCl2) (GE Healthcare, 
Chalfont St. Giles, UK) reconstituted to a final volume of 25 μl with: 5μl of DNA 
template (~80ng/μl), 2.5 μl of each primer (F11 5’-TAC CAG TTG GAA ACG ACT 
GT-3’ and F5 5’-CCT TTT TGA GTT TCG CTC C-3’) at a concentration of 10pmol/ml 
(10µM) and 15μl of ultrapure water. Cycling conditions consisted of an initial 
denaturation step of 2min at 93oC, followed by 35 cycles of: 1min at 94oC, 1min at 65oC 
and 1min at 72oC, and a final extension step of 5min at 72oC in a Biometra TGradient 
Thermocycler (Biometra, Göttingen, Germany). Amplification products were visualized 
on ethidium bromide stained 1% agarose gel after electrophoresis for 35 minutes at 90 
volts.  
2.2.2 Bacterial isolation and identification 
2.2.2.1 Primary isolation and purification  
After preliminary results involving PCR and electron microscopy indicated the presence 
of Francisella spp. in the diseased fish, a follow up visit to the farms took place in 
November 2012 with the aim of isolating the Francisella strains involved and other 
pathogens that could be associated with the outbreak. For this purpose, ten fish were 
randomly selected from each farm, euthanized with a lethal overdose of TPQ and 
sampled. During necropsy, spleens were aseptically collected and homogenised in 1ml 
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of 1X sterile phosphate buffered saline (PBS) using a Cordless Motor Pellet Pestle 
(Sigma-Aldrich, Dorset, UK).  
For primary isolation of the pathogens, 20μl loopfuls of the homogenates were streaked 
onto 5 different media: CHA (BD, Oxford, UK) with 2% bovine haemoglobin solution 
(BD, Oxford, UK) (CHAH); modified Martin Lewis agar (BD, Oxford, UK) (MMLA); 
modified Thayer-Martin Agar, (BD, Maryland, USA) (MTMA); trypticase soy agar 
(Oxoid Ltd., Hampshire, UK) (TSA) and cysteine heart agar with 5% tilapia blood 
(CHTB). The CHAH and CHTB were prepared with and without the following 
antibiotics: polymyxin B sulphate salt 100units/ml (Sigma-Aldrich, Dorset, UK) and 
ampicillin readymade solution 50μg/ml (Sigma-Aldrich, Dorset, UK). All plates were 
incubated at 28oC for 10 days. Dominant colonies consistent with Francisella 
morphology were sub-cultured up to two times on CHAH for purification using the 
culture conditions described. Basic phenotypic characteristics of bacteria from 
Francisella-like isolates of both farms were determined using primary identification tests 
such as: Gram stain, catalase, oxidase, oxidation/fermentation of glucose (O/F test) and 
motility. 
2.2.2.2 Molecular identification 
To confirm the identity of Francisella-like colonies, gDNA was released using the 
boiling technique as outlined by Seward et al. (1997) with modifications. Briefly, five 
colonies were re-suspended in a 1.5ml Eppendorf tube containing 100µl of Tris-EDTA 
(TE) buffer and heated for 10min at 99oC. The suspensions were then cooled on ice for 
5min and centrifuged at 15,800 gravities (g) in a benchtop IEC Microlite Centrifuge 
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(Thermo Electron Corporation, Massachusetts, USA) for 1min. The supernatant 
containing the crude extracted gDNA was then transferred into a fresh 0.5ml tube and 
stored at -20oC. This was subsequently used as a template in the PCR protocols described 
in Section 2.1.4. Once the identity of the isolates was established, bacteria were 
resuspended in liquid medium consisting of modified Mueller-Hinton II cation adjusted 
broth supplemented with 2% IsoVitaleX (BD, Oxford, UK) and 0.1% D-(+)-glucose 
ACS reagent (Sigma-Aldrich, Dorset, UK) (MMHB). The broth cultures were grown 
overnight at 28oC in a shaker incubator at 175rpm and stored frozen at -80oC with 20% 
sterilised glycerol (BDH Prolabo-VWR International Eurolab, Leuven, Belgium). 
2.2.3 Bacterial phenotypic characterisation 
2.2.3.1 Bacterial isolates and growth conditions 
Of the ten Fno isolates recovered in the present study, STIR-MATT-F1-f6 (from fish 6 
from the first farm) and STIR-GUS-F2f7 (recovered from fish 7 from the second farm) 
were selected as the representatives of each farm. The Fno type strain Ehime-1 was 
purchased from the German Culture Collection of Microorganisms and Cell Cultures 
“Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH” (DSMZ) 
collection in Braunschweig Germany, while isolate PQ1104 from tilapia farmed in Costa 
Rica was kindly provided by Dr. Duncan Colquhoun at the Norwegian Veterinary 
Institute (NVI) in Oslo Norway. A quality control bacterium Escherichia coli ATCC 
25922, was obtained from the Bacterial Culture Collection, Bacteriology Laboratory, 
Institute of Aquaculture (IoA), University of Stirling (UoS). The Fno isolates recovered 
and used in the present study are presented in Table 2.1.  
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Table 2.1 Francisella noatunensis orientalis isolates used and recovered in this study 
ISOLATE Location Year Diseased fish 
Ehime-1♣ 
 
Japan 
 
2001 
 
three line grunt or Isaki fish 
(Parapristipoma trilineatum) 
PQ1104 Costa Rica 2006 tilapia (Oreochromis sp.) 
STIR-AVU-F1f5 Europe farm 1 fish 5 2012* red Nile tilapia (O. niloticus) 
STIR-MATT-F1f6 Europe farm 1 fish 6 2012* red Nile tilapia (O. niloticus) 
STIR-AVU-F1f7 Europe farm 1 fish 7 2012* red Nile tilapia (O. niloticus) 
STIR-AVU-F1f9 Europe farm 1 fish 9 2012* red Nile tilapia (O. niloticus) 
STIR-AVU-F1f10 Europe farm 1 fish 10 2012* red Nile tilapia (O. niloticus) 
STIR-GUS-F2f7 Europe farm 2 fish 7 2012* red Nile tilapia (O. niloticus) 
STIR-AVU-F2f9 Europe farm 2 fish 9 2012* red Nile tilapia (O. niloticus) 
STIR-AVU-F2f10 Europe farm 2 fish 10 2012*  red Nile tilapia (O.s niloticus) 
* From present study; ♣ indicates the Fno type strain.      
 
For both the phenotypic and genetic characterisation the Fno isolates were grown on 
CHAH and MMHB, while the quality control bacterium was grown on TSA and 
trypticase soy broth (Oxoid Ltd., Hampshire, England) (TSB). Fno was cultured on solid 
media for 96h and the quality control for 24h.  The broth cultures were incubated in 15ml 
aliquots for 18 to 21h (i.e. mid log phase of the growth curve) in a shaker incubator at 
150rpm. All isolates were grown at 28oC (optimal in vitro temperature) in both agar and 
broth. 
2.3.3.2 Optimal growth temperature and growth curves in vitro 
The optimal in vitro growth temperature of each Fno isolate was investigated on agar by 
plating triplicates of six 20μl drops containing the same bacterial concentration (dilution 
10-6 with an optical density of 0.4 at 600 nanometres (nm) (OD600)) and incubating them 
at 5oC, 15oC, 18oC, 21oC, 22oC, 24oC, 26oC, 28oC, 29oC, 30oC, 32oC, 33oC and 37oC for 
10 days. 
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Growth curves for STIR-GUS-F2f7 and Ehime-1 were established by inoculating and 
incubating triplicate culture flasks containing 99ml of MMHB with 1ml of starting 
culture (OD600 1.0) for 72h at 28oC, on an orbital shaker incubator at 150rpm. To monitor 
the bacterial growth, a sample of 1ml was taken every 3h and the optical density recorded. 
The bacterial growth curve was produced by plotting the density OD600 against time (h). 
2.3.3.3 Carbohydrate fermentation and enzymatic activity  
The enzymatic activity and fermentation of carbohydrates of all Fno isolates and the 
quality control Escherichia coli ATCC 25922  were assessed in triplicate using API 20E 
and API ZYM kits (BioMerieux, Marcy l’Etoile, France). The kits were used as described 
by the manufacturer with the following modifications: the bacteria were grown in CHAH 
as described in Section 2.4.1.2, the API ZYM kit-strips were visually read at 4, 8 and 24h 
post inoculation and the API20E strips after 24h.  
2.3.3.4 Carbon metabolism (metabolic fingerprint)  
To assess the metabolic activity (carbon utilisation) of the novel Fno strains, the Biolog 
GN2 micro plates (Biolog Inc., California, USA) were used. These plates contain an array 
of 95 different carbon (C) sources i.e. carbohydrates, lipids, sugars, amino acids, nucleic 
acids and other metabolites. The C sources are coupled to a redox (tetrazolium) dye that 
is immediately reduced when metabolic activity starts, producing a change in colour that 
can be colourimetrically measured to develop a metabolic fingerprint.  
The GN2 Biolog micro plates were set up and analysed according to the following 
protocol: bacteria were grown, as described in Section 2.4.1. For each isolate three GN2 
Biolog micro plates were used and three 50ml centrifuge tubes containing 15ml of 
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MMHB were used. After incubation at 28 ⁰C for 18 to 21h the cultures were centrifuged 
in a Sigma 4K15C refrigerated benchtop centrifuge (Sigma Laborzentrifugen GmbH, 
Osterode am Harz, Germany) at 4oC for 15min at 2602g. 
The bacterial pellets were then washed by resuspending them in 20ml of 1X sterile PBS 
(a sterile disposable 5µl loop was required to break the pellets) and vortexing for 5min. 
The tubes were centrifuged as before and the PBS discarded. Each pellet was then 
suspended in 3ml of GN inoculating fluid (Biolog Inc., Hayward, California, USA) in 
one 50ml centrifuge tube. The OD600 of the suspension was adjusted to the desired 
bacterial concentration by adding GN inoculating fluid.  
The plates were inoculated with 150µl of the adjusted bacterial suspension per well, using 
a multichannel pipette and a sterile reservoir (Biolog Inc., California, USA). After 
inoculation, the Biolog GN2 micro plates were kept at 28oC for 24h and the colour change 
recorded every 6h by visual inspection, computer scanning with an Epson Perfection 
V370 Photo scanner (Epson, London, UK) and absorbency measurements at 450nm 
using a 96-well plate spectrophotometer (Biotek Instruments, Friedrichshall, Germany).  
In order to optimise the protocol and find the optimal inoculation density, a gradient of 
densities, was prepared for type strain Ehime-1 and STIR-GUS-F2f7. The optical 
densities tested were 0.36, 0.46, 0.56, 0.66, 0.76, 0.86, 0.96, 1.06 and 1.5 and 
subsequently the remaining Fno isolates were tested at an OD600 0.85. 
2.3.3.5 Chemotaxonomic analyses (cellular fatty acids methyl esters) 
The cellular fatty acid methyl esters (FAME) composition of Fno was analysed by gas 
chromatography (GC) in the Lipids Laboratory of the IoA, UoS.  
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The two novel Fno isolates and the type strain Ehime-1 were grown in MMHB as 
described in Section 2.4.1, using three 50ml centrifuge tubes containing 20ml of MMHB 
per isolate, and incubated for 43h; after incubation, the OD600 of the cultures was 
determined and the bacterial suspension centrifuged at 4oC for 15min at 2602g. The 
resulting bacterial pellets were then washed by suspending them in 5ml of sterile 1X PBS 
and vortexing them for 5min.  
The lipid content was extracted from the pellets by suspending them in 5ml of ice-cold 
chloroform/methanol (2:1 v/v) using a disposable glass Pasteur pipette according to 
Folch et al. (1957) and quantified gravimetrically. FAME from lipid were prepared by 
acid-catalysed trans-esterification at 50oC for 17h (Christie, 1993).  
FAME were extracted (not purified) as described previously (Tocher and Harvie, 1988) 
and separated and quantified by GC using a Fisons GC-8160 (Thermo Scientific, Milan, 
Italy) equipped with a 30m x 0.32mm x 0.25mm ZB-wax column (Phenomenex, 
Cheshire, UK) ‘on column’ injection and flame ionization detection. Hydrogen was used 
as carrier gas with an initial oven thermal gradient from 50oC to 150oC at 40oC min to a 
final temperature of 230oC at 2oC min. Individual FAME were identified by comparison 
to known standards (SupelcoTM 37-FAME mix; Sigma-Aldrich, Dorset, UK) and 
published data (Tocher and Harvie, 1988). Data were collected and processed using 
Chromcard for Windows version 1.19 (Thermoquest Italia SpA., Milan, Italy).  
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2.3.3.6 Antibacterial susceptibility tests 
a) Quantitative assay “broth microdilution method” 
The minimal inhibitory concentration (MIC) of 39 different antimicrobial compounds to 
Fno and the quality control E. coli ATCC25922 were investigated using GN2F and 
AVIAN1F Sensititre Plates (Trek Diagnostic System, West Sussex, UK). This procedure 
was performed in duplicate following the manufacturer’s instructions and previously 
published protocols for Fno and Francisella tularensis (Baker et al., 985; Brown et al., 
2004; García del Blanco, 2004; Soto et al. 2012b; Urich and Petersen, 2008).  
The media preparation, inoculation densities, incubation temperature, quality-control 
organism and interpretation of results were performed in compliance with the Clinical 
and Laboratory Standards Institute (CLSI) values (CLSI, 2006a).  
Briefly, the Fno isolates and E. coli ATCC 25922 were plated on CHAH agar and 
incubated as described in Section 2.4.1. Colonies were suspended in 1X sterile PBS to a 
McFarland standard 0.5. This suspension was diluted 100-fold (Fno) or 1000-fold (E.coli 
ATCC25922) in MMH and 50µl added with a multichannel pipette to each well of the 
sensititre plates. The plates were then incubated at 28oC and the bacterial growth visually 
checked at 48h (Fno isolates) or 24h (E. coli ATCC 25922) post inoculation. The MIC 
value was defined as the lowest concentration exhibiting no visible growth. The MIC 
assay for the quality control E. coli ATCC 25922 was determined utilizing MMHB at 
28oC following the CLSI protocol (CLSI, 2006a).  
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b) Qualitative assay disc diffusion (Kirby–Bauer) method 
The susceptibility or resistance of Fno isolates to 16 different antibiotics in agar plates 
was investigated following the protocol established by Soto et al. (Soto et al., 2012b). 
Briefly, Fno bacteria were harvested after incubation in CHAH for 72h at 28oC as 
described in Section 2.4.1, and suspended in 1X PBS to achieve a turbidity equivalent to 
McFarland standard 0.5. A fresh set of CHAH plates were inoculated with 100µl of the 
suspension using sterile disposable Drigalski spatulas. After 60min when the plates were 
dried, the antibiotic discs were dispensed using a self-tamping antimicrobial 
susceptibility disc dispenser (Oxoid Ltd., Hampshire, England). Plates were incubated at 
28oC for 96h and results recorded after 72h by measuring the diameter of the inhibition 
zones. The antibiotic discs were commercially obtained (Oxoid Ltd., Hampshire, 
England). 
2.2.4 Bacterial genetic characterisation 
2.2.4.1 Bacterial genomic DNA extraction 
The total bacterial gDNA from the representative isolate of the second European farm 
STIR-GUS-F2f7 was released by the boiling method as described in the Section 2.2.2. 
The purity and concentration of the crude DNA was assessed by 260/280 and 260/230 
ratios with a NanoDropTM ND1000 (ThermoScientific, Delaware, USA). 
2.2.4.2 Housekeeping genes (selection and sequencing) 
Twelve housekeeping genes were selected for amplification and sequencing: 16SrRNA, 
16SrRNA-23SrRNA intergenic spacer (ITS), 23SrRNA, malate dehydrogenase (mdh), 
chromosomal replication initiator protein alpha subunit (dnaA), DNA mismatch repair 
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protein (mutS), phospho-glucomutase (pgm), peptide chain release factor 2 beta subunit 
(prfB), bifunctional proline dehydrogenase⁄pyrroline-5-carboxylate dehydrogenase alpha 
subunit (putA), DNA-directed RNA polymerase alpha subunit (rpoA), DNA-directed 
RNA polymerase beta subunit (rpoB) and triose-phosphate isomerase alpha subunit 
(tpiA). The suitability of these genes for phylogenetic analysis has been previously 
reported for the genetic characterisation of novel Francisella spp. recovered from farmed 
aquatic organisms (Bohle et al., 2009; Brevik et al., 2011; Nylund et al., 2006; Ottem et 
al., 2009). 
To design the primers for amplification of the housekeeping genes, the complete genome 
sequence of Fno Toba04, GenBank® accession number NC_017909 (Sridhar et al., 
2012) and the software Primer3 (Untergasser et al. 2012) were used. The primers were 
in silico tested using the software developed by Bikandi et al. (2004) available at 
http://insilico.ehu.es/ and their attributes are presented in Table 2.2 
The PCR was performed using the ready to use 2x MyTaq™ HS Mix, (Bioline, London, 
UK), each reaction contained 25𝜇𝜇l of the mix, 1.0 𝜇𝜇l of both forward and reverse primers 
(20𝜇𝜇M), 200ng of the DNA template (~4𝜇𝜇l) and ultrapure water to a total volume of 50𝜇𝜇l. 
Cycling conditions consisted of an initial denaturation step of 1min at 95oC, followed by 
35 cycles of: 15s at 95oC, 15s at 66oC and 10s at 72oC performed in a Biometra TGradient 
Thermocycler (Biometra, Göttingen, Germany). 
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Table 2.2 Overview of the primers designed for amplification and sequencing of selected 
housekeeping genes from Fno STIR-GUS-F2f7 
 
Gene short name Primer Sequence  Position in Toba04 Tm °C GC-Content % Expected amplicon (bp)
dnaA dnaA-F1 AAAACCTTTCTACGTTTGAAT 56-76 50.1 28.6
dnaA dnaA-R1 GCAACTCATAATCATCAGAT 1471-1452 51.2 35 1415
mutS mutS-F1 TAGTTCAAAGAGTATATTTAG 703305-703325 54.0 38.1
mutS mutS-R1 TGACATTGAAAGGATAATTTCTC 704814-704792 57.3 50
mutS mutS-F2  GGCGTCTGATATACTCAGCT 704375-704394 53.5 30.4
mutS mutS-R2 AGAAGTTTCAAATCACACACC 705831-705811 48.1 23.8 2526
pgm pgm-F1 TGGCTATTCAGACTGTATCTAC 1084092-1084113 56.5 40.9
pgm pgm-R1 CAGTCATTCCTGTCAGAGAT 1085705-1085686 55.3 45 1613
prfB prfB-F1 TTGAATCTTTACGGGACTAT 141503-141522 56.5 40.9
prfB prfB-R1 AACTTATCTAAATCACCATCTA 142512-142491 57.1 39.1 1009
putA putA-F1 CTTATTGAACCATTCAGGTGAG 1737813-1737834 56.5 40.9
putA putA-R1 GCTTGGTAAGAAACATCTGTATG 1738970-1738948 57.1 39.1
putA putA-F2 AGAGCAAGGCTTAGCAGGTT 1738905-1738924 57.3 50
putA putA-R2 GAGTTTGTTCAGCAGGTTTA 1739995-1739976 53.2 40
putA putA-F3 GACTTCGCAGTGTTAGCAGA 1739407-1739426 57.3 50
putA putA-R3 GACCAAATTGTTCTCTACCAA 1740613-1740593 54.0 38.1
putA putA-F4 TGATTGTTGGTGCGATGAAAG 1740371-1740391 55.9 42.9
putA putA-R4 CGATAGTATCAACACTGACAG 1741828-1741808 55.9 42.9 4015
rpoA rpoA-F1 CAGGAATTTGTACCTAATATAC 220361-220382 52.8 31.8
rpoA rpoA-R1 TGAACACCTAGAGATAAGTTG 221274-221254 54.0 38.1 913
rpoB rpoB-F1 ATTCGCAAAGAGTTTGGGGT 616228-616247 55.3 45
rpoB rpoB-R1 GCTGAAACCATCTGCTTAGC 618194-618175 57.3 50
rpoB rpoB-F2 ATTCTTTACATCTGGTGCTT  617718 -617737 51.2 35
rpoB rpoB-R2 CTGGAGTACCATCTTCCATA 619519-619500 55.3 45
rpoB rpoB-F3 GGCGCGTAAAGATTTCGATG 619068-619087 57.3 50
rpoB rpoB-R3  TTCCTCAGATGAGTAGTCAA 620268-620249 53.2 40 4040
tpiA tpiA-F1 TGGGAAATTGGAAAATGAAT 553453-553472 49.1 30
tpiA tpiA-R1 CAATCAAGCCACCATCAAC 554127-554109 54.5 47.4 674
mdh   mdh-F1 ACTTTCTGCCATTTGAATAC 1769342-1769361 53.2 40
mdh   mdh-R1 GCTTATTGGTGCTGGTAATA 1770056-1770037 52.1 35 714
16srRNA+ITS+23srRNA 16-23s-F1 GTTTCCCTTTCCACTGCG 461307-461324 53.7 50
16srRNA+ITS+23srRNA 16-23s-R1 GTGTTAATCTGCGATAAG 462231-462214 53.7 50
16srRNA+ITS+23srRNA 16-23s-F2 CACTTCGCTCGCCACTACTA 462036- 462055 57.3 50
16srRNA+ITS+23srRNA 16-23s-R2 TGGTAGTCCACGCTGTAAAC 463338-463319 59.4 55
16srRNA+ITS+23srRNA 16-23s-F3 ACCAGGTAAGGTTCTTCG 463144-463161 49.1 38.9
16srRNA+ITS+23srRNA 16-23s-R3 AACGGTAACAGGTCTTCG 464059-464042 56.00 55.60 2752
The location of the primers is given in relation to  to the open reading frame (ORF) of the protein encoding and rRNA genes from the Fno reference 
 genomeToba04, NCBI accesion number  NC_017909.
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Amplification products were visualized on a 1% agarose gel stained with ethidium 
bromide after electrophoresis. The PCR products were purified for sequencing with the 
QIAquick PCR purification kit (QiaGen, Valencia, California USA) as directed by the 
manufacturer’s instructions and sent for Sanger sequencing to GATC Biotech (GATC 
Biotech, Cologne, Germany).  
The quality of the resulting sequences from both primers was visually checked against 
the ABI chromatogram using the The BioEdit® software version 7.1.11 (Hall 1999), 
assembled using the Multiple sequence comparison by Log-Expectation (MUSCLE) 
application of the MEGA (Molecular Evolutionary Genetic Analyses) package version 5 
(Tamura et al., 2011) and the overlapped region (consensus sequence) deposited in the 
GenBank database (Benson et al., 2013) of the National Centre for Biotechnology 
Information (NCBI) (http://www.ncbi.nlm.nih.gov/) with the accession numbers and 
lengths shown in Table 2.3. 
Table 2.3 The GenBank accession number and final length of the sequenced genes 
from Francisella noatunensis orientalis STIR-GUS-F2f7 
 
 
2.2.4.3 Sequence homology and phylogenetic analyses 
The nine sequences (16SrRNA, ITS and 23SrRNA genes were considered as a 
concatenated sequence) were individually compared for homology (as percentage of 
Gene accesion number Length (bp)
dnaA KP657905 1331
mutS KP657899 2429
prfB KP657900 991
putA KP657901 3929
rpoA KP657902 852
rpoB KP657903 3900
tpiA KP657904 651
mdh KP657898 696
16SrRNA+ITS+23SrRNA KP657897 2679
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similarity) with those stored in GenBank database using the nucleotide-nucleotide basic 
local alignment search tool BLASTN® (Zhang et al., 2000) program from NCBI.  
For every house keeping gene, the most similar sequences available from members of 
the genus Francisella were retrieved from GenBank and the BioEdit software version 
7.1.11 (Hall, 1999) was used to convert the sequences from .txt into .fas formats.  
The rRNA concatenated sequence was aligned as DNA and the coding sequences as 
codons with the Unweight Pair Group Method with Arithmetic Mean (UPGMA) using 
the MUSCLE application (Edgar, 2004) of the MEGA package version 6 (Tamura et al., 
2013).  All the sequences retrieved were indicated with their NCBI accession number.  
The alignments were manually adjusted by trimming excess sequences and their 
suitability for phylogenetic analyses double checked by computing the pairwise and the 
overall mean distances in MEGA 6 software (Tamura et al., 2013). The nine alignments 
were used to build phylogenetic trees and analyse the evolutionary relationship of Fno 
STIR-GUS-F2f7 with its closest members in the genus.  
Additionally, following the same procedure, the partial 16SrRNA gene (1425bp) of 
STIR-GUS-F2F7 was selected from the 16SrRNA-ITS-23SrRNA concatenated 
sequence  to build a phylogenetic tree with homologous sequences from 47 other 
members of the genus Francisella, including all the currently validly described species 
and subspecies, and the fish pathogens Edwardsiella piscicida C07-087 and 
Piscirickettsia salmonis AL10015 as outgroups. 
The ten evolutionary analyses were constructed in MEGA6 software (Tamura et al., 
2013) using the Maximum Likelihood (ML) (Nei and Kumar, 2000) approach with 
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complete deletion of gaps and missing data. The method chosen for every tree was the 
best combination of model and rates among sites, and this was investigated for each 
alignment using the default settings of the “find best DNA/protein model” option. The 
reliability of the trees (reproducibility) was tested using the bootstrap method with 2000 
replications. In all the analyses the nearest-neighbour-interchange was chosen as the ML 
heuristic method. 
2.2.5 Experimental infections 
To fulfil Koch’s postulates and further investigate the pathogenesis of Fno in Nile tilapia, 
an intraperitoneal (IP) injection challenge model was established with STIR-GUS-F2f7 
in Nile tilapia. During the trials, mortalities were monitored and recorded at least 4 times 
per day, and dead and moribund fish were sampled for bacterial recovery and 
histopathology.  
2.2.5.1 Standard curve for bacterial quantification of Fno STIR-GUS-F2f7 
A standard curve was produced to determine the number of bacteria present at different 
optical densities of a solution prepared in 1X PBS. The biomass or number of cells was 
expressed as colony forming units (CFU) and the turbidity of the suspension measured 
by OD600. The bacterium was grown in triplicate in broth as previously described in 
Section 2.2.3.1, and the pellets washed and adjusted to an initial OD600 of 1.0 with PBS. 
This solution was subsequently diluted to yield optical density values of 0.9, 0.8, 0.7, 0.6, 
0.5, 0.4, 0.3, 0.2, and 0.1. Each sample was then cultured on CHAH after preparing 10 
fold series of dilutions from 10-1 until 10-7 to perform drop counts using the method 
reported by Miles et al. (1938) to enumerate the number of viable bacterial cells at every 
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OD. The average number of cells per ml (CFU/ml) was plotted against the corresponding 
OD.  
2.2.5.2 Experimental fish origin 
Healthy red and wild type Nile tilapia fingerlings, 6-7 months/~11g (7-13g), were 
obtained from the Tropical Aquarium (TA) at the IoA UoS a source previously confirmed 
to be free of francisellosis as indicated in section 2.2.1.1. 
To perform the infections, the fish were moved into a flow-through system in the Aquatic 
Research Facility (ARF), IoA, UoS, for an acclimation period of ten days at 23 ± 2 oC to 
replicate the natural epidemiological conditions at which the disease occurs. A high 
stocking density and air bubbles were used to prevent the hierarchical aggression 
commonly presented in this species. During periods of acclimation and infection, fish 
were fed twice a day at a rate of 2% of their biomass. 
2.2.5.3 IP challenge model 
Sixteen fish were placed in a 2 litre plastic tank with a water volume adjusted to 1.8 litres. 
On the day of the challenge, the fish were anaesthetised with MS-222 (100mg/l) and IP 
injected with 0.1ml of a bacterial suspension at an OD600 of 0.4 (~1.0x109 CFU/ml).  
2.2.5.4 Ethics 
These experiments were performed in accordance with the UK Animal (Scientific 
Procedures) Act 1986 and complied with local institutional regulations. Due to the nature 
of the experiment and to comply with the British legislation no replicate nor control tanks 
were used. 
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2.3 Results 
2.3.1 Presumptive diagnosis 
2.3.1.1 Diseased fish examination  
During the follow up visit to the farms experiencing the outbreaks, the examined fish 
showed frayed fins, scale loss, pale skin, white gills and emaciation. At necropsy most 
of the organs were enlarged and either haemorrhagic or pale. In some fish, the anterior 
kidneys were hyperaemic, protruding and up to 3X enlarged, resembling a raspberry in 
appearance. Most of the fish presented white nodules in the spleen, posterior kidney and 
liver, and in some severe cases, these covered over 60% of the tissue surface. Figure 2.2. 
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Figure 2.2 Diseased red Nile tilapia (O. niloticus) examined at the farms. A Fish seven from the second farm “F2f7” (size of average sampled 
fish) sl indicates scale loss. B Enlarged and haemorrhagic head kidney (ek) and pale liver (pl). C Enlarged spleen with white nodules (wn), pale 
gills (pg), atrophic liver (al). D Enlarged head kidney with raspberry appearance (ek) and enlarged-haemorrhagic liver (hl). Scale bar=1.0 cm.
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2.3.1.2 Histopathological analyses 
Histological observations revealed the presence of extensively distributed granulomatous 
inflammation. The affected tissues showed necrotising vasculitis and infiltration of 
mononuclear cells and neutrophils. The granuloma content was dominated by 
hypertrophied macrophages, fibroblasts and leukocytes. Most granulomas exhibited 
necrotic cores. The most severely affected tissues were the spleen and the anterior kidney, 
with granuloma structures covering up to 60% of the parenchyma. Granuloma formation 
was also seen in heart, liver, gills (Figure 2.3). 
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Figure 2.3 Histopathological findings of diseased red Nile tilapia (O. niloticus) using H&E technique. A Heart; B Spleen; C Gill; D Head kidney; 
E Liver; F Posterior kidney. Letter g indicates the presence of granuloma and cg coalescence of granulomas. The micrographs were taken at 40X 
magnification. The arrows indicate the section amplified in the black upper squares which show pictures taken at 200X magnification. 
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2.3.1.3 Transmission scanning and electron microscopy analyses 
By TEM, it was possible to find pleomorphic coccobacillary bodies ranging in size from 
0.2-0.4µm (width) to 0.4-1.7µm (length) Figure 2.4. These structures could be observed 
inside the phagocytic cells, sometimes free in the cytoplasm and most frequently within 
vacuoles surrounded by an electron lucent membrane. 
For the SEM analyses the tissues were dry-fractured after being gold sputter coated to 
release the content of the granulomas. On the SEM micrographs the 3 dimensional 
structure of the bacteria resembled the shape of a corn grain and was visible in both 
samples from the spleen and head kidney Fig. 2.5. 
Additionally, the presence of vesicles with electron dense membranes detaching from the 
bacterial cells was detected in TEM. The size of these structures was 60-80nm width for 
90-100nm length Figure 2.6. Similar ultra-structures have been recently described by 
Brudal et al. ( 2014b) as “outer membrane vesicles” (OMVs) in Fnn grown in vitro and 
in vivo in zebrafish and in that study the structures contained virulence factors that played 
a key role in pathogenesis. More research is required to confirm if the structures here 
described in STIR-GUS-F2f7 are OMVs with similar functions to those presented in Fnn. 
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Figure 2.4 Transmission electron micrographs of diseased Nile tilapia head kidney. A to C Show extracellular localisation of pleomorphic 
Francisella-like structures. C Shows the replication of bacteria. In A to C Scale bars=200nm. D to F Intracellular localisation of Francisella-like 
cells. D Infected macrophage showing early signs of apoptosis, cytoplasmic condensation (asterisk), chromatin aggregation and marginalisation 
(white arrow), nucleus (N), black square (bacterial replicating within a phagosome), white square (bacteria surrounded by electron lucent space), 
black arrowhead (bacteria free in the cytoplasm). Scale bar=1µm. E intra-phagosomal replication of bacteria, black arrow phagosome membrane, 
white arrow (electron lucent space surrounding the bacteria), stars (vesicular and membranous bodies). Scale bar=500nm. F Bacterial cell free in 
the cytoplasm, black arrow (cell wall), star vesicular bodies. Scale bar=100nm. 
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Figure 2.5 Scanning electron micrographs of moribund Nile tilapia spleen and head kidney. A Enlarged spleen with several granuloma formations. 
Red square shows single granuloma presented at a higher magnification where the scale bar=50µm. B Content of the spleen after fracturing the 
tissue, several Francisella-like structures coloured in orange. C Enlarged head kidney with multiple granulomas. D Interior of the kidney tissue, 
pleomorphic Francisella-like cells coloured in green. 
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Figure 2.6 Transmission electron micrographs of OMV-like structures.  A to C Extracellular localisation of Francisella-like cells, white arrows 
indicate the OMV-like structures. A Bacterial membrane blebbing (arrowed). Scale bar=100nm. B Budding and secretion of vesicular membranous 
bodies (arrowed). Scale bar=200nm. C Bacterial cell next to a free floating vesicle (arrowed). Scale bar=200nm.
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2.3.1.4 Molecular diagnosis using a genus specific PCR 
For molecular diagnosis, the PCR used to amplify a genus Francisella specific sequence, 
yielded a product of approximately 1.2Kbp in five of the ten samples tested, confirming 
the presence of a Francisella sp. in the tissues of the diseased fish. The band intensity 
was high in lanes 4, 9 and 11, moderate in lane 5 and almost imperceptible in lane 7 
Figure 2.7. 
 
Figure 2.7 Molecular diagnosis of piscine francisellosis. PCR amplification of a genus 
Francisella specific sequence.  L 1Kb ladder; 1 negative control (water); 2-6 samples 
from Farm-1. 7-11 samples from Farm-2, blue square, a weak band from sample six.
2.3.2 Bacterial isolation and identification 
After molecular identification and purification, a total of 10 new Francisella sp. isolates 
(seven from the first farm and three from the second farm) were recovered and preserved 
(Table1). Of the different culture media tested to isolate the pathogen, the CHAH, 
CHATB and the commercial MTMA were successful for primary recovery of novel 
isolates. No noteworthy differences were observed between the CHATB plates with and 
without antibiotics, and no dominant or notable colonies were observed on TSA. The 
commercial MMLA failed to isolate any bacterium directly from fish tissues and 
although some growth was observed after plating pure Fn, this was not sufficient to be 
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considered an option for culturing these isolates. The results obtained with the spleen 
homogenates of the 9th fish 2nd farm (STIR-AVU-F2f9) are presented in Figure 2.8. 
The recipe to prepare 100ml of the new 5% tilapia blood enriched CHA without 
antibiotics is: 95ml of water, 5ml of tilapia blood and 5.1g of CHA. The blood can be 
heparinised and should be added after autoclaving the agar when it has cooled down to 
~52°C. 
 
Figure 2.8 Media used for the primary isolation of Francisella sp. from Nile tilapia. A 
Cysteine heart agar + bovine haemoglobin. B Modified Thayer Martin agar. C Cysteine 
heart agar tilapia blood. D Modified Martin Lewis agar. E Trypticase soy agar. In all the 
plates the colonies were convex, smooth and with a grey-greenish colour.
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2.3.3 Bacterial phenotypic characterisation 
2.3.3.1 Optimal growth temperature and growth curves in vitro 
The optimal culture temperature in vitro was 28.0-28.5 °C on agar plates for all Fno 
isolates tested, at this temperature the colonies appeared after 64h. No growth was 
observed at temperatures of 18°C or lower, nor at 33°C or higher. Visible colonies 
appeared after 120h at 22°C, 87h at 24°C and 69h at 26°C.  
Although growth started to appear after only 48h on plates incubated above 28°C, 
colonies on these plates were only visible after 72h at 29°C, 75h at 30 °C and 144h at 
32°C. The growth of the novel isolate STIR-GUS-F2f7 occurred a few hours faster than 
the type strain Ehime-1. 
Under the conditions described, the exponential phase of the growth curve started after 
15 hours, the mid log phase was between 18 to 23 hours and the stationary phase was 
reached after 30 hours.  
2.3.3.2 Carbohydrate fermentation and enzymatic activity 
Using the API20E kit, only the CIT (citrate), VP (Voges–Proskauer) and GEL 
(gelatinase) panels showed a positive reaction. This demonstrated the ability of the strains 
to utilise the citrate as a carbon source, produce acetoin from sodium pyruvate and 
hydrolyse gelatine. No differences were observed between the novel Fno isolates and the 
type strain Ehime-1. 
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The use of the APIZYM kit revealed an identical profile among the different Fno isolates 
where eight of the twenty enzymes were reactive. These enzymes are (in decreasing order 
of intensity): acid phosphatase, naphthol-AS-BI-phosphohydrolase, esterase lipase (C8), 
alkaline phosphatase, esterase (C4), Lipase (C14), α-chymotrypsin, and β-galactosidase. 
2.3.3.3 Carbon metabolism (metabolic fingerprint)  
According to the inoculum gradient, an OD600 of 0.86 was optimal to test the Fno isolates 
in the Biolog GN2 micro plates. With this density several false negatives appeared now 
as positives and the plates developed a full profile after only six hours post inoculation 
with the control well remaining clearly as negative. The use of higher densities led to the 
appearance of colour in the control well making the interpretation of these results 
unreliable or biased. For this reason although D-cellobiose (A12), mono-methyl- 
succinate (C12), α-keto glutaric acid (E4), D,L-lactic acid (E6), succinic acid (E12), 
bromo succinic acid (F1), glycyl-Lglutamic acid (F12), L-ornithine (G4) and Thymidine 
(H4) appeared to be positive using OD600 of 0.96 and 1.06 they were recorded as negative. 
The digitalised images of the scanned STIR-GUS-F2f7 Biolog GN2 plates at an OD600 
0.86 and 0.96 are presented in Figure 2.9.  
The results of the spectrophotometer did correlate in most of the plates with the colour 
change in the wells. The numeric value of the control well was subtracted from the rest 
of the wells to normalise the results and a control reading was taken immediately after 
inoculating. These figures were useful to support the findings when they were correlated 
with the visual inspection of the plates but they are not shown in this study since a high 
OD was presented in some wells in with no colour change i.e. well A10.
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Figure 2.9 Phenotypic fingerprint of Fno STIR-GUS-F2f7. A Photograph of the plates 
with an OD600 0.86. Well A1 is negative, green plus symbol (+) indicate positive wells 
where colour has changed. B Photograph of the plate with an OD600 0.96. Blue squares 
indicate ambiguous results when control well A1 appears to be positive.  
 
  
  
      
    
  
  
Chapter One 
 
69 
 
The phenotypic fingerprints of all the isolates tested in this study at an OD600 of 0.86 are 
presented in Table 2.4. No differences were observed between the metabolic fingerprints 
of the isolates recovered from tilapia in the present study and the type strain Ehime-1. 
The isolate PQ1104 from Costa Rica had an almost identical profile to the other Fno 
isolates with only in 1 difference of the 95 carbon sources tested (i.e. acetic acid).  
Table 2.4 Metabolic fingerprint of the different Fno isolates at an OD600 of 0.86 
Well 1 2 3 4
A1 Water - - - -
A3 Dextrin + + + +
A8 N-Acetyl-Dglucosamine + + + +
B2 D-Fructose + + + +
B6 α-D-Glucose + + + +
B12 D-Mannose + + + +
C11 Methyl Pyruvate + + + +
D1 Acetic Acid + + - +
E3 α-Keto Butyric Acid + + + +
F4 L-Alaninamide + + + +
F6 L-Alanine + + + +
F7 L-Alanylglycine + + + +
F8 L-Asparagine + + + +
F10 L-Glutamic Acid + + + +
G6 L-Proline + + + +
G9 L-Serine + + + +
G10 L-Threonine + + + +
H2 Inosine + + + +
H3 Uridine + + + +
H9 Glycerol + + + +
H10 D,L-α-Glycerol Phosphate + + + +
H11 Glucose-1-Phosphate + + + +
H12 Glucose-6-Phosphate + + + +
4, STIR-MATT-F1f6. 
CARBON SOURCE TEST Fno  0.86
Isolates: 1, Ehime-1; 2, STIR-GUS-F2f7; 3 PQ1104;
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2.3.3.4 Chemotaxonomic analyses (cellular fatty acids methyl esters) 
The FAME profiles were similar for all the Fno isolates tested and no differences in the 
order of the major components among the isolates were observed. The predominant fatty 
acids for the novel strain STIR-GUS-F2f7 were: 24:1 (20.3%), 18:1n-9 (16.9%), 24:0 
(13.1%) 14:0 (10.9%), 22:0 (7.8%), 16:0 (7.6%) and 18:0 (5.5).  An overview of the 
relative composition of the Fno strains here analysed is presented in Table 2.5 
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Table 2.5 Relative fatty acid composition (%) of Fno STIR-GUS-F2f7 and the other Fno 
isolates after 43h incubation in Modified Muller Hinton broth   
Fatty acid
14:0 10.96 ± 0.03 10.92 ± 0.30 9.72 ± 0.52
Iso 15:0 0.03 ± 0.03 0.06 ± 0.04 0.13 ± 0.03
15:0 0.27 ± 0.05 0.35 ± 0.05 0.37 ± 0.02
16:0 7 ± 0.18 8 ± 0.51 8 ± 0.12
17:0 0.45 ± 0.01 0.52 ± 0.04 0.54 ± 0.03
18:0 6.03 ± 0.09 5.50 ± 0.20 5.26 ± 0.12
19:0 0.17 ± 0.01 0.19 ± 0.01 0.25 ± 0.01
20:0 4.01 ± 0.10 3.61 ± 0.27 3.50 ± 0.07
16:0 3-OH 0.37 ± 0.05 0.52 ± 0.01 0.49 ± 0.02
21:0 0.09 ± 0.00 0.10 ± 0.01 0.15 ± 0.01
17:0 3-OH 0.18 ± 0.03 0.22 ± 0.09 0.39 ± 0.00
22:0 8 ± 0.09 8 ± 0.35 8 ± 0.06
18:0 3-OH 1.95 ± 0.22 2.67 ± 0.16 2.58 ± 0.16
23:0 0.42 ± 0.01 0.50 ± 0.04 0.63 ± 0.05
24:0 13 ± 1.38 13 ± 1.13 12 ± 0.09
25:0 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
26:0 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Total saturated 53.61 ± 1.61 53.67 ± 1.22 51.39 ± 0.51
16:1n-9 0.29 ± 0.09 0.21 ± 0 0.24 ± 0.03
16:1n-7 0.54 ± 0.08 0.72 ± 0.18 0.66 ± 0.12
17:1 0.54 ± 0.02 0.78 ± 0.14 0.79 ± 0.05
18:1n-9 18 ± 0.28 17 ± 0.09 17 ± 0.31
18:1n-7 0.10 ± 0.06 0.12 ± 0.07 0.18 ± 0.01
19:1 0.17 ± 0.01 0.23 ± 0.02 0.24 ± 0.02
20:1 1.68 ± 0.03 1.63 ± 0.11 1.42 ± 0.03
21:1 0.01 ± 0.01 0.02 ± 0.02 0.00 ± 0.00
22:1n-11 3.55 ± 0.19 4.40 ± 0.83 3.93 ± 0.39
23:1 0.75 ± 0.02 0.98 ± 0.10 1.23 ± 0.07
24:1 21.0 ± 1.15 20 ± 0.82 23 ± 0.91
Total monounsaturated 46.32 ± 1.61 46.25 ± 1.21 48.46 ± 0.52
18:2n-6 0.07 ± 0.0 0.08 ± 0.01 0.29 ± 0.01
Total n-6 PUFA 0.07 ± 0 0.08 ± 0.01 0.29 ± 0.01
TOTAL 100 ± 0 100 ± 0 100 ± 0
STIR-MATT-F1f6 STIR-GUS-F2f7 EHIME-1 Fno  avergae 
8
11
0
0
8
1
6
0
4
0
0
0
0
2
1
13
0
0
53
0
1
1
17
0
0
0
100
2
0
4
1
21
47
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2.3.3.5 Antibacterial susceptibility tests 
a) Broth microdilution method  
There were no differences between the MIC of the antimicrobial compounds to STIR-
GUS-F2f7 and the other Fno isolates, including type strain Ehime-1, and these results 
were consistent among replicates performed for all the strains. From the values obtained 
for the quality control, 37 of 39 fell within the range given by the CLSI (CLSI, 2006a) 
validating the use of the broth for this test and appropriateness of the assay. The 
antimicrobial MIC values obtained with the GN2F and AVIAN1F Sensititre Plates are 
presented in Table 2.6 including the range of variability observed. 
b) Disc diffusion method  
The inhibition zones observed on CHAH were clear, consistent and repeatable for all 
isolates. No substantial differences were found when comparing STIR-GUS-F2-f7 with 
the other Fno isolates. The largest zones of inhibition were found with enrofloxacin 
(5µg), kanamycin (30µg), and gentamicin (2µg); the results obtained using the Kirby–
Bauer method are summarised in Table 2.7. 
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Table 2.6 Minimal inhibitory concentration (MIC) of the Francisella noatunensis orientalis isolates and the quality  
control Escherichia coli ATTC 25922 by the broth micro-dilution method to 39 antimicrobial compounds 
Antimicrobial tested (concentration) Fno
1 2 1 2 1 2 1 2 range present results CLSI range
Enrofloxacin (2–0.12 mµ/ml) <0.12 <0.12 0.25 <0.12 <0.12 <0.12 <0.12 <0.12 <0.12 <0.12 0.008-0.03
Gentamycin (8–0.5 mµ/ml) <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 0.5 0.25-1
Ceftiofur (4–0.25 mµ/ml)  >4 4  >4 2  >4 4  >4 4 2 to >4 0.5 0.25-1
Neomycin (32–2 mµ/ml) <2 <2 <2 <2 <2 <2 <2 <2 <2 8 0.5-2
Erythromycin (4–0.25 mµ/ml) >4 >4 >4 >4 >4 >4 >4 >4 >4 >4 N/A
Oxytetracycline (8–0.5 mµ/ml) 4 0.5 4 <0.25 1 0.5 2 0.5  <0.25 to 4 2 0.5-2
Tetracycline (8–0.25 mµ/ml) 4 0.5 4 0.25 2 1 2 0.5 0.25 to 4 8 0.5-2
Amoxicillin (16–0.25 mµ/ml) >16 >16 >16 >16 2 2 16 2 2 to >16 4 4.0-16.0
Spectinomycin (64–8 mµ/ml) 32 <8 16 <8 32 16 32 <8 <8 to 32 >64 8.0-64.0
Sulphadimethoxine (256–32 mµ/ml) >256 128 256 <128 256 256 >256 128 128 to >256 >256 8.0-64.0
Trimethoprim/sulfamethoxazole (2/38–0.5/9.5 mµ/ml) >2/38 >2/38 >2/38 >2/38 >2/38 >2/38 >2/38 >2/38 >2/38 <0.5/9.5 <0.5/9.5
Florfenicol (8–0.25 mµ/ml) 4 <1 4 <1 2 <1 2 <1  <1 to 4 8 4.0-16.0 2-8
Sulphathiazole (256–32 mµ/ml) >256 64 256 64 >256 64 256 64 64 to >256 >256 N/A
Penicillin (8–0.06 mµ/ml)  >8  >8 >8 4 >8 4 >8 4 4 to >8 >8 N/A
Streptomycin (1024–8 mµ/ml)  <8  <8  <8  <8  <8  <8  <8  <8  <8 16 4.0-16.0
Novobiocin (4–0.5 mµ/ml) 2 1 2 <0.5 2 1 1 <0.5 <0.5–2 >4 N/A
Tylosin tartrate (20–2.5 mµ/ml) >20 20 >20 20 >20 20 >20 20 20 to >20 >20 >32
Clyndamycin (4–0.5 mµ/ml) >4 >4 >4 >4 >4 >4 >4 >4 >4 >4 N/A
Amikacin (64–8 mµ/ml) <8 <8 <8 <8 <8 <8 <8 <8  <8 16 0.5-4.0
Ampicillin (32–4 mµ/ml)  >32  <4  >32  <4  >32  <4 16 <4 <4 to >32 <4 2.0-16.0 2-8
Ampicillin/sulbactam 2:1 ratio (4/2–32/16 mµ/ml)  32/16 < 4/2  >32/16 < 4/2  >32/16 < 4/2  >32/16 < 4/2 <4/2 to >32/16 <4/2 2/1-8/4
Aztreonam (32–8 mµ/ml) >32 32 >32 16 >32 32 >32 16 16 to >32 <8 0.06-0.25
Cefazolin (32–4 mµ/ml)  >32 32  >32 32 >32 32  >32 32 32 to >32  <4 1.0-4.0
Cefepime (32–4 mµ/ml)  >32 <4  >32 <4 >32 <4  >32 <4  <4 to >32  <4 0.015-0.12
Cefotetan Na (32–8 mµ/ml)  >32 >32  >32 >32 >32 >32  >32 >32 >32 <8 0.12-1
Ceftriaxone (64–1 mµ/ml) >64 <1 >64 <1 >64 4 >64 <1  <1 to >64 <1 0.03-0.12
Ceftazidime (32–1 mµ/ml)  >32 <1  >32 <1 >32 <1  >32 <1  <1 to >32 <1 0.06-0.5
Cefuroxime (32–4 mµ/ml)  >32 32  >32 32 >32 32  >32 32 32 to >32 8 2.0-8.0
Ciprofloxacin (4–0.5 mµ/ml) <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 0.004-0.015
Gatifloxacin (8–1 mµ/ml) <1  <1 <1 <1 <1 <1 <1  <1 <1 <1 0.008-0.03
Meropenem (8–1 mµ/ml) >8 4 >8 2 8 4 >8 2 2 to >8 <1 0.008-0.06
Imipenem (16–2 mµ/ml) >16 8 >16 16 >16 16 >16 <2 <2 to >16 <2 0.06-0.25
Nitrofurantoin (128–16 mµ/ml) <16  <16 <16  <16 <16  <16 <16  <16 <16 <16 4.0-16.0
Cefoxitin (32–4 mµ/ml)  >32 >32  >32  >32  >32 >32  >32  >32  >32 8 2.0-8.0
Piperacillin (128–16 mµ/ml) >128  <16 >128  <16 >128  >128 >128  <16  <16 to >128 <16 1.0-4.0
Piperacillin/tazobactam constant 4 (128/4–16/4 mµ/ml) >128 /4 <16/4 >128 /4 <16/4 >128 /4 <16/4 >128 /4 <16/4 <16/4 to >128/4 <16/4 1/4-4/4
Ticarcillin/clavulanic acid constant 2 (64/2–16/2 mµ/ml)  >64/2 <16/2  >64/2 <16/2  >64/2 <16/2  >64/2 <16/2 <16/2 to >64/2 <16/2 4/2-16/2
Tobramycin (8–4 mµ/ml) <4 <4 <4 <4 <4 <4 <4 <4 <4 <4 0.25-1
Cefpodoxime (16–2 mµ/ml) >16 <2 >16 <2 >16 <2 >16 <2 <2 to >16 <2 0.25-1
PQ1104 STIR-GUS-F2f7 Ehime-1 STIR-MATT-F1f6 E. coli ATCC 25922
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Table 2.7 Antimicrobial susceptibility test by the disc-diffusion (Kirby–Bauer) method for STIR-GUS-F2f7 and other Fno isolates in CHAH 
after 72h incubation, the mean zone diameters (mm) and standard deviation are presented. 
Antimicrobial  (concentration) STIR-GUS-F2f7 Ehime-1 STIR-MATT-F1f6 PQ1104
Enrofloxacin (5µg/disk) 42 ± 3.46 40.5 ± 1 42.5 ± 1.91 43.5 ± 3.42
Kanamycin (30µg/disk) 35.3 ± 4.16 34.5 ± 4.12 38 ± 1.63 42.5 ± 1.91
Gentamicin (2µg/disk) 32 ± 2 29 ± 3.83 32.5 ± 1.91 33 ± 5.03
Tetracycline (30µg/disk) 22 ± 2 20 ± 2 23 ± 1.41 20 ± 2
Oxytetracycline (30µg/disk) 29.5 ± 4.43 26 ± 4.9 28.5 ± 1.91 27.5 ±  1.91
Florfenicol (30µg/disk) 22.8 ± 1.1 25.3 ± 1.15 24.8 ± 5.4 24.8 ± 2.28
Oxolinic acid (2µg/disk) 20.5 ± 4.73 18.5 ± 3.79 18.5 ± 4.12 21.5 ± 1.91
Streptomycin (10µg/disk) 27.5 ± 1.91 23 ± 1.41 22 ± 2 23 ± 1.41
Penicillin G (10units ) 0 0 0 0
Lincomycin (15µg/disk) 0 0 0 0
Oleandomycin  (15µg/disk) 0 0 0 0
Amoxycillin (10µg/disk) 0 0 0 0
Carbenicillin (100µg/disk) 0 0 0 0
Polymyxin B (300 units) 0 0 0 0
Ampicillin (10 µg/disk) 0 0 0 0
Sulphamethoxazole/ trimethoprim 19:1 (25µg/disk) 0 0 0 0
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2.3.4 Bacterial genetic characterisation 
2.3.4.1 Bacterial genomic DNA extraction 
According to the NanoDropTM data, the crude gDNA from STIR-GUS-F2f7 had an initial 
concentration of 622ng/µl and values of 2.1 and 1.8 for the 260/280 and 260/230 ratios 
respectively. The initial concentration of the DNA was adjusted to 50ng/µl prior to its 
use in the PCRs. 
2.3.4.2 Housekeeping genes (selection and sequencing) 
Of the 18 pairs of primers tested for amplification of the 12 housekeeping genes, 17 
yielded the product size expected Figure 2.10. The primers for the gene pgm did not 
amplify the expected product in the PCR and this gene was therefore not sequenced nor 
further analysed. 
 
Fig. 2.10 PCR amplification of Fno STIR-GUS-F2f7 housekeeping genes. L’s 1Kb 
ladders. 1 dnaA. 2 mutS-1.  3 mutS-2. 4 prfB. 5 putA-1. 6 putA-2. 7 putA-3. 8 putA-4. 9 
rpoA. 10 rpoB-1. 11 rpoB-2. 12 rpoB-3. 13 tpiA. 14 mdh. 15 16SrRNA-ITS-23SrRNA-
1. 16 16SrRNA-ITS-23SrRNA-2. 17 16SrRNA-ITS-23SrRNA-3.
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2.3.4.3 Sequences homology  
The nine STIR-GUS-F2F7 gene sequences shared an identity of 99-100% with those 
from other Fno strains. After Fno, the closet genetically related sequences were those 
belonging to members of Fnn and Fp, followed by sequences from the 4 Ft subspecies, 
F. halioticida and F. guangzhouensis. The similarity in percentage (%) between the 
sequences from STIR-GUS-F2f7 and the sequences from these taxa is presented in Table 
2.8. 
Table 2.8 Range of gene sequence similarity in percentage (%) between Fno STIR-GUS-
F2f7 and the validly described members of the genus Francisella 
 
2.3.4.5 Phylogenetic analyses 
The 16SrRNA tree (Fig. 2.11) was constructed with several sequences from all the 
validly described Francisella species and subspecies; this tree illustrates the evolutionary 
history and current taxonomy of the genus while. The trees generated with the nine 
housekeeping genes (Fig. 2.12) depict the evolutionary relation of STIR-GUS-F2f7 with 
its closest genetically related taxa: Fnn and Fp.  
Gene sequences Fno Fnn Fp Ft ssp.* Fhal Fg
dnaA 99-100 99 94-95 85-86 84 n/a
mutS 100 93-94 92-93 76-77 75 n/a
prfB 99-100 94 93-95 84-86 81 n/a
putA 99 96 96-97 80-81 75 n/a
rpoA 99 99 92-93 83-84 83 77
rpoB 99 91 92 86 84 87
tpiA 99-100 98 94-96 78-80 79 n/a
mdh 100 98-99 96 84-86 85 84
16SrRNA+ITS+23SrRNA 99-100 98-99 99 97 98 94-95
* Includes data from isolates of the four F. tularensis subspecies 
n/a: not sequences were available in the GeneBank database
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In both figures (2.11 and 2.12) the NCBI accession numbers are indicted next to the 
sequences retrieved. The final number of nucleotides in the STIR-GUS-F2f7 sequences 
were 16SrRNA 1339, dnaA 1299, mdh 576, mutS 2327, prfB 882, putA 2340, rpoA 496, 
rpoB 3042, tpiA 507 and 16SrRNA-ITS-23SrRNA 2679 after trimming and manually 
adjusting them. 
The optimal models determined for the phylogenetic analyses were Kimura 2-parameter 
(K2) (Kimura, 1980) for 16SrRNA tree; Tamura 3-parameter (T92) (Tamura, 1992) for 
dnA, mdh rpoA and tpiA; Tamura-Nei (TN93) (Tamura and Nei, 1993) model for mutS 
and rpoB; and Hasegawa-Kishino-Yano (HKY) (Hasegawa et al.,1985) for prfB, putA 
and the concatenated 16SrRNA-ITS-23SrRNA. A summary of the specific model used, 
rates among sites, number of positions on the final datasets and number of sequences 
used on each phylogenetic tree are presented in Table 2.9.  
Table 2.9 Evolutionary models used on the phylogenetic analyses 
 
In all the phylogenetic trees, the novel isolate STIR-GUS-F2f7 was seen to group within 
the Fno clade and the evolutionary divergence between the two Fn subspecies seemed as 
distant as, or even bigger than, that between them and the F. philomiragia species (Fp). 
Gene-sequence Model Rates among sites positions sequences
16SrRNA K2 Discrete gamma distribution 1350 50
dnaA T92 Discrete gamma distribution 1298 12
mdh T92 Uniform rates 576 12
mutS TN93 Discrete gamma distribution 2326 13
prfB HKY Discrete gamma distribution 880 12
putA HKY Discrete gamma distribution 2333 12
rpoA T92 Discrete gamma distribution 464 17
rpoB TN93 Discrete gamma distribution 3042 13
tpiA T92 Discrete gamma distribution 507 15
16SrRNA+ITS+23SrRNA HKY Uniform rates 2676 9
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In 8 of the 11 trees a subclading was observed within the Fn taxon, this subdivision 
clustered the sequences of isolates recovered in the northern hemisphere mainly from 
diseased cod in Norway and separated them from those isolated from diseased salmon in 
Chile. This branching was well supported with bootstrap values ranging from 70% in the 
16SrRNA tree to 97% in the mdh, putA and rpoB trees. 
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Figure 2.11 Molecular phylogenetic analysis of the genus Francisella based on 50 partial 
16SrRNA sequences. The evolutionary history was inferred using the Maximum Likelihood 
method based on the Kimura 2-parameter model (Kimura, 1980). The tree with the highest log 
likelihood (-4004.5670) is shown. The percentage of trees in which the associated taxa clustered 
together is shown next to the branches. Initial tree(s) for the heuristic search were obtained by 
applying the Neighbour-Joining method to a matrix of pairwise distances estimated using the 
Maximum Composite Likelihood (MCL) approach. 
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         Figure 2.11 Molecular phylogenetic analysis of the genus Francisella based on 50 partial 16SrRNA sequences (continued).  
        View of the subtree clustering pathogenic isolates from fish and molluscs. 
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Figure 2.12 Maximum Likelihood trees for all the housekeeping gene sequences. The evolutionary history was inferred using the Maximum 
Likelihood method based on the model and rate differences among sites specified for each gene on Table 2.9. The tree with the highest log 
likelihood is shown. The percentage of trees in which the associated taxa clustered together is shown next to the branches. Initial tree(s) for the 
heuristic search were obtained by applying the Neighbour-Joining method to a matrix of pairwise distances estimated using the Maximum 
Composite Likelihood (MCL) approach. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. All 
positions containing gaps and missing data were eliminated. 
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Figure 2.12 Maximum Likelihood trees for all the housekeeping gene sequences (continued). 
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2.3.5 Experimental infections 
Koch’s postulates were successfully fulfilled in both the red and the wild type Nile tilapia 
as the infections resulted in the death of fingerlings with widespread multifocal white 
nodules/granuloma formations and pure cultures of Francisella sp. (confirmed by colony 
morphology and conventional PCR) were recovered from the moribund fish Figure 2.13. 
The standard curve indicated that ~1.1x109 CFU were presented in 1ml of 1X PBS with 
an OD600 of 0.4 (r2=0.98). In both Nile tilapia groups the clinical signs observed were 
consistent with those presented at the farms. 
 
Figure 2.13 Fulfilment of Koch’s postulates in naïve Nile tilapia (wild type).  A Naïve 
tilapia fingerlings. B to C Reproduction of clinical signs and gross lesions (mortalities). 
C to D Isolation of pure colonies from the spleen of experimentally infected fish. 
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2.4 Discussion 
During the last ten years the application of molecular techniques has facilitated the 
identification of Francisella spp. causing severe mortalities in farmed fish. 
Unfortunately, despite the use of enriched selective media and established protocols, the 
causative agent has not always been isolated and little or almost no existing information 
is available regarding the phenotypic properties of this pathogens.  
In the present study, the anamnesis, gross pathology and histopathological findings at the 
farms were similar to previous reports of chronic francisellosis in tropical aquaculture 
(Colquhoun and Duodu, 2011; Leal et al., 2014; Soto et al., 2013b). This clearly 
warranted inclusion of this disease as a differential diagnosis, which subsequently led to 
isolation and comprehensive characterisation of the pathogen. 
The electron microscopy observations of heavily infected fish tissues allowed the 
visualisation of extracellular pleomorphic bacteria as well as cytoplasmic bounded 
bacterial like cells within macrophages. Interestingly, ultra-structures consistent with 
those recently described by Brudal et al. (2014b) as “outer membrane vesicles” (OMVs) 
in Fnn grown in vitro and in vivo in zebrafish embryos were also observed. While that 
study and previous work in other members of the genus Francisella (Burke and Nano, 
1991; Golovliov et al., 2003; Pierson et al., 2011) strongly suggest that OMVs may also 
be presented in Fno, further research is required to confirm this. If the vacuoles observed 
in STIR-GUS-F2f7 are OMVs that contain virulence factors that play a key role during 
the pathogenesis of the bacterium, these could have a potential application in the 
development of vaccines against francisellosis in tilapia (Brudal et al., 2014b).  
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Although the conventional PCR developed by Forsman et al. (1994) has the advantages 
of being cost effective, and was easy and rapid to perform, its specificity and sensitivity 
are limited. In the present study 4 of 10 fish yielded a positive result and the intensity in 
one of these bands was almost undetectable. This was thought to be due to the fact that 
some of the fish tested were older and the PCR could have failed to detect the small 
amounts of bacterial DNA that are normally presented in adults or carrier fish. 
If economic and technical resources at the farm level are limited, the conventional PCR 
still remains a good option for diagnosis but preferably younger or smaller fish should be 
tested. However if detection of carrier or asymptomatic fish is necessary (especially prior 
to the international movement of fish or the introduction of new stocks) a more sensitive 
assay e.g. a quantitative real time PCR such as that recently proposed by Duodu et al. 
(2012) should be considered.  
The primary isolation of the bacterium was successful in 10 of the 20 fish sampled and 7 
isolates were obtained from the first farm. It is believed that this may be due to the higher 
number of brood stock sampled in the second farm, where 50% (n=5) of the fish were 
not fingerlings. These results correlate with the findings at necropsy and histopathology, 
where the most severely affected fish were from the on growing facilities.   
Of the culture medium tested, MMLA was included as an alternative to the MTMA which 
is not readily available in Europe. The difference in their composition is minimal, only 
in the components added to inhibit Gram positive bacteria and yeasts: in MMLA the 
concentration of vancomycin was increased slightly from 3.0 to 4.0µg/ml and nystatin 
(1250 units) was substituted for anisomycin (2.0mg/plate). Despite being almost 
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identical, the MMLA failed to support the growth from fish tissues and pure cultures, and 
is therefore not considered to be an option to isolate or culture Fno.  
On the other hand, the medium containing cysteine heart agar and tilapia blood with and 
without antibiotics proved successful for isolating and growing the bacterium, and even 
preliminary results of antimicrobial sensitivity tests with the disc diffusion method (data 
not presented) were successful using this agar.  
The use of tilapia blood in agars to culture fish pathogens has been previously reported 
and discussed by Pasnik et al. (2005). In addition the use of CHTB for francisellosis 
could be useful for the production of vaccines in countries where the use of bovine by-
products is banned from veterinary vaccine development due to the bovine spongiform 
encephalopathy disease or where the accessibility to these products is limited. 
The growth characteristics of the bacterium on CHAH and MMHB were the same for all 
Fno isolates including the type strain Ehime-1, with growth from 21-33°C and an optimal 
in vitro growth temperature of 28°C-28.5°C. These results differ to reports by Ottem et 
al. (2009) and Mikalsen and Colquhoun (2009) where growth at 18°C was reported and 
22°C was indicated as the optimal in vitro growth temperature for the TS Ehime-1. 
The API ZYM profiles were identical between all Fno isolates, and these results were 
similar to those previously reported for Fno by Ottem et al. (2009) and Mikalsen and 
Colquhoun (2009). These kits have the disadvantage that they are not designed for the 
characterisation of intracellular bacteria, but instead for the identification of less 
fastidious pathogens. Consequently, although some information can be obtained from 
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them, the interpretation of the results should be used with caution and is clearly limited 
for differentiation between species or subspecies of Fn. 
In contrast to the API tests, the Biolog GN2 micro plates do not depend upon bacterial 
growth for reaction because their chemistry is based on the reduction of tetrazolium, as 
a response to the metabolism of the carbon source rather than to metabolic by-products.  
There are no reports of the use of the Biolog GN2 micro plates to characterise Fno 
isolates, but these plates have been used for the automated identification of several 
Francisella tularensis strains (Elkins et al., 2010; Gyuranecz et al., 2010a; Gyuranecz et 
al., 2010b; Kreizinger et al., 2013; Urich and Petersen, 2008; Versage et al., 2003; Whipp 
et al., 2003) using either the OmniLog™ System or Biolog MicroStation® plate readers 
and the GN database provided by the manufacturer. This database can separate Fp from 
Ft strains, but cannot differentiate the Ft subspecies. 
Gyuranecz et al., (2010a) used the Biolog GN2 micro plates to characterise several 
Francisella tularensis strains but instead of using the automated system, the plates were 
manually read at 4h and 24h post inoculation. When they compared the results with the 
information provided in the GN2 database an important number of discrepancies were 
found and the authors were then able to consistently differentiate between subspecies of 
Francisella tularensis.  
These plates have been also manually read, for characterisation and description of F. 
hispaniensis, and one strain of F. philomiragia and one of Fnn were also included (Huber 
et al., 2010). 
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The biggest advantage of the Biolog systems is that there are alternate uses for them to 
satisfy a broad range of needs e.g. characterising slow growing fastidious pathogens, and 
experimenting with different cell densities, incubation times and reading system, which  
may be appropriate in particular cases (Shea et al., 2012). 
Considering that premise and the special features of Fno (small size and fastidious 
nature) a gradient of bacterial densities was used in this study to identify the optimal 
inoculum density and prevent false negatives caused by the use of low bacterial 
concentrations. Additionally the plates were incubated at 28⁰C, the optimal in vitro 
growth temperature of the pathogen. Similar to the procedure performed by Gyuranecz 
et al. (2010a), the plates were also manually read at different time points but in contrats 
to their results, in the present study 6h was shown to be the earliest time to achieve a fully 
developed profile. 
The gradient of densities revealed a number of positive reactions which would otherwise 
have been reported as negative using the inoculant concentrations recommended by the 
manufacturer. Conversely when higher densities than the optimal were used, an apparent 
positive reaction was presented in 9 carbon sources.: D-cellobiose (A12), mono-methyl- 
succinate (C12), α-keto glutaric acid (E4), D,L-lactic acid (E6), succinic acid (E12), 
bromo succinic acid (F1), glycyl-Lglutamic acid (F12), L-ornithine (G4) and Thymidine 
(H4). 
Due to the saturation of the control well, these results were considered ambiguous and 
not included as a part of the final metabolic fingerprint. However further research must 
be performed to rule out whether Fno cells have the capability or not to metabolise those 
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sources. In spite of the high number of false negative results unveiled and the small 
number of ambiguous results, the Biolog GN2 plates still remain the most useful 
(practical and powerful) tool for phenotypical characterisation of Fno.  
Given the results obtained in this study, it is proposed to standardise the use of the Biolog 
GN2 micro plates as a useful tool for the characterisation of fastidious Francisella spp. 
isolates by determining the optimal inoculum density for every type strain and incubating 
the plates at the optimal in vitro growth temperature, especially for comparative studies 
between different species and subspecies.  
As with the Biolog GN2 micro plates, there are no previous reports of FAME profiling 
reported for any Fno isolate. The results obtained in this study for STIR-GUS-F2f7 and 
the other Fno isolates are consistent with the FAME signature of the genus Francisella 
(Jantzen et al., 1979; Nichols and Mayberry, 1985).   
On comparison of the FAME profiles obtained for Fno in this study and those available 
for the closest members of the genus F. philomiragia and Fnn (Huber et al., 2010; Ottem 
et al., 2006; Ottem et al., 2007b) the most dissimilar groups are Fno and Fp with 8 fatty 
acids having at least 3% of difference between them. Unexpectedly more differences 
were found between Fno and Fnn than between Fno and Fp.   
The most divergent fatty acids between the Fno here reported and those available for Fnn 
in (Ottem et al., 2007a; Ottem et al., 20007b) are: 24:1, 20-23% for Fno vs 1% for Fnn; 
18:1n-9, 17-18% for Fno vs 10-12% for Fnn; 24:0, 12-13% for Fno vs 5-6% for Fnn; 
16:0, 7-8% for Fno vs 4% for Fnn; while only two differences over 3% were seen 
between Fnn and F philomiragia: 22:0 5-6% vs 2% and 18:0 3-5% vs 1%. 
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The differences between the Fno strains studied here and those presented by Ottem et al. 
(2007a and 2007b), for F. philomiragia are: 24:1, 20-23% vs 0%; 24:0, 12-13% vs 2%; 
22:0 8% vs 2%; 22:1n-11 4% vs 9%; 18:1n-9 17-18% vs 11%; 18:0 5-6% vs 1%; 16:0 
7-8% vs 4% and 20:0, 4% vs 1%; 
Based on these comparisons, it is possible that FAME can be used as phenotypic marker 
for Fno, Fnn and Fp if special attention is paid to the fatty acids 24:1, 24:0, 18:1n-9, 
16:0, 22:0 and 18:0 as they could be useful to group and separate isolates even at the 
subspecies level. 
As the FAME profile of Fnn is more similar to Fp  than to Fno and Fno is completely 
different to Fp, further phenotypic studies using other techniques like metabolic profiles, 
polar lipids, antimicrobial susceptibility etc. should be performed with more Fn and Fp 
strains to investigate whether these dissimilarities are stable among these groups.   
Regarding the antimicrobial susceptibility studies, due to the recent emergence of the 
disease, there are currently no standards or methodologies established to test Fn strains. 
In order to standardise and compare the present results with other reports, the 
methodology of the analyses performed in the current study, was based on those recently 
presented by Soto et al. (2012b), and for these reason the commercial AVIAN and GN2F 
micro plates were chosen for the broth micro-dilution assay together with the disc 
diffusion method. 
The broth micro-dilution results indicated that the addition of the supplements in the 
broth did not interfere with the results of the quality control as 37 out of the 39 results 
were found in the rank established by the CLSI (CLSI, 2006a). These results are in 
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accordance with those presented by Soto et al. (2012b), but inconsistent with Baker et al. 
(1985) for whom the use of IsoVitaleX affected their results. 
All the isolates tested in the present study had a similar profile in the broth microdilution 
method, and after comparing the range of results of these strains with the range of those 
obtained by Soto et al. (2012c), minor discrepancies were found in 17 of the 39 
antimicrobials. Such inconsistencies may have been caused by the differences in the 
number of bacterial cells inoculated into the plates. In order to prevent this, it is suggested 
here that the inoculum densities should be standardised at a specific OD600 rather than a 
McFarland standard.   
Based merely on the MIC results, it appears that the isolates may be susceptible to 
neomycin, novobiocin, amikacin, ciprofloxacin, imipenem, gatifloxacin, meropenem, 
tobramycin, nitrofurantoin, and levofloxacin. 
According to Soto et al. (2012b) although the composition of the CHAH influences the 
disc diffusion assay enough to prevent it from being in compliance with the CLSI (CLSI, 
2006b), this technique still provides useful information for the classification of bacteria 
tested on it if clear and consistent diameters of inhibition are presented.  
In this study 8 of the 16 antimicrobials tested developed clear and repeatable zones of 
inhibition and these were similar among the Fno strains. From these, enrofloxacin, 
gentamicin, tetracycline and florfenicol were also used by Soto et al. (2012b) with almost 
identical results. This is the first time that a Francisella ssp. isolated from fish has been 
tested with kanamycin. 
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Although there are currently no established diameters to classify Fno as resistant, 
intermediate or sensitive, it can be suggested from the large inhibition zones that the 
isolates tested in this study are susceptible to enrofloxacin, kanamycin, gentamicin, 
tetracycline, oxytetracycline, florfenicol, oxolinic acid and streptomycin. This is also 
supported by the fact that the 6 compounds of this list that were tested by the broth 
microdilution method had very low MIC values. Though oxolinic acid was not tested in 
the micro plates, previous results for Fnn (Bohle et al., 2009; Ottem et al., 2007; Isachsen 
et al., 2012) and Fno (Soto et al., 2012b) support the present findings.  
From the combination of both methods, the broth micro-dilution and the disc diffusion, 
it can be established that the isolates tested here are resistant to penicillin G, lincomycin, 
oleandomycin, amoxicillin, carbenicillin, polymyxin B, ampicillin and 
sulphamethoxazole/ trimethoprim. 
From the compounds that inhibited the Fno isolates, florfenicol and oxytetracycline 
seemed to be the most adequate to treat the outbreaks as these two are authorised 
antibiotics for use in fish in most state members of the European Union and previous 
reports have documented their kinetics in live fish treating FLB and Fn infections (Chern 
and Chao 1993; Mauel et al., 2003; Ostland et al., 2006; Soto et al., 2010c; Soto et al., 
2013a).    
The genetic analyses indicated that the identity of the novel isolate STIR-GUS-F2f7 was 
100% similar to that of other isolates belonging to the subspecies Fno. This was also 
supported by the phylogenetic trees generated with the house keeping genes that grouped 
all of them together. Surprisingly, when the closest members of the genus Fp and Fnn 
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were included in the trees, the clade of Fno appeared to be distant enough from the clade 
that groups Fnn to be considered a separate species, indicating a possible taxonomic 
misplacement of the Fno group. 
This could explain the results observed when comparing the FAME and Biolog GN2 
profiles with those available in the literature for Fnn and Fp (Huber et al., 2010; Ottem 
et al., 2006; Ottem et al., 2007b). The possible taxonomic misplacement of the taxon Fno 
has also been suggested by other authors (Soto et al., 2009a; Ottem, 2011). However to 
clarify this, further research based on a suitable polyphasic approach with several 
members of Fno, Fnn and Fp simultaneously analysed would be required.  
The establishment of the experimental infection models mimicking conditions presented 
at the farms allowed fulfilment of the third and fourth Koch’s postulates, showing that 
isolate STIR-GUS-F2f7 was able to cause the disease in naïve Nile tilapia and its re-
isolation in pure culture from the experimentally infected fish confirmed that this 
bacterium was the causative agent of the disease outbreaks. What is more, the challenge 
model established here could be further used to investigate the pathogenesis of this 
bacterium in different genetic groups of tilapia and to develop strategies for its control 
and prevention.  
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2.5 Conclusion 
In the present study, the diagnosis of francisellosis in tilapia was confirmed by different 
methods and several isolates of Fno including STIR-GUS-F2f7 were recovered from the 
diseased fish. To achieve a successful primary isolation of the Fno pathogen, the kidney 
of diseased or moribund fish should be aseptically collected and homogenised in 0.5ml 
of 1X PBS. The homogenate should be streaked with sterile loops in CHAH or CHATB 
and the plates should be incubated at 28-29 °C for 3 days. Electron microscopy 
observations indicated that Fno, like other members of the genus Francisella, may 
secrete OMVs. A suitable methodology for the characterisation of the isolates collected 
here and other Fno is presented. This approach is proposed for further taxonomic studies 
of the genus Francisella as the results of its use provided insight into several phenotypical 
characteristics of Fno including antimicrobial susceptibility, and suggested a possible 
taxonomic misplacement of the taxon Fno. Finally, experimental infections with Fno 
STIR-GUS-F2f7 were successfully established in naïve tilapia, confirming it as the 
causative agent of the disease outbreaks and opening a research avenue to investigate the 
pathogenesis of the bacterium in this group of fish. 
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Chapter Three 
Complete genome sequence of Francisella noatunensis orientalis STIR-GUS-F2f7 a 
highly virulent strain isolated from diseased red Nile tilapia farmed in Europe. 
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3.1 Introduction  
A highly virulent strain of Francisella noatunensis orientalis “STIR-GUS-F2f7” was 
isolated from the spleen of a moribund red Nile tilapia farmed in Europe (Chapter 2). In 
this communication the complete genome sequencing of this bacterium is reported.  
Francisella noatunensis orientalis (Fno) is a Gram negative, non-motile, non-
sporulating, aerobic, fastidious, pleomorphic coccobacillus (size 0.2-1.7 µm) bacterium 
associated with disease of fish farmed in tropical aquatic environments.  
This pathogen is the causative agent of the disease piscine francisellosis recently 
described in several fresh and sea water fish species causing a significant negative 
economic impact in the aquaculture industry for which there are currently no 
commercially available products for the treatment or prophylaxis (Colquhoun and 
Duodu, 2011).  
In November 2012, STIR-GUS-F2f7, a highly virulent strain of Fno, was recovered from 
farmed red Nile tilapia using a novel 5% tilapia blood enriched cysteine heart agar after 
homogenising the spleen of the fish in sterile 1X phosphate-buffered saline (PBS) 
(Chapter 2). The diseased fish (~10 grams/5.5cm) had been reared in a recirculating 
system with fresh water at 25°C and the mortalities were around 60% during the 
outbreak. During experimental infections in vivo, only as few as 12CFU per fish were 
required to cause mortality in red and wild type Nile tilapia fingerlings maintained at 
23°C ± 2°C. The optimal in vitro temperature for culturing this isolate was 28-29°C in 
both, agar plates and supplemented modified Mueller-Hinton II cation adjusted broth. 
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3.2 Materials and methods 
3.2.1 Genome sequencing and assembling 
The genomic DNA (gDNA) of STIR-GUS-F2f7 was extracted as delineated in section 
2.2.3.2 The purity, integrity and concentration of the crude DNA was assessed by 
electrophoresis in 1% agarose gel stained with ethidium bromide at 0.001%, 260/280 and 
260/230 indices determined with a NanoDropTM ND1000 (ThermoScientific, Delaware, 
USA) and Qubit® 2.0 fluorometer (Invitrogen, Life Technologies, California, USA).  
Thereafter, three aliquots with 2µg of DNA were sent for high-throughput sequencing to 
the NGI Uppsala (SNP&SEQ Technology Platform) Science for Life Laboratory, at 
Uppsala University in Uppsala Sweden, where the Fno STIR-GUS-Ff7 genome was 
sequenced using Illumina® HiSeq2500™ platform (Illumina, California, USA). 
The parallel, paired-end sequence assembler ABySS (Assembly By Short Sequences) 
version 1.3.4 (Simpson et al., 2009) was used to de novo assemble a total of 10 sequence 
reads, all of them which had a length longer than 100bp. 
3.2.3 Genome annotation  
The genome of Fno STIR-GUS-F2f7 consists of 1,887,347 base pairs distributed in 10 
contigs assembled in one single circular chromosome with no plasmids and a G+C 
content of 32.4% as visualised with the DNA browser Artemis version 16.0.0 (Carver et 
al., 2012) and the software DNAPlotter (Carver et al., 2009) (Figure 3.1). 
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3.3 Results 
3.3.1 Genome annotation  
The RNAmmer programme (Lagesen et al., 2007) predicted 19 copies of rRNA genes: 
seven of 5S and six of 16S and 23S. The annotation of the genome was performed using 
the RAST server (Overbeek et al., 2014) which predicted a total of 1970 protein coding 
sequences and 63 non coding rRNA sequences in 328 subsystems. (Figure 3.2.) 
Of the protein coding genes, 510 (25.8%) were annotated as hypothetical proteins. From 
the 1460 non-hypothetical genes, 239 were predicted as being involved in protein 
metabolism, 199 in synthesis of amino acids and derivatives, 122 in carbohydrate 
catabolism, 116 in cofactors, vitamins, prosthetic groups, or pigment production, 100 in 
RNA metabolism, 95 in fatty acid, lipid, and isoprenoid synthesis, 82 in DNA 
metabolism, 79 in respiration, 74 in capsule and cell wall synthesis, 71 in stress response, 
59 in nucleoside and nucleotide synthesis, 54 in membrane transport, 32 in virulence, 
disease and defence mechanisms, 24 in cell division and cell cycle, 17 in potassium 
metabolism, 16 in regulation and cell signalling, 11 in phosphorus metabolism, 10 in iron 
acquisition and metabolism, 10 in  sulphur metabolism, 6 in  the metabolism of aromatic 
compounds, 5 in secondary metabolism, 5 in  nitrogen metabolism, 1 in dormancy and 
34 as miscellaneous proteins.  
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Figure 3.1 Circular map of the genome of Francisella noatunensis orientalis strain 
STIR-GUS-F2f7. The outer scale is marked in base pairs. From outer to inner: First circle 
(black) all the nucleotides. Second circle (light blue) coding sequences (CDS) in forward 
strand. Third circle (light blue) CDS in reverse strand. The innermost circles show: GC 
skew (orange/blue) and G+C content (purple and green).
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Figure 3.2 Annotation of Fno STIR-GUS-F2f7 genome using RAST server. The graph shows the subsystem features distribution (number of 
genes in brackets) by categories. 
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3.3.2 Nucleotide accession number  
This genome sequence has been deposited at DDBJ/EMBL/GenBank databases under 
the accession number: XXX-XXX-XXX 
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3.4 Discussion and conclusions  
Currently there are only two fully sequenced genomes of this taxon readily available in 
public databases, TOBA04 (Sridhar et al., 2012) and LADL-07-285A (Soto et al., 
2009a), however neither of those strains have been characterised and no reports are 
available of the isolation or characterisation of the first strain. 
 This genome sequence is important because STIR-GUS-F2f7 has been comprehensively 
characterised and several of its metabolic and chemotaxonomic properties have been 
described in Chapter 2. Thus, accessibility to this sequence will allow further 
investigation on the genes involved on metabolic and evolutionary pathways and 
comparative analyses with other Francisella spp. including the closely related human 
pathogens F. tularensis and F. philomiragia.  
Additionally the availability of this genome will favour the identification of mechanisms 
of pathogenicity towards the development of vaccines against piscine francisellosis in 
both tropical and cold water fish species and we anticipate it will contribute to the 
clarification of the intricate taxonomy of the genus Francisella particularly those isolates 
recovered from diseased fish. 
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Chapter Four 
Elevation of Francisella noatunensis subsp. orientalis (Ottem et al., 2009) to the rank 
of species as Francisella orientalis comb. nov., sp. nov., and description of 
Francisella noatunensis subsp. chilense subsp. nov. 
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4.1 Introduction 
Members of the genus Francisella family Francisellaceae, order Thiotrichales, class 
Gammaprotobacteria, phylum Proteobacteria are Gram negative, non-motile, non-
sporulating, aerobic, pleomorphic coccobacillar prokaryotic cells (size 0.2-1.7 µm), that 
are widely distributed in nature with a well-established association with aquatic 
environments (Colquhoun et al., 2014). 
Following the rules established in “The International Code of Nomenclature of 
Prokaryotes” (Lapage et al., 1992) there are currently six validly described species and 
six subspecies described within the genus Francisella: F. tularensis (Ft) with its four 
subspecies, tularensis (Ftt), holarctica (Fth), mediasiatica (Ftm) and novicida (Ftn); F. 
philomiragia (Fp); F. hispaniensis (Fh); F. noatunensis (Fn) with two: subspecies 
noatunensis (Fnn) and orientalis (Fno); F. halioticida (Fhal) and F. guangzhouensis (Fg). 
With the exception of F. guangzhouensis the rest of the species have been described as 
facultative endosymbionts of eukaryotic cells with the ability to cause severe diseases in 
their hosts (Colquhoun et al., 2014). 
Francisella noatunensis is one of the most recently recognised species of the genus and 
is the causative agent of piscine francisellosis, an emerging disease reported worldwide 
affecting several farmed or captured fish species (Birkbeck et al., 2011; Colquhoun and 
Duodu, 2011).  
Since first described, as with other Francisellaceae members, the nomenclature of Fn 
has been under constant rearrangement. Initially in July 2007, a comparative 
characterisation of a single Francisella sp. strain recovered from farmed Norwegian 
Atlantic cod (Gadus morhua) was made with the type strain of F philomiragia, in that 
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study the cod isolate was classified as a novel species named F. piscicida (Ottem et al., 
2007).  
A few months later in September 2007, after the name F. piscicida had been published 
but not yet validated, Mikalsen et al. (2007) compared seven cod isolates against four 
strains of Fp (including the type strain) and validly published a new nomenclature of the 
bacterium i.e. F. philomiragia subsp. noatunensis.  
In January 2008, F. piscicida was published as a valid species (Euzeby, 2008) and 
because of the similarity of its 16S rRNA gene the bacterium was considered to be a 
heterotypic synonym of F. philomiragia subsp. noatunensis thus, according to the rule 
of priority, the epithet “noatunensis” remained over “piscicida”.  
Later the same year, the current taxonomical status of fish Francisella was revised. In 
that study, the type strains of F. piscicida and its heterotypic synonym F. philomiragia 
noatunensis were compared against each other and five isolates of Fp including the type 
strain. Additionally, one strain from a diseased fish farmed in warm water environment 
in Japan called Ehime-1 and DNA from one strain recovered in Indonesia 
(Ind04/Toba04) were included (Ottem et al., 2009). 
As a result of those comparisons F. piscicida was shown to be the heterotypic synonym 
of F. philomiragia subsp. noatunensis and both were elevated to the rank of species as 
F. noatunensis, while the strain Ehime-1 was described as the type strain of the new 
subspecies F. noatunensis orientalis on the basis of a few phenotypic traits (Euzeby, 
2009a; Euzeby, 2009b; Ottem et al., 2009). 
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Since the validation of F. noatunensis, no further studies have been perfomed to 
investigate the phenotypic characteristics of this bacteria. Recently, a novel strain of Fno 
STIR-GUS-F2f7 was recovered from moribund red Nile tilapia farmed in Europe, and a 
new methodology for the characterisation of Fno strains was proposed (Chapter 2),   
This approach proved to be successful as it provided insight into the phenotypic 
variability of the isolates analysed, and the results obtained demonstrated a high degree 
of phenotypic and genetic association within the strains belonging to the subspecies Fno, 
however it also suggested the possible misplacement of this taxon within the species F. 
noatunensis and highlighted the need for standardised descriptions of species and 
subspecies within the genus Francisella. 
The present study characterise and revise the taxonomical status of more than 30 strains 
of the species Francisella noatunensis. The isolates analysed were recovered at different 
laboratories from several diseased fish species over a period of 15 years. In addition the 
type strain of Fp, the closest related member of the genus, was included in all the 
comparisons. The characterisation of the strains was performed using the methodology 
previously proposed in Chapter 2, which comprises basic phenotyping, metabolic 
fingerprinting, and chemotaxonomic analyses in combination with DNA-DNA 
hybridization comparisons and analyses of geographical, ecological and high quality 
genomic data.  
Chapter Four 
 
109 
 
4.2 Materials and methods 
4.2.1 Bacterial strains 
A total of 33 strains, recovered from diseased fish (16 Fno and 16 Fnn) of different 
geographical origin and the type strain of Fp, were phenotypically characterised. The 
genetic characterisation was based on DNA-DNA hybridisation of the type strains and 
several genome sequence derived parameters.  
In this project the whole genome (WG) of nine F. noatunensis subsp. orientalis (Fno) 
and one F. noatunensis subsp. noatunensis (Fnn) strains was sequenced as per the method 
described in Section 3.2. In total 13 Fno, 7 Fnn and 6 F. philomiragia (Fp) WG sequences 
were included; additionally the WG sequences of each of the type strains of other validly 
described members of the genus Francisella were included. At the time of this study no 
genome sequences of F. halioticida were available in public databases. The metadata of 
the 47 strains that were phenotypically and/or genetically characterised are presented in 
Table 4.1. The accession number of the new genomes and those publicly available are 
presented in the section “Bioproject” of such table. 
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Table 4.1 Strains of Francisella spp. analysed in this study. 
Species and subspecies Designation Genome Bioproject PRESENT ID NVI FOI DSM CCUG BCCM/LMG OTHER Country Location Year
F. noatunensis orientalis Ehime-1T     PRJNA73447 Fo1 5887 FSC 771 21254T - LMG 24544T - Japan Ehime prefecture 2001 Three-line grunt (Isaki) Parapristipoma trilineatum
F. noatunensis orientalis F. Victoria n/a Fo2 - FDC 191 - - - - Unknown Unknown Unknown Nile tilapia Oreochromis niloticus
F. noatunensis orientalis RUSVM-LA1 n/a Fo3 - FDC 192 - - - - Unknown Latin America 2012 Nile tilapia Oreochromis niloticus
F. noatunensis orientalis F. CAL2 n/a Fo4 - FDC 193 - - - - USA California Unknown Hybrid striped bass Morone chrysops x M. saxatilis
F. noatunensis orientalis F. CAL1 n/a Fo5 - FDC 194 - - - - USA California Unknown Hybrid striped bass Morone chrysops x M. saxatilis
F. noatunensis orientalis LADL-07-285A n/a Fo6 - FDC 195 - - - - Costa Rica Alajuela 2007 Nile tilapia Oreochromis niloticus
F. noatunensis orientalis LADL-11-060 n/a Fo7 - FDC 196 - - - - USA Texas Unknown Tilapia Oreochromis spp.
F. noatunensis orientalis LADL-01-100 n/a Fo8 - FDC 197 - - - - USA Midwest 2010 Nile tilapia Oreochromis niloticus
F. noatunensis orientalis LADL 10-075 #5 n/a Fo9 - FDC 198 - - - - USA Midwest 2010 Nile tilapia Oreochromis niloticus
F. noatunensis orientalis Franc-COS1 - Fo10 9535 - - - - - Mexico Queretaro 2013 Blue tilapia Oreochromis aureus
F. noatunensis orientalis Austria - Fo11 9449 - - - - - Austria Vienna 2013 Malawi  cichlid Aulonocara maleri
F. noatunensis orientalis STIR-GUS-F2f7 n/a Fo12 - FDC 410 - - - - Unknown Europe 2012 Red Nile tilapia Oreochromis niloticus
F. noatunensis orientalis STIR-MATT-F1f6 - Fo13 - - - - - - Unknown Europe 2012 Red Nile tilapia Oreochromis niloticus
F. noatunensis orientalis PQ1104 PRJNA73389 Fo14 5409 FSC 770 - - - - Costa Rica Unknown 2006 Tilapia Oreochromis spp.
F. noatunensis orientalis Cefas n/a Fo15 8373 FDC 190 - - - - UK England Unknown Nile tilapia Oreochromis niloticus
F. noatunensis orientalis STIR-AVU-F2f9 - Fo16 - - - - - - Unknown Europe 2012 Red Nile tilapia Oreochromis niloticus
F. noatunensis orientalis Toba04 PRJNA82619 Fo17 - - - - - - Indonesia Lake Toba 2004 Mozambique tilapia Oreochromis mossambicus
F. noatunensis noatunensis NVI 5330T PRJNA73397 Fn1 5330 FSC 769 12596 - LMG 23800T NCIMB 14265T Norway Hordaland County 2005 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 5340 - Fn2 5340 - - - - - Norway Sogn og Fjordane 2005 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 5396 - Fn3 5396 - - - - - Norway Rogaland County 2006 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 5394 - Fn4 5594 - - - - - Norway Møre og Romsdal 2006 Atlantic cod Gadus morhua
F. noatunensis noatunensis PQ1106 PRJNA73449 Fn5 5888 FSC 772 - - - - Chile Lake Llanquihue 2006 Atlantic salmon Salmo salar
F. noatunensis noatunensis NVI 6086 n/a Fn6 6086 FDC 189 - - - - Norway Sogn og Fjordane 2008 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 6214 - Fn7 6214 - - - - - Norway Møre og Romsdal 2008 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 6422 - Fn8 6422 - - - - - Norway Møre og Romsdal 2008 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 6471 - Fn9 6471 - - - - - Norway Møre og Romsdal 2008 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 6572 - Fn10 6572 - - - - - Norway Sogn og Fjordane 2008 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 6684 - Fn11 6684 - - - - - Norway Nordland County 2009 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 7127 - Fn12 7127 - - - - - Norway Rogaland County 2008 Atlantic cod Gadus morhua
F. noatunensis noatunensis F/134/09A PRJNA73465 Fn13 7061 FDC 178 - - - - Ireland Waterford 2009 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 8087 - Fn14 8087 - - - - - Norway Møre og Romsdal 2011 Atlantic cod Gadus morhua
F. noatunensis noatunensis SVA 74/04 PRJNA73463 Fn15 5518 FSC 846 - - - - Sweden Southern Skagerrak 2004 Atlantic cod Gadus morhua
F. noatunensis noatunensis NVI 6577 - Fn16 6577 - - - - - Norway Sogn og Fjordane 2008 Atlantic cod Gadus morhua
F. noatunensis noatunensis GM2212 (NVI) PRJNA73457 Fn17 5865 FSC 774 18777 - - - Norway Rogaland County 2004 Atlantic cod Gadus morhua
F. noatunensis noatunensis GM2212 (FOI) PRJNA73459 Fn18 - FSC 775 18777 - - - Norway Rogaland County 2004 Atlantic cod Gadus morhua
F. philomiragia O#319LT PRJNA22416 Fp1 5411 - 7535T 19700T LMG7903T ATCC 25015T USA Utah 1959 Muskrat Ondrata zibethica
F. philomiragia O#319-029 PRJNA73371 Fp2 - FSC 037 - - - ATCC 25016 USA Utah 1960 Water -
F. philomiragia O#319-036 PRJNA27853 Fp3 5598 - - 19701 - ATCC 25017 USA Utah 1960 Water -
F. philomiragia O#319-067 PRJNA73373 Fp4 - FSC 039 - - - ATCC 25018 USA Utah 1960 Water -
F. philomiragia CCUG12603 PRJNA73377 Fp5 5596 FSC 145 - 12603 - - Sweden Gothenburg 1982 Human Homo sapiens
F. philomiragia Swiss PRJNA73381 Fp6 5597 FSC 154 - 13404 - CDC E6588 Switzerland Zurich 1979 Human Homo sapiens
F. tularensis holarctica GIEM 503T PRJNA16087 Ft1 - FSC 200T - - - GIEM 503T Sweden Ljusdal 1998 Human Homo sapiens
F. tularensis mediasiatica GIEM 543T PRJNA19571 Ft2 - FSC 147T - - - GIEM 543T Kazakhstan Alma-Alta region 1965 Mid-day gerbil Meriones meridianus
F. tularensis tularensis SCHU S4
♯ PRJNA239340 Ft3 -  FSC 237 - - - USA Ohio 1938 Human Homo sapiens
F. tularensis novicida U112T PRJNA16088 Ft4 - FSC 040T - 33449T - ATCC 15482T; USA Utah 1951 Water -
F. hispaniensis FhSp1T PRJNA73391 Fh1 - FSC 454T 22475T 5802T - FnSp1T; F62T Spain Unknown 2003 Human Homo sapiens
F. guangzhouensis 08HL01032T PRJNA271279 Fg1 - - - 60119T - NCTC 13503T China Guangzhou city 2008 Water -
Host
(n/a) not available yet; NVI: Norwegian Veterinary Institute; FOI: Swedish Defence Research Agency; DSM: German Culture Collection of Microorganisms and Cell Cultures; CCUG Culture Collection, University of Göteborg, Sweden; Belgian Coordinated Collections of Microorganisms;
 NCIMB: National Collection of Industrial, Food and Marine Bacteria; ATCC: American Type Culture Collection; CDC: Centers for Disease Control and Prevention; GIEM: Gamalei Institute of Epidemiology and Microbiology; NCTC:National Collection of Type Cultures; 
(-) not applicable; ♯ Is the prototypic virulent strain not the type strain.
Chapter Four 
 
111 
 
4.2.2 Phenotypic characterisation  
All the strains phenotypically characterised were grown on CHAH and MMHB prepared 
as indicated in Section 2.2.2.The optimal in vitro temperature of Fno, Fnn and Fp was 
confirmed by incubating the type strains on agar plates at a wide range of temperatures 
as indicated in Section 2.2.3. The mid logarithmic phase of the type strains was 
investigated by constructing a growth curve on MMHB at the optimal in vitro 
temperature as indicated in Section 2.2.3.1 The bacterial biomass for the different 
phenotypic techniques was produced at the optimal in vitro temperature of each taxon 
and the cells were harvested at the mid log phase.  
4.2.2.1 Colony morphology and basic phenotype  
The colony morphology of the strains used was compared on CHAH and the basic 
phenotypic characteristics were confirmed using primary identification tests such as: 
Gram stain, catalase, oxidase and motility. 
4.2.2.2 Metabolic fingerprint 
To assess the metabolic activity of the isolates Fp1, Fo2-Fo16 and Fn1-Fn14, the Biolog 
GN2 micro plates (Biolog Inc., California, USA) were used. These plates contain an array 
of 95 different carbon (C) sources i.e. carbohydrates, lipids, sugars, amino acids, nucleic 
acids and other metabolites to test the capability of the bacterial cells to metabolise them. 
To avoid appearance of false negatives the GN2 Biolog micro plates were set up 
according to the manufacturer’s instructions with the modifications indicated in Section 
2.2.3.1.  
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After inoculation, the microplates were incubated at the optimal in vitro temperature of 
each taxon. The results were visually read at six and twelve hours and recorded for 
posterior comparisons with a computer photo scanner model Epson Perfection V370 
Photo scanner (Epson, London, UK).   
4.2.2.3 Chemotaxonomic analysis 
The cellular fatty acid methyl ester (FAME) composition of the strains Fp1, Fn1, F12-
F14, Fn1-Fn12 and Fn14-Fn16 was investigated at the Lipids Laboratory IoA, UoS as 
per the protocol described in Section 2.2.3.1 with slight modifications. Briefly, the 
FAME extracted were purified on HPTLC (high performance thin layer chromatography) 
plates (10cm X 10cm X 0.15mm) pre-coated with silica gel 60 (without fluorescent 
indicator) (Merck KGaA, Darmstadt, Germany).  
In order to investigate if the percent composition of individual fatty acids could be used 
as a suitable tool to differentiate between Fno, Fnn and Fp, statistical analyses were 
performed using Minitab® v.16.1.0 software (Minitab Inc., Coventry, UK) considering 
each isolate as a biological replicate of the respective taxon. Briefly, the data obtained 
were assessed for normality with the Kolmogorove-Smirnov test and for homogeneity of 
variances by Bartlett’s test and then transformed using the natural logarithm or arcsine 
transformation. Only the data of those FAME with normal distribution were compared 
by one-way analysis of variance (ANOVA), with post hoc comparisons using Tukey’s 
test (Zar, 2007). A significance of P < 0.05 was applied to all statistical tests performed.  
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4.2.3 Genetic characterisation  
4.2.3.1 DNA-DNA hybridisation (DDH) 
The gold standard for species delineation was performed in duplicate experiments at 
62°C at the German Culture Collection of Microorganisms and Cell Cultures “Deutsche 
Sammlung von Mikroorganismen und Zellkulturen GmbH” (DSMZ) lab in 
Braunschweig Germany. The F. noatunensis orientalis strain Fo14 was compared against 
the type strain of Fnn.  
Three grams of wet biomass of the strains were grown at the NVI (Norwegian Veterinary 
Institute) and sent suspended in 1:1 isopropanol and water solution (v/v) at room 
temperature to the DSMZ. At arrival, bacterial cells were disrupted by using a Constant 
Systems TS 0.75 KW cell disruptor (IUL Instruments, Braunschweig, Germany) and the 
DNA in the crude lysate was purified by chromatography on hydroxyapatite as described 
by Cashion et al. (1977). DNA-DNA hybridization was carried out as outlined by de Ley 
et al. (1970) with modifications described by Huss et al. (1983) using an ultraviolet 
visible spectrophotometer Cary100 Bio UV/VIS (CaryBio, California, USA) equipped 
with a Peltier-thermostate multicell changer and a temperature controller with in situ 
temperature probe.  
4.2.3.2 16S rRNA gene sequence similarity and phylogeny 
The complete 16S rRNA gene sequence was retrieved from all the genomes doing an in 
silico PCR with the universal primers EUBB 5’AGAGTTTGATCMTGGCTCAG’3 and 
EUBA 5’AAGGAGGTGATCCANCCRCA’3 described by Suzuki and Giovannoni 
(1996) using the Sequence Manipulation Suite platform (Stothard, 2000) with 
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modifications in the script for an input limit of 3,000,000 characters. After extraction the 
sequences were aligned as DNA with the Unweight Pair Group Method with Arithmetic 
Mean (UPGMA) using the MUSCLE application (Edgar, 2004) of the MEGA package 
version 6 (Tamura et al., 2013).  
After alignment the nucleotide composition of the sequences and their evolutionary 
divergence (pairwise distances) were estimated using the software MEGA version 6 
(Tamura et al., 2013). These values and the length of the aligment were used to calculate 
the pairwise percent similarity of the sequences. 
A phylogenetic tree was constructed for each alignment using MEGA6 software (Tamura 
et al., 2013) with the Maximum Likelihood (ML) (Nei and Kumar, 2000) approach and 
complete deletion of gaps and missing data. The model used was a combination of the 
Hasegawa-Kishino-Yano method (HKY) (Hasegawa et al., 1985) with a discrete gamma 
distribution of rates among sites. The reliability of the tree (reproducibility) was tested 
using the bootstrap method with 1000 replications while the nearest-neighbour-
interchange was chosen as the ML heuristic method. 
4.2.3.3 Whole genome average nucleotide identity (wg-ANIm) 
Pairwise comparisons were performed within and between the taxa analysed using the 
programme JSpecies (Richter and Rosselló-Móra, 2009) with the MUMmer algorithm 
(Kurtz et al., 2004) to calculate the ANIm across the genome sequences.  
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4.2.3.6 Genome to genome distance (GGD) and in silico DDH 
The GGD between all the types trains of the genus as well as the correspondent DDH 
value for those comparisons were estimated using the genome to genome distance 
calculator version 2.0 (Meier-Kolthoff et al., 2013) available at the DSMZ website 
http://ggdc.dsmz.de/  
4.2.3.6 Multilocus sequence analysis (MLSA) 
This analysis was performed with the following eight housekeeping genes: malate 
dehydrogenase (mdh), chromosomal replication initiator protein alpha subunit (dnaA), 
DNA mismatch repair protein (mutS), peptide chain release factor 2 beta subunit (prfB), 
bifunctional proline dehydrogenase⁄pyrroline-5-carboxylate dehydrogenase alpha 
subunit (putA), DNA-directed RNA polymerase alpha subunit (rpoA), DNA-directed 
RNA polymerase beta subunit (rpoB) and triose-phosphate isomerase alpha subunit 
(tpiA).  
The suitability of these genes for phylogenetic analyses was previously reported in 
section 2.3.4.5 when they were used as single sequences to infer the evolutionary 
relationship of Francisella noatunensis orientalis STIR-GUS-F2f7 with other bacterial 
pathogens of fish. In this study the 8 housekeeping genes were analysed as a concatenated 
sequence.   
The housekeeping genes were retrieved, aligned, and concatenated from the genome 
sequences according to the following procedure. For each genome, the gene models and 
fasta sequences of all the predicted were obtained using the programme Prodigal version 
2.6.2 (Hyatt et al., 2010).  
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The house-keeping genes of each genome were subsequently identified using NCBI 
BLASTN version 2.2.28+ (by default settings) and the corresponding sequences from the 
STIR-GUS-F2f7 genome as query by retaining the best hit for each genome. The 
predicted genes were blasted against prototypic Francisella genomes using NCBI 
BLASTN v. 2.2.28+ with the blastn task selection and an e value of 0.01.  
Resulting hits were filtered to exclude alignments shorter than 80% of the query genes 
and a lower identity than 75% for genomes representing F. noatunensis and F. 
philomiragia; 70% for genomes representing F. tularensis and F. hispaniensis and 65% 
for the sole representative of F. guangzhouensis. Hits corresponding to the previous 
criteria were saved in GFF format and subsequently used for visualization in the 
DNAplotter (Carver et al., 2009) software packaged within Artemis v.16.0 (Carver et al., 
2012). 
All sequences for each gene were aligned subsequently separately using MUSCLE 
(Edgar, 2004) and visually inspected to ensure a correct selection of gene sequences and 
good performance of the alignment.  
The aligned gene sequences corresponding to each genome were subsequently 
concatenated using an in-house script developed with the programing language Perl 
available at www.perl.org. Finally, pairwise percent similarity values were estimated 
using the final length of the aligment and the pairwise distances as inferred using MEGA6 
(Tamura et al., 2013).  
The phylogenetic tree for the concatenated sequence was constructed using the 
Neighbour Joining (NJ) algorithm and previously the suitability of the data for this 
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analysis was confirmed using the average pairwise Jukes-Cantor (JC) distance (Nei and 
Kumar, 2000). 
4.2.3.9 Whole genome G+C content and phylogeny 
The genomes were aligned using a novel objective score called “a sum-of-pairs 
breakpoint score” available with the progressive Mauve software (Darling et al., 2004) 
version 2.4.0 development snapshot (2015-02-13). Due to poor performance using all 
genomes in a single multiple alignment, multiple alignments were performed in sets of 
12/13 genomes using tree genomes commonly represented in all three alignments (F. 
philomiragia ATCC25017, F. tularensis holarctica FSC200 and F. noatunensis 
orientalis LADL-07-285A).  
Using an in-house script, the resulting alignments were processed to match nucleotide 
positions in the LADL-07-285A genome sequence, enabling merging of the sub 
alignments into a single multiple alignment of all genomes. Processing included 
extending gap positions by 15bp in both the 5’ and 3’ directions to limit the potential 
impact of misalignments that may arise in such regions. Prior to the alignment the 
genome sequences of the strains Fh1, Ft2 and Fp1 were reassembled using the parallel 
assembler for short read sequence data ABySS (Assembly By Short Sequences) version 
1.3.4 (Simpson et al., 2009). 
The nucleotide composition of the genomes and the WG phylogenetic tree were 
computed using the software MEGA version 6 (Tamura et al., 2013). A phylogenetic tree 
was built using the Neighbour Joining (NJ) algorithm and the suitability of the data for 
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this analysis was confirmed using the average pairwise Jukes-Cantor (JC) distance (Nei 
and Kumar, 2000). 
An un-rooted phylogenetic network was constructed using the software SplitsTree4 
version 4.12.3 (Huson and Bryant, 2006) with the default settings and the alignment 
previously generated in Mega 6. A circular map was generated for each of the type strains 
genomes and STIR-GUS-F2f7 using the genome viewer and annotation tool Artemis 
16.0.0 (Carver et al., 2012) and the software DNAPlotter (Carver et al., 2009).
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4.3 Results 
4.3.1 Colony morphology and basic phenotype 
As expected the basic phenotypic analyses confirmed all the isolates to be Gram negative 
and non-motile. Fnn and Fno were oxidase negative and catalase positive while the Fp 
type strain was positive in both tests.  
Colonies of Fno on CHAH were greenish-greyish, circular, convex and smooth, with 
complete margins and slightly mucoid appearance. The optimal growth temperature was 
28-29°C and at this temperature pin-point colonies appeared after 59h and were clearly 
visible (~1mm) after 65-75h; colonies integrate with each other after 90h and couldn’t 
be recovered after 4 weeks. No growth was observed at temperatures of 18°C or lower 
or at 33°C or higher. Visible colonies appeared after 120h at 22°C, 87h at 24°C and 69h 
at 26°C. The pellets harvested from broth by centrifugation were particularly sticky and 
mechanical disruption was required with sterile disposable loops as they could not be 
dissolved by vortexing. 
The Fnn isolates recovered from Scandinavia were white, slightly translucent, with a 
clearly mucoid appearance, and their optimal temperature was at 22°C when the colonies 
appeared after 4 day of incubation.  No growth was observed at 15°C or lower 
temperatures or at 28°C or higher. The pellets of these strains were easy to disrupt by 
vortexing. Replication of this bacterium was slower as indicated not only by the 
incubation time, but also by the concentrations required in the starting cultures to produce 
similar amounts of biomass as Fno.  
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The Fnn isolate recovered from Ireland was slightly more greyish. In contrast the colour 
of the Chilean isolate was grey-greenish somehow resembling the Fno isolates colour 
and it also had a particular odour not presented in the Fnn strains and different to the Fno 
particular smell.  
Interestingly, when Fnn and Fno type strains were cultured overnight in the same broth 
and drops of the mixed culture were plated, the cells of Fnn grouped with each other to 
form well defined white colonies that emerged among the Fno colonies Fig. 4.1 letter E. 
The colonies of the Fp type strain were white but not translucent, with a bigger size than 
Fnn and Fno and a faster growth rate; they were able to grow at a similar pace in a range 
of temperature from 15°C to 37°C. Overnight cultures at 34°C were able to produce as 
much as twice the biomass of Fnn and Fno (as measured by OD600). A plate of the colony 
morphology of the 3 type strains is presented in Fig 4.1. 
 
Figure 4.1 Colony morphology on CHAH of the taxa analysed.  A Fp, B Fno, C Fnn. D 
Drop count of Fno. E Drop count of mixed Fnn and Fno culture, arrows indicate growing 
Fnn and were distinct from Fno. 
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4.3.2 Phenotypic (metabolic) fingerprint 
The cultures used to inoculate the Biolog GN2 micro plates with Fno and Fnn were OD600 
0.85, while 0.65 was adequate for Fp. A picture of the phenotypic fingerprint of Fnn 
(Fn1) at OD600 0.85 and 1.06 is shown in Figure 4.2. 
There were 24 differences between Fp and Fnn, 17 between Fno and Fp¸ 10 between 
Fnn and Fno and additionally some differences were seen within the Fnn taxon where 
the isolates recovered from Chile, Ireland and Sweden showed differences with those 
from Norway. The largest number of differences within this taxon was seen between the 
Fnn from Chile and the strains recovered from Norway, where a total of 9 differences 
were seen. Finally, as with the Norwegian Fnn strains, the comparison of the Chilean 
Fnn with the Fp type strains also indicated 24 differences.  
The number of positive reactions recorded was 39 for Fp, 22 for Fno, 17 for the Irish 
Fnn, 16 for Norwegian Fnn and 15 for the Chilean and Swedish strains. A summary of 
the results obtained with the modified protocol of the Biolog GN2 plates is presented in 
Table 4.2. 
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Figure 4.2 Phenotypic fingerprint of F. noatunensis noatunensis (Fn1). A Photograph of 
the plate with an OD600 0.85. Well A1 is negative and green + is used to indicate positive 
wells (where colour has changed). B Photograph of the plate with an OD600 1.06 the blue 
squares indicate ambiguous results when well A1 appears to be positive. 
Chapter Four 
 
123 
 
Table 4.2 Metabolic fingerprint of the different Francisella spp. analysed in this study 
WELL CARBON SOURCE
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
A3 Dextrin + + + + + + + + + + + + + + + - - - - - - - - - - - - - - -
A4 Glycogen - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
A8 N-Acetyl-Dglucosamine + + + + + + + + + + + + + + + + + + + - + + + + + + + + + +
A12 D-Cellobiose - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
B2 D-Fructose + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
B4 D-Galactose - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
B6 α-D-Glucose + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
B10 Maltose - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
B12 D-Mannose + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
C3 D-Psicose - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
C7 Sucrose - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
C8 D-Trehalose - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
C9 Turanose - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
C11 Methyl Pyruvate + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
C12 Mono-Methyl- Succinate - - - - - - - - - - - - - - - + + + + - + + + + + + + + + +
D1 Acetic Acid + + + + + + + + + + + + + + + - - - - + - - - - - - - + - -
D10 α-Hydroxy Butyric Acid - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
D11 β-Hydroxy Butyric Acid - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E3 α-Keto Butyric Acid + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
E6 D,L-Lactic Acid - - - - - - - - - - - - - - - - - - - + - - - - - - - - - -
F4 L-Alaninamide + + + + + + + + + + + + + + + + + + + - + + + + + + + + + +
F5 D-Alanine - - - - - - - - - - - - - - - + + + + - + + + + + + + - + -
F6 L-Alanine + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
F7 L-Alanylglycine + + + + + + + + + + + + + + + + + + + - + + + + + + + + + +
F8 L-Asparagine + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
F9 L-Aspartic Acid - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
F10 L-Glutamic Acid + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
F12 Glycyl-LGlutamic Acid - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
G6 L-Proline + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
G7 L-Pyroglutamic Acid - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
G9 L-Serine + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
G10 L-Threonine + + + + + + + + + + + + + + + - - - - + - - - - - - - - - -
H2 Inosine + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
H3 Uridine + + + + + + + + + + + + + + + - - - - - - - - - - - - - - -
H4 Thymidine - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
H9 Glycerol + + + + + + + + + + + + + + + - - - - + - - - - - - - + - -
H10 D,L-α-Glycerol Phosphate + + + + + + + + + + + + + + + - - - - - - - - - - - - - - -
H11 Glucose-1-Phosphate + + + + + + + + + + + + + + + - - - - - - - - - - - - - - -
H12 Glucose-6-Phosphate + + + + + + + + + + + + + + + - - - - - - - - - - - - - - -
Francisella noatunensis orientalis Francisella noatunensis noatunensis
1= Fp; 2-16= Fo1-Fo15; 17-31=Fn1-Fn15; In green phenotypic differences between Fno  and Fnn ; In red differences within Fnn strains.
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4.3.3 Chemotaxonomic analyses  
The FAME results per strain showed homogeneity within the Fno taxon, but variations were seen amongst the Fnn strains where differences of up 
to 11% were seen between Fn11 and Fn12 on the total content of saturated fatty acids. The FAME content per isolate is shown in Table 4.3.  
Table 4.3 Relative fatty acid composition (%) per isolate of the Francisella spp. analysed in this study
 
Fatty acid
Fp1 Fp3§ Fp6§ Fo1 Fo12 Fo13 Fo14 Fn1 Fn2 Fn3 Fn4 Fn6 Fn7 Fn8 Fn9 Fn10 Fn11 Fn12 Fn14 Fn16
14:0 7 10 7 8 8 6 10 10 11 9 11 10 9 11 7 8 9 12 9 9
16:0 10 10 12 8 8 6 9 9 10 7 10 9 9 9 8 9 8 9 8 9
17:0 0 0 1 1 1 0 1 0 0 0 1 0 1 1 0 0 0 0 0 1
18:0 5 3 4 7 6 7 6 4 5 4 5 5 5 5 5 5 5 5 5 5
20:0 5 3 4 4 4 4 4 4 4 5 5 4 4 4 5 5 5 4 5 5
22:0 9 4 6 9 9 11 9 9 7 14 9 9 7 9 15 11 12 7 11 10
23:0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0
24:0 2.3 1 2 11 13 11 11 5 5 8 4 4 4 5 9 5 9 1 7 5
26:0 1 0 0 1 2 1 1 1 0 1 0 0 0 0 1 0 1 0 1 0
Total saturated 39 32 37 52 53 48 53 42 42 50 45 43 39 45 50 44 50 39 45 44
16:1n-7 1 1 1 0 0 0 0 1 2 1 1 1 1 1 1 1 1 1 1 1
17:1 0 0 0 1 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0
18:1n-9 17 19 19 15 16 17 16 17 17 15 20 18 18 17 15 18 14 18 17 19
20:1n-9 2 4 3 2 2 2 2 3 3 3 4 3 3 3 3 4 3 3 3 3
20:1n-7 0 0 0 0 0 0 0 0 1 0 1 0 1 0 0 0 0 0 0 0
22:1 5 10 7 3 3 4 3 7 7 6 8 6 8 6 6 7 6 7 6 7
23:1 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0
24:1n-9 30 29 28 23 21 25 21 26 23 20 18 24 26 25 22 23 23 28 24 23
26:1 5 4 3 2 2 2 2 3 2 4 2 2 3 2 2 2 2 3 2 2
Total monounsaturated 61 68 62 48 47 52 47 58 57 50 55 57 60 55 50 56 50 61 55 56
18:2n-6 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
F. philomiragia F. noatunensis orientalis F. noatunensis noatunensis
Strains are labelled according to Table 4.1.
§Isoltes were donated for this comparison by Dr. Duncan Colquhoun at the The Norwegian Veterinary Institute.
Chapter Four 
 
125 
 
The results per taxon showed that levels of 24:0, and the total amount of saturated and 
total monounsaturated FAMEs were significantly different from each other. The 
content of 24:1n-9 in Fp was significantly higher than in Fnn and in Fno and the 
content of 22:1 was lower in Fno than in Fp and Fnn. The relative FAME composition 
per taxon is presented in Table 4.4. 
Table 4.4 Relative fatty acid composition (%) of the taxa analysed in this study 
 
4.3.4 DNA-DNA hybridisation (DDH) 
The DDH value between Fno and Fnn strain was 60% (62.1 in round one and 58.40 in 
round two), clearly indicating that the two fish pathogens constitute separate bacterial 
species. Table 4.5 shows these results with other wet lab DDH values available in the 
literature for fish pathogenic Francisella spp.   
Fatty acid Average
14:0 8 ± 2 8 ± 2 10 ± 1 9
16:0 11a ± 1 8b ± 1 9b ± 1 9
18:0 4 ± 1 7 ± 1 5 ± 0 5
20:0 4 ± 1 4 ± 0 5 ± 1 4
22:0 6b ± 2 9ab ± 1 10a ± 3 9
24:0 2c ± 1 11a ± 1 6b ± 2 6
Total saturated 36c ± 3 51a ± 2 44b ± 4 44
18:1n-9 18 ± 1 16 ± 1 17 ± 2 17
20:1n-9 3a ± 1 2b ± 0 3a ± 0 3
22:1 7a ± 2 3b ± 0 7a ± 1 6
24:1n-9 29a ± 1 23b ± 2 23b ± 3 25
26:1 4 ± 1 2 ± 0 2 ± 1 3
Total monounsaturated 63a ± 4 49c ± 2 55b ± 4 56
Total 100 100
Data are presented as mean + SD (range per taxon ).
Green colour suitable markers for species diferentiation.
Fp Fno Fnn
100 100
Chapter Four 
 
126 
 
Table 4.5 DNA-DNA hybridisation values (%) between members of the genus 
Francisella  
Species Strains* Round 1 Round 2 Average 70% criteria Temperature
Fno vs Fnn Fo14 vs Fn1 62.1 58.40 60 different species 62°C
†Fno vs Fnn Fo1 vs Fn17 64.0 73.4 69 different species 63°C
♫ Fno vs Fnn Fo1 vs Fn17 69.7 70.1 70 same species 62°C
¥Fnn vs Fp Fn1 vs Fp1 65.2 70.8 68 different species 62°C
♯Fnn vs Fp Fn17 vs Fp1 69.5 70.8 70 same species 61°C
♫Fnn vs Fp Fn17 vs Fp1 68.0 74.0 71 same species 62°C
♫Fnn vs Fp Fnn§ vs Fp1 74.5 67.0 70 same species 62°C
†Fno vs Fp Fo1 vs Fp1 57.3 64.3 61 different species 63°C
Fno vs Fp Fo1 vs Fp1 76.5 68.7 73 same species 62°C
♫ Fnn vs Fnn Fnn§ vs Fn17 87.2 81.0 84 same species 62°C
♣Fp  vs Fp Fp1 vs Fp1 - - 100 same species 65°C
♣Fp  vs Fp Fp1 vs Fp2 - - 77 same species 65°C
♣Fp  vs Fp Fp1 vs Fp3 - - 83 same species 65°C
♣Fp  vs Fp Fp1 vs Fp4 - - 78 same species 65°C
♣Fp  vs Fp Fp1 vs Fp6 - - 79 same species 65°C
♣Fp  vs Ftn Fp1 vs Ft4 - - 51 different species 50°C
♣Fp vs Ftt Fp1 vs Ft3 - - 35 different species 50°C
♦Fh  vs Ft Fh1 vs Ft1 57 38 48 different species -
♦Fh  vs Ft Fh1 vs Ft2 61 35 48 different species -
♦Fh  vs Ftn Fh1 vs Ft4 52 54 53 different species -
♦Fh  vs Fp Fh1 vs Fp1 39 43 41 different species -
♦Fh  vs Fnn Fh1 vs Fn17 47 28 38 different species -
¶Fhal  vs Fp Fhal vs Fp1 58.4 63.5 61 different species 62°C
¶ Fhal  vs Fnn Fhal vs Fn1 49.8 48.5 49 different species 62°C
¶ Fhal  vs Fno Fhal vs Fo1 59.6 53.3 56 different species 62°C
ψFg vs Fp Fg vs Fp1 - - 38 different species -
§Refers to the Fnn  Chilean strain UA2660 not analysed in this study;
¥ Mikalsen et al. (2007); † Ottem et al . (2008); ♯ Ottem et al . (2007); ♫Ottem et al . (2011);
♣Hollis et  al . (1989);♦Huber et al . (2010); ¶ Brevik et al . (2011); ψ Qu et al . (2013);
*As identified in this study (Table 4.1); Same colour are parallel studies with members of the same taxa ;
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4.3.5 16S rRNA gene similarity and phylogeny  
The length of the 16S rRNA of the Fno and Fnn strains was 1520 nucleotides, which was 
2bp smaller than in all the Fp strains. The nucleotide composition of the 16S rRNA gene 
of each type strain analysed is presented in Table 4.6. 
   
Table 4.6 Nucleotide composition (%) of  the 16S rRNA 
gene of the Francisella type strains 
Strain T(U) C A G GC% Length (bp) 
Fo1 26 31 22 21 52 1520 
Fn1 26 31 22 21 52 1520 
Ft1 26 31 22 21 52 1520 
Ft2 26 31 22 21 52 1520 
Ft4 26 31 22 21 52 1520 
Fh1 26 31 22 21 52 1520 
Ft3 26 31 22 21 52 1519 
Fg1 27 30 23 20 51 1519 
Fp1 26 31 22 21 52 1518 
    
The final length of the alignment was 1516 nucleotides. The average of differences 
between Fno and Fnn was 15bp, between Fno and Fp 13bp and between Fnn and Fp 
10bp. The estimates of evolutionary divergence and the percent similarity of these genes 
are shown in Table 4.7. The phylogenetic tree generated for this gene is presented in 
Figure 4.3. 
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Table 4.7 Estimates of evolutionary divergence and percent similarity of the 16S rRNA gene  
- Fo1 Fo2 Fo3 Fo4 Fo5 Fo6 Fo7 Fo8 Fo9 Fo12 Fo14 Fo15 Fo17 Fn1 Fn5 Fn6 Fn13 Fn15 Fn17 Fn18 Fp1 Fp2 Fp3 Fp4 Fp5 Fp6 Ft1 Ft2 Ft3 Ft4 Fh1 Fg1
Fo1 - 100 100 100 100 100 100 100 100 100 100 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo2 0 - 100 100 100 100 100 100 100 100 100 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo3 0 0 - 100 100 100 100 100 100 100 100 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo4 0 0 0 - 100 100 100 100 100 100 100 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo5 0 0 0 0 - 100 100 100 100 100 100 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo6 0 0 0 0 0 - 100 100 100 100 100 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo7 0 0 0 0 0 0 - 100 100 100 100 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo8 0 0 0 0 0 0 0 - 100 100 100 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo9 0 0 0 0 0 0 0 0 - 100 100 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo12 0 0 0 0 0 0 0 0 0 - 100 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo14 0 0 0 0 0 0 0 0 0 0 - 100 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo15 0 0 0 0 0 0 0 0 0 0 0 - 100 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fo17 0 0 0 0 0 0 0 0 0 0 0 0 - 99.2 99.1 99.2 99.2 99.2 99.2 99.2 99.1 99.1 99.1 99.1 99.2 99.2 97.8 97.8 97.9 98.0 98.0 95.1
Fn1 12 12 12 12 12 12 12 12 12 12 12 12 12 - 99.8 100 100 100 100 100 99.5 99.3 99.3 99.3 99.4 99.4 98.0 98.0 98.2 98.2 98.2 95.3
Fn5 13 13 13 13 13 13 13 13 13 13 13 13 13 3 - 99.8 99.8 99.8 99.8 99.8 99.4 99.2 99.2 99.2 99.3 99.3 98.0 98.0 98.1 98.1 98.2 95.1
Fn6 12 12 12 12 12 12 12 12 12 12 12 12 12 0 3 - 100 100 100 100 99.5 99.3 99.3 99.3 99.4 99.4 98.0 98.0 98.2 98.2 98.2 95.3
Fn13 12 12 12 12 12 12 12 12 12 12 12 12 12 0 3 0 - 100 100 100 99.5 99.3 99.3 99.3 99.4 99.4 98.0 98.0 98.2 98.2 98.2 95.3
Fn15 12 12 12 12 12 12 12 12 12 12 12 12 12 0 3 0 0 - 100 100 99.5 99.3 99.3 99.3 99.4 99.4 98.0 98.0 98.2 98.2 98.2 95.3
Fn17 12 12 12 12 12 12 12 12 12 12 12 12 12 0 3 0 0 0 - 100 99.5 99.3 99.3 99.3 99.4 99.4 98.0 98.0 98.2 98.2 98.2 95.3
Fn18 12 12 12 12 12 12 12 12 12 12 12 12 12 0 3 0 0 0 0 - 99.5 99.3 99.3 99.3 99.4 99.4 98.0 98.0 98.2 98.2 98.2 95.3
Fp1 13 13 13 13 13 13 13 13 13 13 13 13 13 8 9 8 8 8 8 8 - 100 100 100 100 100 98.5 98.5 98.7 98.7 98.7 95.6
Fp2 14 14 14 14 14 14 14 14 14 14 14 14 14 11 12 11 11 11 11 11 3 - 100 100 100 100 98.6 98.6 98.7 98.7 98.8 95.5
Fp3 14 14 14 14 14 14 14 14 14 14 14 14 14 11 12 11 11 11 11 11 3 0 - 100 100 100 98.6 98.6 98.7 98.7 98.8 95.5
Fp4 14 14 14 14 14 14 14 14 14 14 14 14 14 11 12 11 11 11 11 11 3 0 0 - 100 100 98.6 98.6 98.7 98.7 98.8 95.5
Fp5 12 12 12 12 12 12 12 12 12 12 12 12 12 9 10 9 9 9 9 9 1 2 2 2 - 100 98.5 98.5 98.6 98.6 98.7 95.6
Fp6 12 12 12 12 12 12 12 12 12 12 12 12 12 9 10 9 9 9 9 9 1 2 2 2 0 - 98.5 98.5 98.6 98.6 98.7 95.6
Ft1 33 33 33 33 33 33 33 33 33 33 33 33 33 30 31 30 30 30 30 30 22 21 21 21 23 23 - 99.9 99.9 99.9 99.6 95.1
Ft2 33 33 33 33 33 33 33 33 33 33 33 33 33 30 31 30 30 30 30 30 22 21 21 21 23 23 2 - 99.9 99.9 99.6 95.1
Ft3 32 32 32 32 32 32 32 32 32 32 32 32 32 28 29 28 28 28 28 28 20 19 19 19 21 21 2 2 - 99.9 99.6 95.2
Ft4 31 31 31 31 31 31 31 31 31 31 31 31 31 28 29 28 28 28 28 28 20 19 19 19 21 21 2 2 2 - 99.7 95.2
Fh1 30 30 30 30 30 30 30 30 30 30 30 30 30 27 28 27 27 27 27 27 19 18 18 18 20 20 6 6 6 4 - 95.3
Fg1 74 74 74 74 74 74 74 74 74 74 74 74 74 71 74 71 71 71 71 71 66 68 68 68 66 66 75 75 73 73 72 -
The evolutionary divergence is shown below the diagonal where the number of base differences per sequence from between sequences are shown. The % similarity is shown above the diagonal.
In pink Fno vs Fn ; In purple Fp  vs Fno and in blue Fnn  vs Fp ; In yellow, differences and % similarity within the 4 Ft ssp. (below) and between the Chilean and the other Fnn  strains (above).
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Figure 4.3 Phylogenetic analysis based on the complete 16S rRNA sequence of the 32 genomes analysed. The tree is drawn to scale, with branch 
lengths measured in the number of substitutions per site. The percentage of trees in which the associated taxa clustered together is shown next to 
the branches. The strains analysed are identified according to Table 4.1. 
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4.3.6 Whole genome average nucleotide identity (wg-ANIm) 
Whole genome ANI estimated with the software JSpecies (Richter and Rosselló-Móra, 
2009) and the MUMmer algorithm (Kurtz et al., 2004) indicated 100% similarity within 
the Fno strains; with the exception of the Chilean strain, the similarity within the Fnn 
taxon was also 100%. The Chilean strain and the rest of the Fnn strains have an ANI of 
99.5%. The similarity among the four F. tularensis subspecies varied from 98.1 to 99.4%. 
The ANI between Fno and F. philomiragia was 93% and between Fp and Fnn was 95% 
indicating that Fp is more closely related to Fnn than to Fno. Finally the ANI between 
Fno and Fnn was 94-95% confirming that these taxa constitute separate species. The 
results of the whole genome average nucleotide identity including the other validly 
described members of the genus analysed are presented in Table 4.8.
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Table 4.8 Whole genome average nucleotide identity (%) of the genus Francisella 
Fo1 Fo2 Fo3 Fo4 Fo5 Fo6 Fo7 Fo8 Fo9 Fo12 Fo14 Fo15 Fo17 Fn1 Fn5 Fn6 Fn13 Fn15 Fn17 Fn18 Fp2 Fp3 Fp4 Fp5 Fp6 Ft1 Ft2 Ft3 Ft4 Fh1 Fg1
Fo1 --- 100 99.99 100 100 99.99 99.99 99.99 99.98 99.99 99.99 99.99 99.98 94.49 94.38 94.45 94.44 94.48 94.49 94.48 93.13 93.13 93.13 93.15 93.01 84.93 85.01 84.93 85.22 85.74 83.67
Fo2 100 --- 99.98 100 100 100 99.98 99.99 99.98 99.99 99.99 100 99.98 94.47 94.35 94.44 94.44 94.46 94.46 94.46 93.13 93.17 93.13 93.14 93.00 84.81 84.89 84.8 85.09 85.59 83.52
Fo3 100 100 --- 99.99 99.99 99.99 99.98 99.97 99.97 99.98 99.99 99.98 99.97 94.5 94.39 94.46 94.45 94.49 94.5 94.49 93.16 93.17 93.17 93.18 93.04 84.95 85.07 84.95 85.29 85.75 83.8
Fo4 100 100 100 --- 100 100 99.99 99.99 99.98 100 99.99 100 99.98 94.51 94.4 94.48 94.46 94.51 94.51 94.51 93.13 93.16 93.14 93.14 93.01 84.89 84.97 84.88 85.11 85.62 83.64
Fo5 100 100 100 100 --- 99.99 99.99 99.99 99.98 99.99 99.99 99.99 99.97 94.5 94.39 94.47 94.45 94.5 94.5 94.5 93.14 93.17 93.14 93.14 93.01 84.86 84.97 84.88 85.10 85.64 83.65
Fo6 100 100 100 100 100 --- 99.99 99.99 99.98 99.99 99.99 99.99 99.98 94.49 94.37 94.45 94.43 94.48 94.48 94.48 93.14 93.18 93.15 93.15 93.02 84.93 85.01 84.93 85.17 85.67 83.74
Fo7 100 100 100 100 100 100 --- 100 99.99 99.99 99.98 99.99 99.97 94.49 94.39 94.46 94.44 94.49 94.49 94.49 93.14 93.16 93.14 93.15 93.02 84.92 85.00 84.93 85.20 85.67 83.74
Fo8 100 100 100 100 100 100 100 --- 99.98 99.99 99.98 99.99 99.97 94.48 94.37 94.48 94.43 94.48 94.48 94.48 93.12 93.19 93.13 93.14 93.00 84.92 84.91 84.92 85.12 85.64 83.34
Fo9 100 100 100 100 100 100 100 100 --- 99.98 99.97 99.98 99.96 94.49 94.38 94.47 94.44 94.49 94.49 94.49 93.13 93.16 93.13 93.15 93.01 85.00 85.08 84.99 85.22 85.73 83.77
Fo12 100 100 100 100 100 100 100 100 100 --- 99.99 100 99.98 94.48 94.36 94.46 94.42 94.46 94.47 94.46 93.1 93.17 93.11 93.13 92.99 84.92 84.91 84.92 85.12 85.64 83.27
Fo14 100 100 100 100 100 100 100 100 100 100 --- 99.99 99.98 94.49 94.37 94.45 94.43 94.48 94.48 94.48 93.12 93.12 93.12 93.14 93.00 85.36 85.42 85.34 85.64 85.92 83.68
Fo15 100 100 100 100 100 100 100 100 100 100 100 --- 99.98 94.48 94.36 94.48 94.43 94.47 94.48 94.47 93.12 93.19 93.12 93.14 93.00 84.92 84.91 84.91 85.12 85.63 83.26
Fo17 100 100 100 100 100 100 100 100 100 100 100 100 --- 94.48 94.37 94.44 94.43 94.47 94.47 94.47 93.12 93.13 93.12 93.14 93.00 84.91 84.99 84.91 85.20 85.73 83.66
Fn1 94 95 95 95 95 95 95 95 95 95 94 95 94 --- 99.51 99.98 99.94 99.97 99.97 99.96 95.25 95.25 95.25 95.27 95.22 85.19 85.28 85.21 85.39 85.83 83.61
Fn5 94 94 94 94 94 94 94 94 94 94 94 94 94 99.5 --- 99.49 99.47 99.51 99.51 99.5 95.15 95.14 95.15 95.18 95.12 85.19 85.29 85.19 85.41 85.71 83.54
Fn6 94 94 94 94 94 94 94 94 94 94 94 94 94 100 99.5 --- 99.95 99.98 99.99 99.99 95.19 95.16 95.2 95.21 95.16 85.13 85.12 85.14 85.16 85.65 83.23
Fn13 94 94 94 94 94 94 94 95 94 95 94 95 94 100 99.5 100 --- 99.94 99.94 99.95 95.22 95.22 95.22 95.24 95.19 85.01 85.10 85.02 85.25 85.65 83.49
Fn15 94 95 95 95 95 95 95 95 95 95 94 95 94 100 99.5 100 100 --- 99.96 99.99 95.23 95.23 95.23 95.25 95.21 85.15 85.22 85.15 85.36 85.72 83.58
Fn17 94 95 94 94 95 95 95 95 95 95 94 95 94 100 99.5 100 100 100 --- 99.98 95.23 95.22 95.23 95.28 95.23 85.16 85.24 85.16 85.34 85.76 83.6
Fn18 94 95 94 94 95 95 95 95 95 95 94 95 94 100 99.5 100 100 100 100 --- 95.22 95.23 95.22 95.25 95.19 85.13 85.21 85.14 85.34 85.72 83.59
Fp2 93 93 93 93 93 93 93 93 93 93 93 93 93 95 95 95 95 95 95 95 --- 99.99 99.99 97.84 97.86 85.42 85.46 85.48 85.95 86.07 83.69
Fp3 93 93 93 93 93 93 93 93 93 93 93 93 93 95 95 95 95 95 95 95 100 --- 100 97.83 97.86 85.42 85.48 85.49 86.03 86.08 83.78
Fp4 93 93 93 93 93 93 93 93 93 93 93 93 93 95 95 95 95 95 95 95 100 100 --- 97.84 97.86 85.42 85.46 85.48 85.98 86.1 83.74
Fp5 93 93 93 93 93 93 93 93 93 93 93 93 93 95 95 95 95 95 95 95 98 98 98 --- 98.04 85.31 85.37 85.34 85.72 86.02 83.98
Fp6 93 93 93 93 93 93 93 93 93 93 93 93 93 95 95 95 95 95 95 95 98 98 98 98 --- 85.3 85.34 85.27 85.55 85.94 83.7
Ft1 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 --- 99.26 99.32 98.05 91.51 83.31
Ft2 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 99.3 --- 99.43 98.14 91.55 83.76
Ft3 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 99.3 99.4 --- 98.22 91.57 83.35
Ft4 85 86 85 86 86 86 86 86 86 86 86 86 85 85 85 85 85 85 85 85 86 86 86 86 86 98.1 98.1 98.2 --- 91.71 83.99
Fh1 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 92 92 92 92 --- 83.81
Fg1 84 85 84 85 85 85 85 85 85 85 84 85 84 84 84 83 84 84 84 84 84 84 84 84 84 83 84 83 84 84 ---
In green: similarity between strains belonging to the taxon  Fno ; In orange similarity between strains belonging to the taxon  Fnn (in yelow Fnn  Chilean strain);
In blue: similarity between Fno and Fnn ; In purple: similarity within the 4 F. tularensis  subspeceis; 
In pink: similarity of F. philomiragia to Fno and  Fnn ;
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4.3.7 Genome to genome distance (GGD) and in silico DDH 
The genome to genome distances of the type strains and their respective DDH values are 
shown in Table 4.9. 
The values of the in silico DDH between Fno and the strains of Fnn (62-63%) showed 
that these taxa represent separate species. The results confirmed that all the F. tularensis 
strains tested belong to the same species with values ranging from 92-99%. The 
association value (98%) of the Chilean strain with the rest of the Fnn strains was lower 
than that observed within the F. tularensis strains confirming that this isolate represents 
a new subspecies of F. noatunensis.  
F. philomiragia had higher values of association with Fnn (65%) than with Fno (56%). 
All the other strains had values ranging from 21-49%, which confirms their status as 
independent species.  
Table 4.9 In silico DNA-DNA hybridisation and GGD of the type strains 
Fo1 Fn1 Fn5 Fp1 Ft1 Ft2 Ft3 Ft4 Fh Fg
Fo1 - 63 62 56 24 24 24 24 25 21
Fn1 0.407 - 98 65 24 24 24 24 25 21
Fn5 0.409 0.076 - 65 24 24 24 24 25 21
Fp1 0.467 0.388 0.391 - 25 25 25 25 25 21
Ft1 0.890 0.893 0.894 0.880 - 99 99 92 46 21
Ft2 0.896 0.893 0.893 0.880 0.060 - 99 92 47 21
Ft3 0.895 0.890 0.889 0.879 0.055 0.045 - 92 47 21
Ft4 0.892 0.889 0.890 0.868 0.164 0.163 0.164 - 49 21
Fh 0.870 0.871 0.871 0.863 0.561 0.553 0.551 0.531 - 21
Fg 0.966 0.966 0.965 0.963 0.961 0.961 0.961 0.960 0.963 -
GGD values are shown below the diagonal and DDH values  (%)  above.
In blue strains that belong to the same species according the 70% threshold.
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4.3.8 Multilocus sequence analysis (MLSA) 
The total length of the alignment of the concatenated housekeeping genes was 15750 
positions. The pairwise percent similarity of the sequences is presented in Table 4.10. 
The estimates of average evolutionary divergence overall sequence pairs using the Jukes-
Cantor model indicated that the average was 0.09. The phylogenetic tree constructed with 
the neighbour joining method is presented in Figure 4.4. The Perl scrip created to 
concatenate the sequences is: 
#!/usr/bin/perl -w 
# 
#use Sort::Key::Natural qw(natkeysort); 
die "concatenateFromFastas.pl <suffix> <file_Of_strains>\n" if (!(@ARGV)); 
die "concatenateFromFastas.pl <suffix> <file_Of_strains>\n" if ( $#ARGV != 1 ); 
chomp($suff = $ARGV[0]); 
chomp($file = $ARGV[1]); 
open(FH1, "<$file"); 
chomp(@list = <FH1>); 
close(FH1); 
@fastas = <*.$suff>; 
foreach $genome (@list) { 
    $genome =~ s/\s+//g; 
    $hash{$genome} = ""; 
} 
foreach $fasta (@fastas) { 
    open(FH2, "<$fasta"); 
    chomp(@tmp = <FH2>); 
    close(FH2); 
    foreach $row (@tmp){ 
 $row =~ s/\s+//g; 
 if($row =~ />(\S+)/){ 
     $genome = $1; 
     $genome =~ s/_\d+$//g; 
     print "$genome\n"; 
 } 
 else{ 
     if(exists($hash{$genome})){ 
  $concats{$genome} .= $row; 
     } 
 }    } 
    foreach $genome (sort { $a cmp $b } keys(%concats)) { 
 $concats{$genome} .= "--nn--nn--"; 
    } 
} 
$outfile = "concat.genes2.fas";  
open (FH2, ">$outfile"); 
foreach $genome (sort { $a cmp $b } keys(%concats)) { 
    print FH2 ">" . $genome . "\n"; 
    until(length($concats{$genome}) == 0){ 
 print FH2 substr($concats{$genome}, 0, 80, "") . "\n"; 
    } 
} 
close(FH2);
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Table 4.10 Pairwise percent similarity of the concatenated housekeeping genes. 
  
Fo1 Fo2 Fo3 Fo4 Fo5 Fo6 Fo7 Fo8 Fo9 Fo12 Fo14 Fo15 Fo17 Fn1 F5 Fn6 Fn13 Fn15 Fn17 Fn18 Fp1 Fp2 Fp3 Fp4 Fp5 Fp6 Ft1 Ft2 Ft4 Ft3 Fh Fg
Fo1 -
Fo2 100 -
Fo3 100 100 -
Fo4 100 100 100 -
Fo5 100 100 100 100 -
Fo6 100 100 100 100 100 -
Fo7 100 100 100 100 100 100 -
Fo8 100 100 100 100 100 100 100 -
Fo9 100 100 100 100 100 100 100 100 -
Fo12 100 100 100 100 100 100 100 100 100 -
Fo14 100 100 100 100 100 100 100 100 100 100 -
Fo15 100 100 100 100 100 100 100 100 100 100 100 -
Fo17 100 100 100 100 100 100 100 100 100 100 100 100 -
Fn1 95 95 95 95 95 95 95 95 95 95 95 95 95 -
F5 95 95 95 95 95 95 95 95 95 95 95 95 95 99.7 -
Fn6 95 95 95 95 95 95 95 95 95 95 95 95 95 100 100 -
Fn13 95 95 95 95 95 95 95 95 95 95 95 95 95 100 99.7 100 -
Fn15 95 95 95 95 95 95 95 95 95 95 95 95 95 100 99.7 100 100 -
Fn17 95 95 95 95 95 95 95 95 95 95 95 95 95 100 99.7 100 100 100 -
Fn18 95 95 95 95 95 95 95 95 95 95 95 95 95 100 99.7 100 100 100 100 -
Fp1 94 94 94 94 94 94 94 94 94 94 94 94 94 97 97 97 97 97 97 97 -
Fp2 94 94 94 94 94 94 94 94 94 94 94 94 94 97 97 97 97 97 97 97 98.6 -
Fp3 94 94 94 94 94 94 94 94 94 94 94 94 94 97 97 97 97 97 97 97 98.6 100 -
Fp4 94 94 94 94 94 94 94 94 94 94 94 94 94 97 97 97 97 97 97 97 98.6 100 100 -
Fp5 94 94 94 94 94 94 94 94 94 94 94 94 94 97 97 97 97 97 97 97 98.5 98.9 98.8 98.8 -
Fp6 94 94 94 94 94 94 94 94 94 94 94 94 94 97 97 97 97 97 97 97 98.6 98.8 98.8 98.8 98.9 -
Ft1 83 83 83 83 83 83 83 83 83 83 83 83 83 84 84 84 84 84 84 84 84 84 84 84 84 84 -
Ft2 83 83 83 83 83 83 83 83 83 83 83 83 83 84 84 84 84 84 84 84 84 84 84 84 84 84 99.6 -
Ft4 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 99 99 -
Ft3 83 83 83 83 83 83 83 83 83 83 83 83 83 84 84 84 84 84 84 84 84 84 84 84 84 84 99.7 99.8 99 -
Fh 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 94 94 94 94 -
Fg 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 -
In green Fno  vs Fnn  (95%); In orange Fp  vs Fno (94%); In light blue Fp  vs Fnn (97%); Dark blue the 4 Ft ssp.; Red the Chilean isolate with respect to the other Fnn.
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Figure 4.4 Phylogenetic analysis based on the concatenated sequences of the 8 
housekeeping genes. The strains analysed are identified according to Table 4.1. The 
optimal tree with the sum of branch length = 0.44353318 is shown. The tree is drawn to 
scale, with branch lengths in the same units as those of the evolutionary distances used 
to infer the phylogenetic tree. There were a total of 15750 positions in the final dataset. 
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Figure 4.4 Phylogenetic analysis based the concatenated sequences of the 8 housekeeping 
genes (continued). View of the subtree clustering isolates of Fnn. 
4.3.9 Whole genome G+C content and phylogeny 
The amino acid composition (%), total size (bp) and G+C content (%) of each genome 
analysed are presented in Table 4.11. The average percent of G+C content for the taxon 
Fno was 32.3, for Fnn 32.5, for Fp 32.6 and for Ft 32.3. The WG phylogenetic tree is 
presented in Figure 4.5 and the WG phylogenetic network is shown in Figure 4.6. A 
diagram comparing the circular chromosome maps of the whole genome sequences of 
the type strains of the genus Francisella and STIR-GUS-F2f7 is presented in Figure 4.7. 
The Perl script to run the progressive Mauve alignment was: 
#!/usr/bin/perl -w 
 
die "usage: run_progressiveMauve.pl <files postfix> \n" if (!defined(@ARGV)); 
die "usage: run_progressiveMauve.pl <files postfix> \n" if ( $#ARGV != 0 ); 
 
chomp($pf = $ARGV[0]); 
 
@files = <*.$pf>; 
 
$genomes = join(' ', @files); 
 
system("/home/parlar/bin/progressiveMauve --output=alignment.xmfa $genomes"); 
Chilean isolate Fn5
Irish isolate  Fn13
 Fn6
 Fn1
 Fn17
 Fn18
 Fn15
Scandinavian isolates
0.0002
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Table 4.11 Overall composition (%) and G+C content (%) of the genomes analysed 
Strain♣ A C G T(U) Total (bp) G+C average per taxon
Fo1 33.8 15.5 16.7 34.0 1846774 32.2
Fo2 33.6 14.6 17.7 34.0 1914623 32.3
Fo3 33.6 14.5 17.7 34.1 1882841 32.2
Fo4 33.6 14.6 17.7 34.0 1904264 32.3
Fo5 33.6 14.6 17.7 34.0 1930364 32.3
Fo6 33.9 16.2 16.1 33.8 1858986 32.3
Fo7 33.6 14.6 17.7 34.1 1878063 32.3
Fo8 33.6 14.6 17.8 34.0 1890246 32.4
Fo9 33.6 14.7 17.7 34.1 1907963 32.3
Fo12 33.7 17.1 15.4 33.9 1887347 32.4
Fo14 33.9 15.6 16.6 33.9 1875075 32.2
Fo15 33.6 14.6 17.8 34.0 1886598 32.4
Fo17 33.7 14.6 17.7 34.1 1847202 32.2 32.3
Fn1 33.9 16.1 16.4 33.6 1719713 32.5
Fn5 33.7 16.2 16.2 33.9 1701861 32.4
Fn6 33.9 16.1 16.2 33.8 1902019 32.3
Fn13 33.6 16.2 16.2 34.0 1712403 32.4
Fn15 33.8 16.5 16.1 33.7 1699540 32.5
Fn17 33.7 16.5 16.2 33.6 1640505 32.7
Fn18 33.5 16.0 16.6 33.9 1652624 32.6 32.5
Fp1 33.7 16.4 16.2 33.7 2017400 32.6
Fp2 33.7 16.7 15.8 33.7 1985122 32.5
Fp3 33.8 16.1 16.4 33.6 2045775 32.6
Fp4 33.9 16.4 16.1 33.7 1910031 32.5
Fp5 33.8 16.8 15.8 33.6 1916998 32.6
Fp6 33.5 15.4 17.3 33.8 1880223 32.6 32.6
Ft1 33.8 15.9 16.3 34.1 1894157 32.2
Ft2 34.0 16.0 16.3 33.7 1893886 32.3
Ft3 34.0 15.9 16.3 33.7 1892775 32.3
Ft4 33.9 16.4 16.1 33.7 1910031 32.5 32.3
Fh 34.0 16.2 15.9 33.9 1919170 32.1 32.1
Fg 33.9 16.0 16.0 34.1 1658482 32.0 32
♣Strains are identified according to Table 4.1
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Figure 4.5 Evolutionary relationship of the genus Francisella.The evolutionary history 
was inferred using the Neighbor-Joining method. There were a total of 841918 positions 
in the final dataset. 
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Figure 4.5 Evolutionary relationship of the genus Francisella (continued). Close up of 
the subtree clustering fish pathogenic strains. 
 
 
 
 
Figure 4.5 Evolutionary relationship of the genus Francisella (continued). Comparison 
of the subtree clustering pathogenic strains with cold water fish species. 
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Figure 4.6 Whole genome phylogenetic network of the genus Francisella. Split decomposition analysis constructed under neighbour net graph 
and uncorrected p distance options of the SplitTree programme.  
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Figure 4.6 Whole genome phylogenetic network of the genus Francisella (continued). Close up of the lower branch of the network.
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Figure 4.7 Circular map of the genome of the Francisella type strains and STIR-GUS-
F2f7. The outer scale is marked in base pairs. From outer to inner circles: first (black) all 
the nucleotides. Second STIR-GUS-F2f7 coding sequences (CDS) in forward strand. 
Third STIR-GUS-F2f7 CDS in reverse strand. Dark blue F. noatunensisTS. Purple F. 
philomiragiaTS. Yellow F. hispaniensisTS. Green F. tularensisTS. Pink F. 
guangzohuensisTS. Red rRNA genes. 10th circle tRNA’s. The innermost circles show: GC 
skew and G+C content.
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4.4 Discussion 
Recently the taxonomy of the order Thiotrichales (class Gammaprotobacteria phylum 
Proteobacteria, superkingdom Bacteria) was revised by Boscaro et al. (2012) and as a 
result the creation of a new monophyletic taxon within the family Francisellacea (at the 
rank of the genus Francisella) was proposed to comprise the bacteria Wolbachia persica, 
Caedibacter taeniospiralis, “Candidatus Nebulobacter yamunensis” and Fangia 
hongkongensis.  
Such a recommendation attempted to “extend” the boundaries of the family allocating 
the mentioned taxa and clarify the taxonomic status of many incertae sedis and 
unculturable microorganisms i.e. Francisella spp. from soil and water (Barns et al., 2005) 
or Francisella-like endosymbionts from ticks (de Carvalho et al., 2011; Dergousoff and 
Chilton, 2011; Ivanov et al., 2011; Michelet et al., 2013; Montagna et al., 2012; Scoles, 
2004; Sréter-Lancz et al., 2009; Szigeti et al., 2014;).  
However, since such proposal was based on the rules for nomenclature of uncultivated 
bacteria (Murray and Schleifer, 1994; Amann et al., 1995; Murray and Stackebrandt, 
1995) and the “modern” concept of species “metapopulation lineages” (de Queiroz, 
2005), it was not considered as validly published or approved by the International 
Committee on Systematics of Prokaryotes and its Judicial Commission, but appeared in 
the List of Changes in Taxonomic Opinion (Euzeby, 2013). 
Thus, as per the requirements of the International Code of Nomenclature of Prokaryotes 
(Lapage et al., 1992) the genus Francisella with its six species and six subspecies is the 
only validly accepted within the family Francisellacea. 
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The requirements and guidelines for the taxonomic nomenclature of prokaryotes indicate 
that strains thought to constitute a novel taxa must be phenotypically and genetically 
characterised as comprehensively as possible (Tindall et al., 2010). Therefore non-
cultured and consequently non-phenotypically characterised (or poorly characterised) 
strains cannot be described as a new valid taxon or assigned into one (Gevers et al., 2005; 
Kämpfer, 2010; Wayne, 1987) 
Since the Bacterium tularense was first described in 1912 (McCoy and Chapin, 1912), 
several taxonomic rearrangements have taken place from the subspecies or lower ranks 
to the genus level and the ecology, pathogenicity and fastidious nature of the bacteria 
Francisella spp. appears to be the reason and logic explanation as why this has 
historically happened.  
The most recent example of these changes is “Francisella endociliophora”, a bacterium 
that was originally identified as a non-isolated endosymbiont or “Francisella-like 
bacterium” of the marine ciliate Euplotes raikov (Schrallhamme et al., 2011). This 
bacterium was partially genetically characterised, but was at that time, uncultured so 
according to the rules for description of well known (genetically characterised) but yet 
not isolated (Murray and Stackebrandt, 1995) it was classified as a “candidatus” novel 
subspecies of F. noatunensis i.e. “Candidatus F. noatunensis ssp. endociliophora”. A few 
years later it was isolated using acid treatment (Humrighouse, 2011) to release it from 
the ciliate and its genome was fully sequenced (Sjödin et al., 2014). Although the name 
F. endocilipohora was published in the genome announcement, it is not yet considered 
as validly published and it is unlikely that it will be validated if the phenotype is not 
analysed.  
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Like F. endociliophora, there are many other Francisella spp. strains that have been 
isolated and genetically, but not phenotypically characterised (Kugeler et al., 2008; 
Petersen et al., 2009; Respicio-Kingry et al., 2013; Rydzewski et al., 2014). As 
mentioned before, this may be explained due to the fastidious nature of such strains i.e. 
slow growth and low reactivity with standard biochemical identification tests, and 
perhaps little interest from clinical and environmental researchers towards the taxonomy 
of their findings.  
The phenotypic analyses performed in the current study allowed the differentiation of 
two of the closest related taxa within the genus and suggests that this methodology could 
be a suitable inexpensive tool to describe novel Francisella spp. and those isolated, but 
not yet described strains in compliance with the International Code of Nomenclature of 
Prokaryotes and the International Committee on Systematics of Prokaryotes and its 
Judicial Commission (Lapage et al., 1992). 
The morphology of the Fnn and Fno colonies and the optimal temperature described in 
this study are in disagreement with that reported by Ottem et al. (2009) on the description 
of Fno. In the current experiments, the optimal growth temperature found for this 
bacterium was 28-29 °C, but not 25°C and the colonies were greenish-greyish but not 
pale yellowish.  
The Fno FAME profiles obtained in this study were similar to the results obtained in 
Section 2.3.3.4 for STIR-GUS-F2f7 and the other two Fno strains analysed at that time. 
In the present study, several strains of each taxon were simultaneously used and statistical 
analyses were performed to compare the content per taxon, these analyses indicated that 
the fatty acid 24:0 was useful to differentiate between the taxa. Additionally, the 
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summations of the saturated and mono saturated fatty acids were significantly different 
among the groups, confirming that summations and the content of fatty acid 24:0 can be 
considered as taxon-specific chemotaxonomical markers and a reference for future 
research on Francisella spp. taxonomy. The values obtained in the current study for the 
amount of 24:0 in Fnn and Fp were almost identical to those presented by Ottem et al. 
(2007).  
The use of the modified Biolog GN2 protocol allowed better characterisation of Fnn as 
it was possible to identify 10 positive reactions that appeared as false negatives with the 
standard manufacturer’s guidelines. This is clearly in agreement with the results 
presented by Huber et al. (2010) for strain Fn17, who only found six positive reactions, 
as in the present study.  
However, as with Fno in Chapter 2 there were few reactions i.e. dextrin (A3) glycogen 
(A4), D-cellobiose (A12), glycyl-Lglutamic acid (F12), L-threonine (G12), glycerol (H9) 
and D-L-α-glycerol phosphate (H10), that appeared to be positive with higher densities 
in the strains from Norway, and other tests should be considered to confirm whether the 
cells are capable or not of metabolising those carbon sources. This was not seen in F. 
philomiragia, which grows faster, is more biochemically reactive and is considerably less 
fastidious. 
From the reactions that were clearly positive or clearly negative, no differences were seen 
within the Fno strains, despite their widely different geographical origin. However, 
several differences were seen between some of the Fnn strains. In total there were 22 
positive reactions in Fno and 17 in Fnn. 
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On comparison of Fnn with Fno, 10 differences were seen, most notably the inability of 
Fnn to metabolise glucose-1- phosphate (H11), glucose-6-phosphate (H12), and acetic 
acid (D1) and the inability of Fno to metabolise D-alanine (F5).   
All of the Fnn isolates from Norway had the same profiles and they were slightly 
different to the Irish isolate, however almost as many differences as those seen between 
Fno anf Fnn were seen between the Norwegian and Chilean isolates, this was also 
reflected in the colony morphology, where the Chilean isolate was greenish-greyish and 
the others whitish-greyish.  
Some of the phenotypic differences (more reproducible assays) that allowed 
differentiation between species and subspecies in this study are summarised in Table 
4.12. 
Table 4.122 Differential characteristic of fish pathogenic Francisella spp. 
 
In prokaryote taxonomy the gold standards for bacterial species delineation are percent 
similarity in the 16SrRNA gene and DNA-DNA hybridisation (DDH). The current 
guidelines indicate that if two strains share a similarity of 98.65% or lower in the 16S 
rRNA gene they constitute two separate species (Kim et al., 2014). However this rule 
Characteristic F. orientalis
F. orientalis F. noatunensis chilense
Origin/ distribution world wide Europe (Scandinavia) Europe (Ireland) Chile
Optimal temperture °C 28-29 22 22 22
Colony colour on CHAH greenish-greyish white white-greyish greyish-greenish
Mono-Methyl- Succinate - + + -
Acetic Acid + - + +
D,L-Lactic Acid - - - +
D-Alanine - + - -
L-Alanylglycine + + + -
L-Threonine + - - +
Glycerol + - + +
Glucose-6-Phosphate + - - -
F. noatunensis 
F. noatunensis noatunensis
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cannot be applied to all genera, therefore if there are important phenotypic differences 
and the 16S rRNA value is higher, wet lab DDH experiments should be performed to 
clarify the status.  
In such experiments the strains should show DNA-DNA re-association values of 70% or 
higher if they belong to the same species or lower to constitute two separate species. 
Since the wet lab DDH technique has many drawbacks including the fact that it is time 
consuming, labour intensive, expensive and not easily reproducible between laboratories 
(Goris et al., 2007), bacterial taxonomists are looking for new methodologies to replace 
it.  
The new options are based on correlations between DDH values and genome derived 
information (Ramasamy et al., 2014). Among the different proposals, perhaps the most 
widely used are average nucleotide identity value (ANI) (Richter and Rosselló-Móra, 
2009) and genome to genome distance GGD or “in silico DDH” (Meier-Kolthoff et al., 
2013). Although these have been demonstrated to be highly reliable they can only be 
used if the researchers have sequenced the complete genome of their strains. 
Given the high level of relatedness between some members of the genus Francisella, the 
current criteria of 98.65% in the 16S rRNA gene is not suitable to investigate the 
taxonomical status of their members and DDH experiments are usually performed. 
In this study the DDH presented for the comparison of Fno against Fnn was 10% below 
the 70% threshold confirming that they represent separate species nevertheless the values 
between Fnn and Fp and Fp and Fno available in the literature are ambiguous and 
inconsistent. 
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The DDH result shown here (Fo14 in comparison to Fn1) was originally presented in 
Mikalsen and Colquhoun (2009) however since this report is no longer available in the 
scientific literature it is included within this study in collaboration with Dr. Duncan 
Colquhoun. 
In order to validate DDH result presented in this study, clarify the ambiguity of previous 
wet lab DDH values (Table 4.5) and explore the boundaries of species and subspecies 
delineation within Francisella noatunensis, whole genome derived information was 
included in this study.  The inclusion of genomic data for taxonomy “taxo-genomics” 
was useful not only to comply with the future “gold standards” (GGD and ANI), but also 
to investigate and compare the phylogeny at three different levels of resolution i.e. single 
gene, concatenated housekeeping genes and whole genome analyses.  
The phylogenetic trees were consistent across the 3 levels of resolution. In all of them, 
Fno and Fnn clustered in different branches, and the Chilean isolate separated from the 
other Fnn, but was still contained within the same subtree. The Irish isolate showed some 
branching separation from the others, but this was only clearly visible at the whole 
genome scale. 
The WG analyses here included were also useful in establishing a threshold for 
subspecies delineation within Francisella noatunensis, where it is proposed that with an 
ANI of 99.5%, a GGD of 0.076 and an in silico DDH value of 98% with respect to the 
other Fnn, the isolates recovered from Chile constitute a new subspecies, but not the 
isolate from Ireland that even though it showed some differences in the phenotype, had 
100% ANI with respect to all the other Fnn. 
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4.5 Conclusion and description of new taxa 
4.5.1 Conclusion 
In this study a polyphasic approach that incorporated several phenotypic features and 
genome-sequence derived parameters was used to characterise several strains of fish 
pathogenic Francisella ssp. and clarify their taxonomical status.  
Based on the results obtained it is proposed to elevate Francisella noatunensis orientalis 
to the rank of species as Francisella orientalis comb. nov. sp. nov and amend the 
description of Francisella noatunensis. Furthermore it is proposed to create a new 
subspecies within F. noatunensis for which the name F. noatunensis subsp. chilense 
subsp. nov. is proposed. According to the rule 40b of the International Code of 
Nomenclature of Bacteria (Lapage et al., 1992) the creation of this subspecies 
automatically creates the subspecies F. noatunensis subsp. noatunensis subsp. nov.  
4.5.2 Description of Francisella orientalis comb. nov. sp. nov. 
Francisella orientalis (o.ri.en.ta‘lis. L. fem. adj. orientalis from the east, referring to 
where the type strain was isolated). 
The description of this species is as that presented for F. noatunensis subsp. orientalis 
(Ottem et al., 2009) with the following corrections and additions: 
The optimal growth temperature is 28-29 °C and the colonies are greenish-greyish on 
CHAH. The lipase (C14), α-chymotripsin and α-galactosidase tests are weakly positive.  
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It is capable of metabolising dextrin, N-acetyl-Dglucosamine, D-fructose, α-D-glucose, 
D-mannose, methyl pyruvate, acetic acid, α-keto butyric acid, L-alaninamide, L-alanine, 
L-alanylglycine, L-asparagine, L-glutamic acid, L-proline, L-serine, L-threonine, 
inosine, uridine, glycerol, DL-α-glycerol phosphate, glucose-1-phosphate and glucose-
6-phosphate.  
The polyamine profile of the type strain is (µmol/g dry weight): diaminopropane 0.2-1.3, 
putrescine 2.0, cadaverine 22.6, spermidine 11.5 and spermine 0.2. The quinoe system is 
conformed by 78.8% ubiquinone Q8 and 21.2% of Q7. 
The type strain is Ehime-1 (=DSM21254T = LMG24544T) isolated from the farmed 
marine fish three-line grunt or isaki (Parapristipoma trilineatum) in 2001 in Ehime-
prefecture, Japan. 
4.5.3 Emended description of the F. noatunensis (Ottem et al., 2009) 
Francisella noatunensis (no.at.un.en.sis. N.L. n. noatun (enclosure of ships) was the 
coastal abode of the Norse god of fisheries and seamanship; L. fem. suffix -ensis suffix 
meaning ‘belonging to’; N.L. fem. adj. noatunensis belonging to the coast/sea. 
In addition to the descriptions provided by Mikalsen et al.  (2007) and Ottem et al. (2009) 
the strains of this species (both subspecies and atypical strains) are capable of 
metabolising D-fructose, α-D-glucose, D-mannose, methyl pyruvate, α-keto butyric 
acid, L-alanine, L-asparagine, L-glutamic acid, L-proline, L-serine, inosine. In contrast 
to F. orientalis the strains of both subspecies of this taxon are negative for dextrin, 
uridine, DL-α -glycerol phosphate, glucose-1-phosphate, and glucose-6-phosphate. 
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The type strain of the species is 2005⁄50⁄F292-6CT (=NCIMB14265T = LMG23800T) 
isolated from Atlantic cod in Norway in Hordaland county Norway in 2005. 
4.5.4 Description of Francisella noatunensis subsp. chilense subsp. nov. 
Francisella noatunensis subsp. chilense (chi.len′se. N.L. neut adj. chilense referring to 
the country Chile where the type strain was isolated).  
This subspecies has only been isolated in the southern hemisphere from diseased farmed 
or captured fish in fresh or brackish water in Chile. In contrast to the strains of F. 
noatunensis noatunensis the colonies of this subspecies are greenish-greyish and don’t 
grow well with concentrations of NaCl over 2% in the media and is unable to metabolise 
N-acetyl-Dglucosamine, mono-methyl- succinate, L-alaninamide, D-alanine, L-
alanylglycine, but it is positive for glycerol, L-threonine, DL-lactic acid and acetic acid.  
The type strain is PQ1106T NVI5888 T FSC772 T isolated from Atlantic salmon in the 
lake Llanquihue Chile in 2006. 
4.5.5 Description of Francisella noatunensis subsp. noatunensis subsp. nov. 
Francisella noatunensis noatunensis (no.at.un.en.sis. N.L. n. noatun (enclosure of ships) 
was the coastal abode of the Norse god of fisheries and seamanship; L. fem. suffix -ensis 
suffix meaning ‘belonging to’; N.L. fem. adj. noatunensis belonging to the coast/sea. 
The strains of this subspecies have only been isolated from diseased fish farmed or 
captured in northern Europe. The colonies are whitish and can grow in concentrations up 
to 6% of NaCl. In addition to the emended description of the species F. noatunensis 
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presented here, the strains of this subspecies are also able to metabolise N-acetyl-
Dglucosamine, mono-methyl-succinate, L-alaninamide, D-alanine, L-alanylglycine, 
Atypical strains: in contrast with the other Fnn the atypical “Irish” strain has the ability 
to metabolise acetic acid and glycerol but incapable to use D-alanine. A strain isolated 
from Sweden is also incapable to metabolise D-alanine.  
The type strain of this subspecies is 2005 ⁄ 50 ⁄ F292CT (=NCIMB14265T=LMG23800T) 
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Chapter Five  
A whole-cell inactivated Francisella orientalis vaccine protects red Nile tilapia 
against experimental infection via intraperitoneal injection.
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5.1 Introduction 
Francisellosis is an acute to chronic bacterial disease that can affect a diverse spectrum 
of animals including mammals, aquatic animals and invertebrates. This disease is caused 
by members of the genus Francisella, which is currently the only fully recognised genus 
within the family Francisellaceae γ-proteobacteria class (Colquhoun and Duodu 2011). 
The notable pathogenic species of the genus are F. tularensis, causative agent of 
tularaemia, a fatal disease in humans (Nano and Schmerk 2007) and Francisella 
orientalis, causative agent of francisellosis in warm water fish recently described as a 
new species (Chapter 4). 
Outbreaks of Fo have been reported in farmed tilapia in several countries in America, 
Africa, Asia and Europe. The first record of this disease in tilapia was in Taiwan (Chen 
et al., 1994; Chern and Chao 1993) but it has subsequently been reported in several 
cichlids, including a number of ornamental species (Hsieh et al., 2006; Hsieh et al., 2007; 
Kamaishi et al., 2005; Mauel et al., 2007; Ostland et al., 2006; Soto et al., 2009). 
According to FAO (2014) tilapia is the second most important group of freshwater fish 
by production after carps and the most widespread species in aquaculture. The worldwide 
production of tilapia increased from 2.6 million tons in 2005 to 4.2 million tons in 2012, 
and its production is expected to exceed 5 million tons by late 2015 (Fitzsimmons et al., 
2014). 
Francisellosis in tilapia is characterised by widespread (multifocal) granulomas (white 
nodules) in the peritoneal cavity, including organs such as the kidney (anterior and 
posterior), spleen, gastrointestinal tract, liver and mesenteric fat; the clinical signs include 
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exophthalmia, flashing, petechial haemorrhages in gills or fins; it has a high percentage 
of morbidity (80-90%) and mortality (50-90%). Microscopically, the characteristic 
pathological change is granulomatous inflammation in multiple organs, most severe in 
spleen and kidney, but also present in heart, liver, eyes, gills, brain and gut. The 
macrophages in the granulomas contain bacteria, but bacteria can also be found 
extracellularly following release from damaged macrophages.  
Although farming of tilapia species is considered one of the most important sectors in 
aquaculture and Fo is one of the most pathogenic bacteria for them (Chapter 2; Soto et 
al., 2009) there are currently no commercially available products for the treatment or 
prevention of this disease.  
Experimental vaccination trials against piscine francisellosis started in Norway where 
different oil-adjuvanted, whole cell preparations of Francisella noatunensis (Fn), the 
cause of francisellosis in cold water fish species, were tested in Atlantic cod (Krossøy et 
al., 2007; Müller et al., 2011; Schrøder et al., 2009). 
For Fo the only approach for vaccine development was performed by Soto et al., (2011b) 
using a live attenuated strain, with a mutation at the intra-cellular growth locus C gene 
(iglC), which was shown to confer a relative percentage survival (RPS) of 87.5% in Nile 
tilapia after immersion challenge (Soto et al., 2011b). Although such attenuated vaccine 
demonstrated to be effective under laboratory conditions (Soto et al., 2011b; Soto et al., 
2014b), it is unlikely to be licensed for use in Europe due to the fact that regulatory 
authorities in the European Union do not favour licencing of live vaccines in aquaculture.  
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These restrictions reflect the inherent risks presented by live vaccines (e.g. reversion to 
virulence, dissemination into the environment, potential transmission to other aquatic 
species etc.). Thus there is a need for the development of an inactivated vaccine against 
this fastidious pathogen 
Recently, a novel strain of Fo was isolated from moribund red Nile tilapia farmed in 
Europe. The isolate, STIR-GUS-F2f7, was subjected to a comprehensive phenotypic 
characterisation based on morphological, physiological and chemotaxonomic analysis 
(Chapter 2).  
The aims of the current study were to investigate the susceptibility of different genetic 
groups of tilapia to Fo, develop an autologous inactivated vaccine against francisellosis 
and test its efficacy by measuring survival rates, specific antibody production, and 
differential gene expression during the onset of the infection. 
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5.2 Materials and methods 
5.2.1 Fish, bacteria and experimental models 
5.2.1.1 Fish species 
Three genetic groups of tilapia i.e. red and wild type O. niloticus and O. mossambicus 
were used to determine the LD50 of Fo isolate STIR-GUS-F2f7, while red Nile tilapia 
was used for the pre-challenge and the vaccination studies. Healthy naïve tilapia, 6-7 
months/~11g (7-13g), were used as described in Section 2.2.5. 
5.2.1.2 Bacterial strains 
The pathogenic isolate of Francisella orientalis STIR-GUS-F2f7, recently isolated from 
moribund Nile tilapia in Europe, was used. The bacterium was grown on CHA and 
MMHB, as described previously in Section 2.2.3.1. 
5.2.1.3 Virulence and vaccine efficacy testing  
In both the virulence assays and the vaccine efficacy testing, an intraperitoneal (IP) 
injection model was used, as described in Section 2.2.4. For the vaccination procedure, 
including the safety test, the fish were maintained in the TA at a water temperature of 
28°C. For all the infections trials the fish were moved from the TA into a flow-through 
system at the Aquatic Research Facility (ARF), where the water was maintained at 
23±2oC to replicate the natural epidemiological conditions at which the disease occurs. 
Once moved to the ARF, the fish were given an acclimation period of ten days prior to 
beginning the experiments.  
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During periods of acclimation, infection, and vaccination, the fish were fed twice a day 
at a rate of 2% biomass. In all the experiments the fish were anaesthetised with a dose of 
100mg/l of Tricaine Pharmaq 1000mg/g (TPQ) (Pharmaq, Hampshire, UK) prior to 
injection. All moribund fish observed during the experiment were immediately sacrificed 
with an overdose of TPQ. All the survivors were sacrificed also with an overdose of TPQ 
at the end of the trial. All the procedures were performed in accordance with the UK 
Animal (Scientific Procedures) Act 1986 and complied with local institutional 
regulations. 
5.2.2 Lethal dose 50% (LD50) virulence testing 
Three genetic groups of tilapia (a total of 188 fish) and 4 doses of bacteria were used. 
For Oreochromis niloticus and O. mossambicus 16 fish per tank were used, while for O. 
niloticus wild type the stocking density was increased to 20 fish per tank to prevent the 
hierarchical aggression initially observed. 
The fish were placed in 2 litre plastic tanks with the water volume adjusted to 1.8 litres 
and containing individual air stones. Four tanks per genetic group were used and each 
tank was injected with one of 4 different doses of bacteria. The fish were maintained for 
45 days post-infection (dpi) and mortalities recorded 4 times per day. All dead and 
moribund fish were sampled for bacterial recovery and histopathology. 
Based on the standard curve for bacterial quantification, shown in Section 2.3.5, a 
bacterial “stock” suspension with an initial concentration of ~1.0x109 CFU/ml (OD600 of 
0.4) was prepared in 1X sterile PBS. This stock was then serially diluted 10-fold and the 
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dilutions containing 102 CFU/ml (dilution 10-7), 103 CFU/ml (dilution 10-6), 104 CFU/ml 
(dilution 10-5) and 106 CFU/ml (dilution 10-3) selected for the infection doses.  
Each fish received an IP injection with 0.1 ml of the respective dilution of bacteria and 
the actual number of viable bacteria present in the stock solution was estimated on CHAH 
by drop counts using the method reported by Miles et al. (1938). The cumulative 
percentage mortality recorded was used to establish sigmoidal dose-response curves for 
each tilapia species and for each dose.  
5.2.3 Pre-challenge (LD60 confirmation) 
A pre-challenge was established by injecting 20 red Nile tilapia fingerlings IP with a dose 
of 2.4 x104 CFU/fish. The dose and fish group were selected based on the results of the 
LD50 experiment. The objective of this experiment was to confirm that this dose would 
cause around 60% mortality by 21 dpi in naïve red tilapia. 
5.2.4 Vaccine preparation and safety test  
F. orientalis STIR-GUS-F2f7 was cultured in CHAB and MMHB under culture 
conditions indicated in Section 2.2.3.1. Inactivation of the bacteria was achieved using 
formaldehyde at a final concentration of 0.05%. Bacteria were grown overnight (~18h) 
in 15ml of broth. This culture was then centrifuged at 3500g for 20 min, the bacterial 
pellet washed 3 times with 1X sterile PBS and adjusted to an OD600 of 1.0 (2.63 x109 
CFU/ml). The bacteria and 40% formalin were mixed and left overnight at 4°C in a sterile 
glass vessel, with slow stirring. The formaldehyde was neutralized using 10ml per 
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1000ml (1/100 dilution) of 15% sodium metabisulphite stock solution added 96h after 
inactivation.  
Finally, the solution was washed and the bacterial pellets with dead bacteria were diluted 
in 1X PBS to obtain an OD600 of 1.0. Inactivation of the bacteria was confirmed by 
inoculating on to CHAHB and incubating at 28oC for 72h.  
The commercial oil adjuvant Montanide™ ISA763AVG (SEPPIC, Puteaux Cedex, 
France) was emulsified with the bacteria. The protocols followed for this were for W/O 
emulsion in a 30/70 distribution of the continuous and dispersed phases (30% antigen to 
70% adjuvant) according to the manufacturer’s guidelines. The emulsion was 
homogenised for 5min with a hand blender at 4000rpm. For the first 3min a constant 
speed of 4000rpm was used, then the speed was increased to 4500rpm for 30s, after which 
it was decreased to 4000rpm for 1min and then at the second speed for a final 30s. 
The initial concentration of inactivated bacteria was 2.6x109 CFU/ml, and was reduced 
to 1.3x109 CFU/ml after emulsification. As indicated by the adjuvant manufacturer and 
(Aucouturier, 2001) the emulsion was stored at 4°C and its stability checked after 24h 
and 15 and 60 days by performing a visual inspection, droplet test, conductivity readings, 
particle size assessment and syringeability in and out of the fish. 
The final volumes used for the production of the vaccine were 100ml of bacteria in PBS, 
500µl of 40% formalin, 1ml of 15% sodium metabisulphite. The total amount of 
formalin-killed bacteria obtained was 60ml of which 33ml were added to 77ml of 
adjuvant to obtain a total volume of 110ml of vaccine.  
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To perform a safety test, thirty fish were IP injected with 0.2ml of vaccine (i.e. double of 
the vaccination dose) and checked twice a day for 7 days looking for any possible side 
effects, such as changes in behaviour, toxicity, mortalities or other signs that could be 
related to the formulation of the vaccine. 
5.2.5 Vaccination and infection  
5.2.5.1 Experimental design 
The experiment was designed to monitor and quantify the production of specific 
antibodies and assess the efficacy of the vaccine. A total of 678 red Nile tilapia were 
divided between 16 tanks were used. The first set of tanks consisted of treatments 1-3, 
with three tanks per treatment and 52 fish per tank; Fish in the first treatment were 
injected with the vaccine preparation (antigen/adjuvant emulsion), fish in the second 
treatment were injected with PBS as a control group and fish in the third treatment were 
injected with only adjuvant (emulsified with1X PBS) with no antigen.  
The second set of tanks consisted of treatments 4-6 with three tanks in treatments 4 and 
5, and one tank in treatment 6; in this set of treatments 30 fish per tank were used in order 
to assess granuloma formation in the tissues and investigate the spleen and head kidney 
transcriptomic profiles of vaccinated and unvaccinated fish shortly after infection. The 
fish in treatment 4 were vaccinated and then challenged, while the fish in treatment 5 
were challenged without being vaccinated and the thirty fish in tank 16 (treatment 6) 
were not vaccinated/not challenged and kept as a control group.  
For the vaccination process, all the fish were IP injected using stainless hypodermic 
needles 22GX7mm and 21GX8mm (Aqualife Fish Care Professionals, Stirling, UK) with 
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0.1ml of their respective treatment i.e. vaccine, adjuvant or PBS and kept for 30 days at 
the TA. For the challenge all the fish were moved to ARF 31dpv and IP injected with 
0.1ml of a PBS solution containing 4x104 CFU/ml (4x103 CFU/fish), a dose expected to 
produce cumulative mortality between 60% and 80% in the PBS (control) group within 
the first 35dpi. The experimental design is illustrated in Figure 5.1 
 
Fig. 5.1 Experimental design of the vaccination-infection experiment. The picture shows 
the fish after being transferred to the ARF at day 30 post vaccination just before the 
beginning of the experimental infection.  
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5.2.5.2 Sampling points 
Fish in set one (treatments 1-3) were sampled at 4, 8, 15 and 30 days post vaccination 
(dpv). At each sampling point, 8 fish per tank were bled from the caudal vein to 
investigate the kinetics of the serum humoral response (antibody production). The 
remaining 20 fish of each tank were not handled after the infection and their mortalities 
were recorded to determine the efficacy of the vaccine. In the second set of treatments 
the sampling was performed at 24, 48 and 96 hours post infection (hpi). In these tanks 
the spleen and head kidney of the fish were aseptically removed, placed in RNAlater® 
stabilization solution (Life technologies, Paisley, UK), snap frozen in liquid nitrogen and 
stored at -80°C. The spleens of these fish were visually inspected for granuloma 
formation before placing them in the RNAlater. All the sampling handling was performed 
after having sacrificed the fish with a lethal overdose (300mg/l) of TPQ. 
5.2.5.3 Vaccine efficacy assessment (RPS) 
To establish the efficacy of the vaccine as a percentage value, the relative percent survival 
(RPS) was calculated. This value indicates the proportional relationship between 
mortality in the vaccinated group (treatment 1) and the unvaccinated group (treatment 2) 
and was established using the following equation (Amend, 1981): 
𝑅𝑅𝑅𝑅𝑅𝑅 =  �1 − � % 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑚𝑚𝑖𝑖 𝑣𝑣𝑚𝑚𝑣𝑣𝑣𝑣𝑚𝑚𝑖𝑖𝑚𝑚𝑚𝑚𝑣𝑣𝑣𝑣 𝑓𝑓𝑚𝑚𝑓𝑓ℎ% 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑚𝑚𝑖𝑖 𝑖𝑖𝑚𝑚𝑖𝑖−𝑣𝑣𝑚𝑚𝑣𝑣𝑣𝑣𝑚𝑚𝑖𝑖𝑚𝑚𝑚𝑚𝑣𝑣𝑣𝑣 𝑓𝑓𝑚𝑚𝑓𝑓ℎ�� × 100% 
The RPS value was also obtained for fish injected only with the adjuvant for comparisons 
with the value obtained in the vaccinated fish.  
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5.2.5.4 Specific antibody titration by ELISA 
An indirect enzyme linked immunosorbent assay (ELISA) was used to measure the 
specific antibody response of the tilapia sera against whole cells of Fo. The antibody 
titres were determined according to the protocol outlined by (Adams et al., 1995) with 
modifications. Briefly, 96-well ELISA plates were coated with 100 µl of 1% w/v poly-
L-lysine in carbonate–bicarbonate buffer and incubated for 60min at room temperature 
(~21°C). Plates were then washed three times with a low salt wash buffer (LSWB) (0.02 
mol l-1 Trizma base, 0.38 mol l-1 NaCl, 0.05% (v/v) Tween 20, pH 7.2). Bacteria were 
added to each well (100μl /well) and plates were incubated overnight at 4°C. For this, 
bacteria had been cultured overnight and then washed twice with 1X PBS (20 min at 
3500×g) and the concentration of the resulting suspension adjusted to an OD600 of 1.0.  
Fifty microliters of a 0.05 % v/v solution of glutaraldehyde in LSWB was added to fix 
the bacteria and plates were incubated at 21°C for 20 min before washing three times 
with LSWB. Non-specific reactions caused by the bacteria were removed by incubating 
with hydrogen peroxide (1:10 of a 30% stock solution) for 1h, and then non-specific 
binding sites were blocked by incubating the plates with 5% w/v skimmed milk powder 
in water at 21°C for 120 min. After washing plates three times with LSWB, 100µl serially 
diluted fish serum in LSWB (from 1:32 to 1:1024) were added to the plates and incubated 
overnight at 4°C (Palaksha et al., 2008). Plates were then washed five times with high 
salt wash buffer (HSWB) (0.02 mol l-1 Trizma base, 0.5 mol l-1 NaCl, 0.01% (v/v) Tween 
20, pH 7.4) and left for 5 min covered in HSBW after the last wash to remove unbound 
antibodies. 
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The anti-tilapia IgM monoclonal antibody (MAb) (Aquatic Diagnostics Ltd, Stirling, 
UK) was then added (100μl per well) and plates were incubated at 21°C for 60 min. 
Following the subsequent washing of the plates with HSW, as previously described, goat 
anti-mouse immunoglobulin-G labelled with horseradish peroxidase (HRP) (Sigma-
Aldrich, Dorset, UK), diluted 1:4000 in conjugate buffer [1% w/v bovine serum albumin 
(BSA) in LSW] was added to the wells and incubated for 60min at 21°C. Plates were 
once again washed with HSW as previously described.  
The assays were developed with 100μl well−1 of substrate/chromogen (i.e. 15ml substrate 
buffer containing 5µl hydrogen peroxide and 150µl trimethyl-benzidine (TMB) 
dihydrochloride) [150 µl (42 mM 3, 3′5,5′-tetramethylbenzidine hydrate dihydrochloride 
(Sigma-Aldrich, Dorset, UK) added to 6ml of 50% acetic acid) to 15 ml of substrate 
buffer and 5µl of hydrogen peroxide (H2O2). 
Following a 10 min incubation at 21 °C, the reaction was terminated with the addition of 
50μl well−1 of 2 M H2SO4 and the absorbance was measured at OD450 using a 96-well 
plate spectrophotometer (Biotek Instruments, Friedrichshall, Germany).  
The ELISA antibody titre was defined as the reciprocal of the highest dilution (1/x 
dilution) showing an OD450 at least two times greater than the negative control. Both 
positive (vaccinated and challenged fish) and negative controls (serum blanks/ naïve fish) 
were added to each plate.  
5.2.5.5 Spleen granuloma score 
The spleens of fish in treatments 4 and 5 were macroscopically analysed to count and 
record the presence of white nodules and/or the extension of the coalescent nodules in 
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the parenchyma, as well as colour changes and signs of splenomegaly in all the 
treatments.  
5.2.5.6 Transcriptomic profiles 
The spleen and kidney samples that were frozen in RNAlater® were sent to the 
Interdisciplinary Centre for Aquaculture Research (INCAR) in Concepcion University 
Chile for RNA sequencing using next generation sequencing. At arrival to the lab, the 
samples were prepared for total RNA extraction. 
Two methods were compared for the extraction of total RNA from 10mg of spleen and 
head kidney of fish from treatments 4 and 5, the RiboPure™ RNA purification kit 
(Ambion Life Technologies, California, USA) and TRIzol® reagent (Ambion Life 
Technologies, California, USA).  
The total RNA concentration and purity of the samples were initially estimated with a 
NanoDropTM ND1000 (ThermoScientific, Delaware, USA) and their integrity verified by 
electrophoresis in MOPS (3-[N-morpholino] propanesulfonic acid)/formaldehyde, 1.2% 
agarose gel stained with ethidium bromide at 0.001%. 
After comparison of preliminary results of NanoDropTM and gel electrophoresis the 
TRIzol® reagent was chosen as the method to complete the extraction of spleen only 
from fish sampled at 24hpi.  
The RNA extracts with 260/280 and 260/230 ratios equal or greater than 2.0 and apparent 
integral RNA were screened in a Tape Station 2200 system (Agilent Technologies, 
California, USA) using the R6K reagent kit according to the manufacturer’s instructions. 
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The concentrations given by the NanoDrop were used as a reference to adjust each 
sample to ~200µg/µl before screening them on the TapeStation. The samples with the 
best RNA integrity number (RIN) i.e. RIN≥7 were selected (six per treatment) and pooled 
by mixing 15µl of each sample, the RIN values of the head kidney tissues didn’t yield 
the required values and were not further considered; the RNA concentration of the spleen 
pools of both treatments was quantified with a Qubit® 2.0 fluorometer (Invitrogen, Life 
Technologies, California, USA) and their integrity verified on the TapeSation. Finally 
the concentration of the pools was readjusted to 100ng/µl in a volume of 50µl for cDNA 
library construction.   
The cDNA libraries were prepared according to the TruSeq® Stranded mRNA Sample 
Preparation Guide (Illumina, California, USA). The final products were quantified by 
real time PCR with the StepOne™ Real-Time PCR software (Life Technologies Ltd, 
Paislye, UK) and their integrity was assessed and validated with the Tape Station 2200 
system (Agilent Technologies, California, USA) using the D1K screen tape  kit according 
to the manufacturer’s instructions 
5.2.5.7 Statistical analyses 
Comparative susceptibility: due to the different number of fish used in the wild type Nile 
tilapia population, a Z test for two population proportions with a significance level of 
0.05 and one tailed hypothesis was chosen as the statistical method to compare the 
number of dead fish obtained with each dose. The population’s proportions were 
transformed using the natural logarithm or arcsine transformation prior to the analyses. 
The LD50 at 8 different time points was calculated for each tilapia group with the 
statistical method described by Reed and Muench (1938). 
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5.3 Results 
5.3.1 Lethal dose 50% (LD50) virulence assay 
After quantification by the drop count method, the concentration estimated for the 
solution with an OD600 of 0.9 was 1.2x109 CFU/ml of F. orientalis. The cumulative 
mortalities of the different genetic groups of tilapia challenged by IP injection with 
different doses of F. orientalis are presented in Figure 5.1 
Comparisons of cumulative mortalities indicated that mortality in red O. niloticus was 
significantly higher than that of the other two tilapia groups, when 12 and 120 CFU/fish 
were injected into the fish. It was also observed that when a dose of 1200 CFU/ml was 
injected into the fish, the mortality in O. niloticus was significantly lower than that of the 
other two species and no differences were seen when the highest dose (1.2 x105 
CFU/fish) was used. The cumulative mortalities per dose are presented in Figure 5.2. 
At 45 dpi the median lethal dose observed for the red Nile tilapia was just 30 CFU/ml, 
while it was 2.3x104 for the wild type and 3.3x102 for O. mossambicus. This result, where 
the LD50 of the red tilapia was lower than that of the other two groups, was maintained 
during the course of the experiment. The LD50 for the wild type was the most stable with 
values always around 104 CFU/ml and the highest of the three groups from 25dpi 
onwards. 
A comparison of the LD50 values obtained for the different tilapia groups is presented in 
Table 5.1. The lowest amount of bacteria required to cause mortality was 12 CFU/ml and 
this was seen as early as only 24hpi in the red Nile tilapia and in the wild type after 26 
dpi. No mortalities were seen with this dose in the species O. mossambicus. 
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Fig. 5.2 Cumulative percent mortality of different genetic groups of tilapia challenged with F. orientalis STIR-GUS-F2f7. A Nile tilapia red colour. 
B Nile tilapia wild type. C Mozambique tilapia. 
 
A 
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Fig. 5.2 Cumulative percent mortality of different genetic groups of tilapia challenged with F. orientalis STIR-GUS-F2f7 (continued). B Nile 
tilapia wild type. C Mozambique tilapia.  
B 
C 
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Figure 5.3 Cumulative mortalities observed in the different tilapia species with each of the doses tested. The mortalities bearing different letters 
are significantly different (P < 0.05). 
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Table 5.1 LD50 values (CFU/fish) of  different tilapia species during the 
experiment    
Day O. niloticus red O. niloticus wild type O. mossambicus 
10 3.3x104 4.3x104 4.4x104 
15 1.9x104 3.5x104 4.1x104 
20 1.5x104 3.3x104 3.4x104 
25 2.5x102 2.8x104 1.2x103 
30 1.2x102 2.5x104 4.6x102 
35 3.8x10 2.5x104 3.3x102 
40 30 2.5x104 3.3x102 
45 30 2.3x104 3.3x102 
5.3.2 Pre-challenge (LD60 confirmation) 
The estimated dose of bacteria used for this experiment was 2.4x105 CFU/ml (104 
CFU/fish). After 21 dpi, 18 of the 20 fish had died, showing that this dose produced a 
cumulative mortality of 90% (Figure 5.3). As a result of this, the decision was taken to 
use a dose one log lower (i.e. 103 CFU/fish) to challenge the vaccinated fish. 
 
Figure 4 Cumulative mortality of red Nile tilapia challenged with a dose of 2.4x104 
CFU/fish of Francisella orientalis STIR-GUS-F2f7 after 21 days following infection.
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5.3.3 Vaccine stability and safety test 
Separation of the components was observed in the water layer in the drop test, between 
the densities, creating a linear drop where the oily component stayed in the superficial 
layer, while the dispersed stage of the emulsion went to the bottom of the beaker, a major 
portion of the drop stayed at the surface. The conductivity measurement was 30µs/cm. 
The microscopic particles observed were 1µm in size and were homogenously distributed 
of the continuous and dispersed phase of the mixture, showing a dense liquid compatible 
with the 70/30 emulsion. The stability of the emulsion was tested 24h after the 
emulsification, with no separation of the liquid phases of the solution observed. Thus, 
after 24h after preparation, the emulsion was still intact indicating that the vaccine was 
suitably stable for injection in to the fish. The same test, performed after 15, 30 and 60 
days post-preparation showed that the stability of the emulsion remained stable with no 
phase separation.  
In the safety test, all 30 fish injected with a double dose (0.2ml) of the vaccine appeared 
healthy, with no changes in behaviour (such as lethargy, lack of feeding, aggression, 
gaping, flashing) observed. These fish were dissected at the end of the trial to observe 
any possible alteration in the peritoneal cavity. No adhesions of the mesenteries or 
abdominal organs were observed, nor any melanisation. Although 12 fish (40%) had dark 
pigments within the peritoneal walls and mesenteric fat, this could not be related directly 
to the vaccine because peritoneal pigmentation is a common feature of tilapia. All the 
fish had a droplet of the vaccine in the cavity always located dorsal, caudal and lateral to 
the right (below the swim-bladder, posterior section of the cavity). Smaller droplets could 
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also be observed distributed randomly within the cavity. The droplets were contained in 
a smooth soft transparent sac with vascularisation.  
5.3.4 Vaccination and infection  
As in the pre-challenge, all the fish vaccinated with the normal dose of vaccine remained 
healthy and no mortalities or signs of toxicity or disease observed within this group 
during the 30 days of the vaccination period.  
During the challenge, differences in colouration and behaviour were seen between 
treatments. The vaccinated group fish were more active, reactive to stimuli (visual, 
physical and feeding) and had a red/pink coloration. This was also the case for the 
adjuvant treated fish. The non-vaccinated fish were more lethargic, had less active 
feeding behaviour as well as social interaction by hierarchy (aggression), and had pale 
(white) coloration. These signs started from 4dpi and the first mortality occurred at 8dpi. 
Moribund fish were gasping, had erratic swimming (no balance) and had swollen 
abdomens (ascites).  
When dead fish were dissected, granulomas were observed in their spleen and kidneys, 
with varying grades of severity. Some spleens were larger than normal, with dark red 
coloration and white nodules in 80-90 % of the parenchyma, others were bright red with 
90-100 % granulomas and some others shown splenomegaly with large nodules and a 
white membranous lining of the capsule of the spleen which extended over the majority 
of the peritoneal cavity. Head kidneys appeared enlarged, haemorrhagic and full of 
granulomas, in some cases the organ was protruding ventrally towards the anterior 
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section of the cavity, in contact with the spleen, liver, and gut sections. Other organs were 
affected such as the gonads, gut and posterior kidney.  
Histopathological sections of the affected organs showed the typical granulomatous 
lesion with the bacterium contained within enlarged macrophages or an accumulation of 
phagocytic cells enclosing the pathogen covered by fibrin and outlined by inflammatory 
cells and a concomitant mononuclear infiltration and an increased vascularisation of the 
affected areas. Non-specific mortalities were ruled out by clinical signs and lack of 
bacterial recovery, with infected fish showing 100% granulomatous lesions in target 
organs.  
5.3.5 Vaccine efficacy assessment (RPS) 
After 40dpi the average mortality in the control group reached 63.3%. In the adjuvant 
group the mortality was 36.7%. The vaccinated group had no dead fish (0%) in any of 
the tanks during the whole period of experiment. The RPS value at the end of the 
experiment was 100% for the vaccinated group and 42% for the adjuvant group (Figure 
5.5).
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Figure 5.5 Mortality curves during the vaccination-challenge experiment. The graph shows differences in protection of vaccine and adjuvant 
treatment.
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5.3.6 Specific antibody titration by ELISA 
To reduce non-specific reactions, hydrogen peroxide was used together with 5% casein 
or 1% BSA. The dilution of the naïve and immune tilapia serum was evaluated between 
1/32 and 1/65536. In addition, the anti-tilapia MAb was tested at 1/33 and 1/66 as well 
as for the HRP anti-mouse (polyclonal) at 1/1000 and 1/4000.  
The first attempt indicated that a dilution of 1/32 gave high non-specific reactions (ODs 
between 1.05 and 0.6) and no significant difference between the blocking reagents. For 
the second attempt positive (vaccinated and challenged fish), negative (naïve fish) and 
PBS controls were used at serum dilutions of 1/64 to 1/1024.   
For the blocking of reactions, 5% casein and 2% BSA were used. The anti-tilapia MAb 
was tested again at 1/33 and 1/66. This resulted in a difference between MAb dilutions 
but not blocking reagents.   
As shown in Figure 5.6 the antibody response was between 1/64 and 1/128 using 1/33 
MAb, taking into account the threshold (x3 the average of the PBS control multiplied by 
3), providing a threshold of 0.225 (OD450). 
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Figure 5.6 Measurement of specific antibody response in red Nile tilapia (O. niloticus) to Francisella orientalis by ELISA. The graph shows the 
difference between positive and negative responders over a range of serum dilutions. 
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The antibody response in the vaccinated fish at three time points post-vaccination is 
shown in Table 5.2. No specific antibody response was seen in serum sampled from the 
adjuvant or control groups. In the vaccine group the response remained similar between 
time points with no significant variability, therefore the pattern of kinetics in the 
development of the antibody titres was a plateau, with the titre peaking by 30dpv and 
remaining similar at 45dpv. 
Table 5.2 Serum antibody response of experimental fish measured as the mean ±SD of 
the OD values with its respective mean/range of the antibody titre 
 
Treatments Day post-immunisation 
OD values Antibody titre  Threshold 
Mean ±SD Mean Range 
Vaccinated 
15 0.495 0.238 1/245 
1/128 -
1/256 0.401 
30 0.773 0.248 1/281 
1/256 -
1/512 0.752 
45 0.470 0.245 1/281 
1/256 -
1/512 0.337 
Control 
PBS 
15 0.319 0.190 - - 0.392 
30 0.127 0.099  -  - 0.629 
Adjuvant 15 0.086 0.093 - - 0.327 30 0.167 0.176  -  - 0.525 
OD values in vaccinated fish are above the thresholds, indicating specific response to the 
antigen with a titre between 1/256 and 1/512. The threshold is considered after reduction 
of the background data (normalized) being two times the average of the PBS wells. The 
vaccinated groups showed variability between individuals, i.e. non responding fish and 
high responders (with an endpoint titre over 1/512) (Figure 5.7), but the average OD450 
remained above the sensitivity threshold showing a clear positive response.
 
5.3.7 Spleen granuloma score 
The macroscopic analyses of the white nodules in the spleens revealed that 90% of the 
non-vaccinated fish had granulomas, while only 13.4% of the vaccinated fish developed 
such lesions. 
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Figure 5.7 Antibody response of 10 vaccinated fish at days 15, 30 and 45 post injection 
and ±SD. Dotted line indicates sensitivity threshold. Variability per individual is 
observed, such as non-responders: fish 6(15), 1(30), 5(45) and specific response 
measured between 1/64 and 1/512. X = The ten fish analysed; Y = OD values.
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5.3.8 Transcriptomic profiles 
5.3.8.1 RNA integrity and concentration 
All the samples tested had RNA integrity values (RIN) below the ideal required (RIN=9) 
for library preparation. The gel images obtained in the Tape Station with total RNA 
extracted from the spleens of vaccinated and not vaccinated fish (sampled at 24 hours 
post infection) are presented in Figure 5.8 
 
Figure 5.8 Gel images of tilapia spleen RNA analyses. A Vaccinated group: A0 ladder, 
A1 fish4, B1 fish29, C1 fish3, D1 fish8, E1 fish13, F1 fish17, G1 fish24. B Not 
vaccinated group:  A0 ladder, A1 fish5, B1 fish8, C1 fish15, D1 fish17, E1 fish23, F1 
fish27, G1 fish14. In yellow the RIN value of each sample. 
 
The RNA concentrations in the vaccinated group were: fish4 272 ng/µl, fish29 217 ng/µl, 
fish3 239 ng/µl, fish8 205 ng/µl, fish13 183 ng/µl, fish17 247 ng/µl and fish24 185 ng/µl. 
The RNA concentrations in the not vaccinated group were: fish5 277 ng/µl, fish8 283 
ng/µl, fish15 336, fish17 252 ng/µl, fish23 358ng/µl, fish27 209 ng/µl and fish14 
171ng/µl.   
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The graphic representation of the results obtained in the Tape Station with the samples 
with the highest RIN values (fish13 vaccinated group and fish27 not vaccinated group) 
are presented in Figure 5.9.  
 
Figure 9 Graphic representation of the RNA integrity and concentration. E1 fish13 from 
vaccinated group and F1 fish27 from the not vaccinated group.  
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5.3.8.2 Libraries preparation (quality assessment and concentration) 
The pool of the vaccinated individuals was integrated with fish 8, 13 and 17. The pool of 
the non-vaccinated fish was integrated with samples from fish 8, 17 and 27. The RIN 
value of the vaccinated pool was 7.3 and the RIN value of the non-vaccinated pool was 
7.7.  The original concentration of the pools indicated by Qubit was 180ng/µl for the 
vaccinated fish and 284 ng/µl for the non-vaccinated fish and it was adjusted to 20ng/µl 
in a volume of 50µl for library preparation. The initial step (purification of mRNA with 
magnetic beads) of the library preparation is illustrated in Figure 5.10 
 
Figure 5.110 Library preparation for next generation RNA sequencing of the tilapia 
spleen transcriptomes. The red arrow points the purfied mRNA of the vaccinated fish and 
the yellow the purfied mRNA of the vaccinated fish. 
 
The libraries did not yield the expected values in the Tape Station and therefore their 
quality was not considered as adequate to continue with the process. For this reason they 
were not loaded in the cartridge to be sequenced in the Illumina® MiSeq™ platform 
(Illumina, California, USA).  
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5.4 Discussion 
Compared to terrestrial animals, controlling interaction between the aetiological agents, 
the hosts and environment is almost impossible in aquaculture as water is the perfect 
vehicle for bacterial transmission and disinfection of facilities is not always possible. The 
use of chemotherapeutic agent creates a risk of antibiotic resistance and for these reasons, 
it has been proposed that disease control in modern aquaculture should be based firstly 
on good biosecurity measures, but also on stimulation of the immune system of the 
populations. (Austin, 2012; Toranzo et al., 2009; Van Muiswinkel, 2008) 
Preparation of whole cell inactivated vaccines was the first approach for vaccine 
development in aquaculture, and it has proven to be an efficient and successful method 
of prevention and control of various diseases. The main advantage of inactivated vaccines 
over live attenuated vaccines relates to safety, because dead pathogens cannot cause 
infection, but they are able to generate an effective immune response (Austin, 2012). 
The development of the present vaccine with whole inactivated cells of Francisella 
orientalis resulted in a stable emulsion without phase separation. The quality of the 
emulsion is of considerable importance because it has a direct effect on the efficacy and 
safety of the vaccine. The results of the quality controls performed were consistent with 
the manufacturer’s recommendations indicating that the emulsion was suitable for use in 
live organisms. Although in this study the viscosity was not measured, its analysis is 
suggested by the adjuvant manufacturer in order to assess the syringeability of the final 
product and determine the intraperitoneal distribution of the vaccine formulation that 
could help avoid side effects.  
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Fluid water/oil W/O emulsions can be achieved having surfactants with an optimised 
hydrophilic-lipophilic balance (HLB) value called “required HLB”, which depends on 
the nature of the oil. W/O/W emulsions and O/W emulsions have a lower viscosity. The 
ratio between the oil phase and the aqueous phase influences the viscosity. A high 
dispersed phase leads to an increment of the viscosity on the final emulsion, because of 
a packed network between droplets, so the continuous phase must be increased to 
decrease viscosity. For these reason, in W/O emulsions with a ratio of 70/30, the viscosity 
will be ±50 mPa s, in contrast a similar preparation of 50/50 will have a 4 times higher 
viscosity (Aucouturier, 2001).  
The microscopic inspection indicated that the component particles in the solution 
emulsion had an appropriate size (1µm) and distribution, normally emulsions having a 
small particle size and a homogeneous distribution are more stable. According to the 
adjuvant manufacturer an emulsion is not stable if the following features are presented, 
breakage, oil release, white layer and sedimentation. 
Stability is the most important aspect after emulsification as it determines the durability 
and resilience of the vaccine preparation. It can be determined by various parameters: 1) 
the nature of the oil and if it was used alone or in combination; 2) the antigenic phase (its 
ratio in the emulsion and protein contained); and 3) if the emulsification process included 
using high mix homogenization. The commercial hand blender used in the present study 
was successful in mixing the vaccine components uniformly making a very stable 
vaccine.  
The syringeabilty test showed that the gauge of the needles is an important factor in the 
vaccination process. The first practice attempts to perform the vaccination with insulin 
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syringes (30GX8mm) were not successful, the process was slow, complicated and some 
of the syringes broke while injecting the fish. For the vaccination experiment 22GX7mm 
and 21GX8mm hypodermic needles were used. This facilitated the process and enabled 
a smooth and seamless injection, reducing time and labour required to complete the 
experiment. 
The bacterial inactivation process should kill the pathogen, but retain sufficient structural 
preservation to produce an immune response. This procedure can target extracellular 
components of the bacterial cell i.e. surface components (cell membrane) or intracellular 
component (nucleic acids) to impede their replication. The physical methods of 
inactivation include UV light, heat and sonication. UV light basically disables the ability 
of replication by dimerization of the nucleic acids. Heat has been shown to be a very 
effective method, but the downside is that even though it diminishes infectivity it may 
also reduce immunogenicity, therefore the ideal temperatures to destroy the first and 
maintain the latter are in the range of 50-60°C for 10-30 min. Sonication disrupts the 
bacterial morphological structure retaining the immunogenic compounds. The primary 
product for chemical inactivation is formaldehyde at low concentrations, essentially 
because it has the capacity of altering the extra and intracellular compounds while 
maintaining the immunogenic properties.  
The safety test was carried out as suggested in the International Cooperation on 
Harmonisation of Technical Requirements for Registration of Veterinary Medicinal 
Products (VICH) guidelines and the European Pharmacopoeia commission for vaccines 
for veterinary use. This test is performed to determine the performance and safety, with 
regard to toxicity and side effects. The majority of bacterial vaccines are inactivated with 
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0.5 % formalin with viability and sterility tests then carried out at 24 and/or 48 h, although 
there is some question associated with the concentration of formalin used and the effect 
it has on denaturing the vaccine antigens (Gudding et al., 2014). 
Toxicity is a very important aspect; there are reports of some vaccines e.g. Yersinia and 
Aeromonas that have been shown to be toxic to fish (Gudding et al.,  2014); using a 
double dose or “double-safe procedure” helps to highlight any problems with regard to 
vaccine safety. Toxicity problems may include a reduction in feeding behaviour, 
decreased swimming activity, pain, reduced gut function, energy-demanding immune 
response and anaphylactic shock (Gudding et al., 2014).  
The efficiency of a vaccine in terms of protection is difficult to assess, until today the 
only accepted method of determining the effectiveness of a vaccine is with the RPS 
values proposed by (Amend, 1981; Gudding et al., 2014). There is a debate regarding 
ethical issues, involving deliberately infecting and killing experimental fish, but due to 
the fact that mechanisms of protective immune response given by a vaccine are unclear 
in fish, there is currently no alternative that can be considered reliable and/or successful 
enough to be used as a replacement by the aquaculture industry (Austin, 2012). Thus, to 
determine vaccine efficiency, evaluation of the level of protection is essential. Multiple 
factors including the virulence of the pathogen, dose standardization, fish susceptibility, 
optimization of experimental unit, as well as the general experimental design and 
statistical analysis must be taken into account to establish and standardise the challenge 
procedure. Keeping these variables (and the replicability of challenge) constant is 
difficult to achieve and that is why it is not easy to compare the efficiency between 
different vaccine batches of the same or different bacteria. To counteract this, an 
Chapter Five 
 
190 
 
alternative way to measure effectiveness can be to determine the mechanisms of vaccine 
protection or the mode of action, rather than evaluating mortality rates, especially in cases 
where the mortality rates ae unknown or the disease does not cause high mortality rates 
but has elevated morbidity (Gudding et al., 1999; Gudding et al., 2014). 
In order to investigate the susceptibility of different genetic groups of tilapia a series of 
experiments was developed to estimate the medium lethal dose value (LD50) of F. 
orientalis STIR-GUS-F2f7 in Mozambique (Orecochromis mossambicus) and red and 
wild type Nile tilapia (O. niloticus). The cumulative mortalities and the LD50 results 
clearly indicated a significant variation where the red Nile tilapia appears to be the most 
susceptible while the wild type is the most resistant.  
The mortality rates of the pre-challenge generated a major query about the ideal dose 
(concentration of bacteria) to be used in the main experiment and this was due to the 
LD50. Results indicated that with 1x103 CFU/fish, the median lethal dose was achieved 
at day 23 post challenge, with 105 CFU/fish at day 6 and with 102 CFU/fish at day 35. 
For the pre-challenge and vaccination challenge 104 CFU/fish seemed to be a very high 
dose (90% mortality in 21 days) and 103CFU/fish correlated with the findings of the 
previous trial where in 27 days, 58.3% of the population had died (60% in two tanks) 
compared to 60% at day 25 determined in the LD50. 
Soto et al. (2009b) used a different strain of Nile tilapia and a different isolate, and 
compared IP and immersion challenge, using the cumulative mortalities at 20 and 40 dpi, 
the LD50 for the IP challenged tilapia were 10−5.1 (1.8×104 CFU/fish), and 10−5.3 (1.2×104 
CFU/fish), respectively.  
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The mortality curves in the vaccine trial in the present study showed a high level of 
protection (100%). The vaccine could perform differently under farm production 
conditions however, due to a range of factors such as stocking densities, husbandry, 
social behaviour, tank conditions, water quality or concomitant diseases or variations in 
the isolates present on the fish farm. It could be expected that the range of protection of 
an autogenous vaccine would differ when comparing lab conditions and the farm 
environment, but this can only be established if a vaccination trial is performed at the 
farms (Gudding et al., 2014).  
The difference in RPS values between the vaccinated, adjuvant and the control fish 
reflects the cellular and/or innate response given by the adjuvant (Schijns and Tangerås, 
2005) and differences in the adaptive immune response observed in the vaccinated fish 
(Sarder et al., 2001; Gudding et al., 2014). The mode of protection of a vaccine can rely, 
in part, on the production of humoral antibodies in the host. If there is a disagreement 
between the presence of humoral antibodies to bacterial immunizations i.e. no correlation 
between protection and antibody production, this could be related to a lack of antibody 
assembly or low titres of antibodies indicating that these do not perform a key role in 
protection. Once antibody levels reach a level above a threshold considered to be 
protective, then they are said to have reached a signature for protective immunity 
(Pulendran et al., 2010).  
Besides the antibody response, there is the possibility that the mechanism of protection 
is centred on an innate or cellular response, for example stimulation of T cell, leukocyte 
proliferation, lysozyme activity and macrophage activating factor production (Gudding 
et al., 2014). Also a joint response involving humoral, cellular and innate immunity can 
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be possible as well as the involvement of other mechanisms including the enhancement 
of nitric oxide response, mucosal immunity and immune gene expression (Gudding et 
al., 2014; Schrøder et al., 2009).  
The main function of adjuvants is the antigen presentation process, distinguishing them 
in Signal 1 (actual antigenic presentation) and Signal 2 (secondary signal) facilitators; 
both involved in the activation of lymphocytes T and B (O'Hagan and Singh, 2003; 
Tafalla et al., 2013). Signal 1 adjuvants depend on the status of the antigen in terms of 
time, injection site and concentration allowing immune cell aggregation. Unlike Signal 
1, Signal 2 depends almost entirely on immune receptors; they are known to stimulate an 
increased innate response with discharge of cytokines and PAMPS/DAMPS; leading to 
receptor expression (PRRs) and T cell differentiation (T helper cells), involving the MHC 
peptides being recognized (co-stimulation signals during antigen recognition); the T 
helper (Th) cells will differentiate into Th1 and Th2 to activate the B cells that will 
differentiate to memory B cells (long lived antigen specific B cells) or plasma cells 
(effector cells that secrete antibodies). Th1 cells secrete IFN-y, which activates 
macrophages and induces production of opsonizing antibodies (pathogen is marked for 
ingestion and destruction by a phagocyte) by B cells, producing a cell mediated response 
protective against intracellular pathogens, with activation of cytotoxic T lymphocytes 
and natural killer cells. Meanwhile the Th2 cells secrete cytokines IL-4, IL-5 and IL-13 
that induce B cells to produce neutralizing antibodies. 
Further functions of adjuvants include enhancing and prolonging immune response, 
modulation of antibody response (spectrum and specificity), increase in  immunogenicity 
of poor antigens and antibody production for weak responders, induction of mucosal 
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immunity and reducing dose of antigen as well as competition between antigens 
(polyvalent vaccines). 
In the present study the adjuvant, Monatanide TM ISA 763 AVG, showed a functional 
behaviour towards general vaccine efficiency. Examples of Montanide emulsions for 
bacterial diseases include formalin killed Pseudomonas plecoglossicida (Ninomiya and 
Yamamoto, 2001; Sitjà-Bobadilla, 2008).  
Studies of Aeromonas hydrophila vaccinations (in Hippoglossus hippoglossus and 
Cyprinus carpio) showed the comparison between Freund´s and Montanide ISA 711, 
evaluating antibody titres and intraperitoneal adhesions, in terms of humoral antibodies 
Freund´s adjuvant displayed an earlier and higher response compared to Montanide 
(Montanide 4 of 47 fish reached 1:1000 in 6 months; FCA 27 of 48 2 months), but 
Montanide produced less side effects (Bowden et al., 2003).  
Montanide ISA 763 was also tested in Oncorhynchus mykiss as adjuvants in A. 
hydrophila and Lactococcus garvieae vaccines and provided a high degree of protection, 
with 70% mortality obtained in control fish, and cumulative mortalities of 6.7 and 16.7% 
(30 and 90 days PV challenge) in vaccinated fish (Bastardo et al., 2012) . 
Another example in O. mykiss against Yersinia ruckeri using Montanide IMS 1312 VG 
(bath immersion). The control groups had a maximum survival of 6.6% and in vaccinated 
fish survival ranged from 93.3–100% and 80.1–100% in fish vaccinated with vaccine 
with and without Montanide, respectively (Soltani et al., 2014). 
A combination of RPS values and the specific antibody response strongly suggested that 
the vaccine tested in the current study was high efficacy. 
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The ELISA showed a clear detection of specific antibodies for F. orientalis in vaccinated 
fish and not in control nor adjuvant individuals, and this can be related to the reduction 
of mortalities (0%) in the challenge compared to 60% and 32% in the control and 
adjuvant treatments  (Gudding et al., 2014) .  
Examples of the correlation between antibody levels and survival rates include work 
carried out in Atlantic salmon vaccinated with IPNV, showing that antibodies produced 
during the challenge reduced post-challenge mortalities (Gudding et al., 2014). In 
addition, a furunculosis vaccine in the same fish species showed correlation between 
increased humoral antibodies and decreased mortality (Gudding et al., 2014). Others 
examples include Aeromonas salmonicida (Lund et al., 2008), Streptococcus difficilis 
(Bercovier et al., 1997) and Flavobacterium psychrophilum (Crump et al., 2005).   
For the present study, there seems to be a direct relationship between protection and 
adaptive immunity. Although the bacterium is a facultative intracellular pathogen that 
can invade phagocytic cells and avoid detection, it is possible that the vaccine acts during 
the extracellular phase of the bacterial pathogenesis (Soto et al., 2010a). In addition, as 
variability in individual response within vaccinated fish was detected at the three time 
points, it may be a matter of individual characteristics, determined by factors such as fish 
weight-size (variability of ±2 g), sex or even social hierarchy.  
The importance of this result is based on the fact that the average the humoral response 
was over the threshold, indicating that it had reached a significant level of protective 
immunity (Gudding et al., 2014), even falling within the concept of herd immunity that 
takes into account the protection provided to the whole population to prevent a disease 
outbreak including individuals with or without low immunity (Anderson and May, 1985; 
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Gudding et al., 2014). This means that the proportion of high responders seen in the study 
would help to protect the poor responders.  
The kinetics of the serum antibody response were unexpected, because very similar mean 
antibody titres (and ± SD) were observed between samples taken at the various time 
points dpv. This was highlighted when comparing the results to studies in Nile tilapia 
with heat-killed Aeromonas hydrophila vaccine and Montanide (no specifications) 
(Sarder et al., 2001), where the kinetics showed a typical bell shaped curve, with the 
highest titre at 28 dpv and a decrement by 42dpv. 
Many factors can influence the behaviour of the humoral response, in this case it is 
suggested that the vaccine stimulated a response by 15dpv, had its peak by 30dpv and 
remained elevated even at 45dpv, indicating that it is a continuous stimulation due to the 
properties of immunomodulation of the adjuvant, providing constant and long lasting 
release of the antigen.  
In regarding the transcriptomic profiles, many factors could have influenced the low 
quality in the RNA. The fact that the samples were stop for 10 days at the customs in 
Santiago airport in Chile is thought to be the main reason for these results. Attempt to 
construct the libraries were performed despite the low RIN values obtained in the pools 
but as expected the quality of the libraries was not considered good enough to perform 
the sequencing. Further attempts to extract total RNA and construct new libraries are 
being performed with the samples left and other kits are being performed at the INCAR 
laboratory. 
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In tilapia there is a current patented vaccine developed by (Hawke and Soto, 2012; Soto 
et al., 2011b) based on a genetically attenuated Fo strain. The efficacy studies for this 
vaccine consisted of testing the attenuated mutant and determining the protection 
acquired by injection and immersion with the wild type strain. The intraperitoneal 
injection of the mutant induced a strong humoral response in adults and enhanced the 
production of antibodies, with serum and mucus antibody response titres >52000. They 
also tested the functional ability of the antibodies by opsonophagocytosis and killing 
assays, and passive immunization trials. The tissues recovered were evaluated by mean 
number of granulomas found in a 10X microscopic field and their bacterial loads were 
measured by PCR.  
After immersion immunisation with 107 CFU/ml of the mutant strain for 30-180 min, the 
RPS values obtained were 68.75 and 87.5% respectively, while with 103 CFU/ml RPS 
values were 56.25 and 62.5%. Although this vaccine was later patented in the USA for 
tilapia, it cannot be commercially used in Europe, as such vaccines must be authorized 
for the entire European Union via the European Medicines Agency due to a more strict 
legislation on genetically modified organisms (GMOs) prevailing in this continent.  
In this context, the vaccine developed in the present study, represents not only the most 
efficient approach for prevention of piscine francisellosis, but also the most biologically 
safety and eco-friendly produced so far. 
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5.5 Conclusion  
In conclusion, the vaccine here prepared against F. orientalis proved to be 100% effective 
in red Nile tilapia under laboratory conditions, when the fish was challenged at day 
31dpv. What is more, the vaccinated fish developed an adaptive immune response that 
correlated directly with protection. It is imperative to consider the antigen dose in 
correlation to protective immunity, taking into account a threshold dose. Also it is 
important to consider the function of the adjuvants to assist with early immunity onset, 
long effector response (antibody titres; T cell activity) and diminishing requirement of 
boosters. The next step is to test the vaccine against other geographical isolates of F. 
orientalis under laboratory conditions as well as test its efficacy in the field.  
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Chapter Six  
General discussion and final conclusions 
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6.1 General discussion  
Piscine francisellosis in an infectious emerging disease that continues expanding to new 
hosts and new geographical regions and for which no commercial treatment or vaccine 
exist. When the pathogen was first detected in the mid 90’s using electron microscopy it 
was associated with the genus Rickettsia (due to its intracellular nature) and was referred 
to as a “rickettsia-like organism”.  
Another term used to refer the bacterium was Piscirickettsia-like organisms due to its 
similarity in ultrastructural morphology with Piscirickettsia salmonis which was first 
confirmed as the causative agent of granulomatous disease in farmed salmon in 1991 
(Fryer et al., 1992). 
It took more than a decade after the disease was first reported to molecularly identify 
members of the genus Francisella as the cause of the disease outbreaks and it was then 
when researchers started to use specially formulated synthetic media to successfully 
isolate it.  
The use of this enriched medium allowed the recovery of several strains of Francisella 
spp. from diseased cod in northern Europe, but this was not always achieved in tropical 
aquaculture where there were many reports of francisellosis with no successful isolation 
of the pathogen despite having molecular identification of Francisella-like bacteria. 
Some reasons for this difficultly could be the fastidious nature of the bacterium (slow 
growth and exigent nutritional requirements) and its ability to enter into a viable but not 
culturable status. These properties have not only complicated the primary isolation of the 
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pathogen, but consequently prevented its adequate phenotypic and genetic 
characterisation.   
At the start of this study there were only 3 reports of isolation of Fno and very little 
information was available on their phenotypic characteristics. In this context the selective 
tilapia blood agar proposed in Chapter 2 resulted in an excellent option for the primary 
isolation of the pathogen, especially where bovine products are not readily available or 
their use is not desirable in veterinary vaccine development. Using this agar a total 10 
new isolates of Fno were recovered from tilapia for the first time in Europe, including 
STIR-GUS-F2f7.  
After purification, the isolates were analysed for antimicrobial resistance. The MIC 
results indicated that the isolates were susceptible to neomycin, novobiocin, amikacin, 
ciprofloxacin, imipenem, gatifloxacin, meropenem, tobramycin, nitrofurantoin, and 
levofloxacin. The large inhibition zones in the disk diffusion method indicate that they 
are susceptible to enrofloxacin, kanamycin, gentamicin, tetracycline, oxytetracycline, 
florfenicol, oxolinic acid and streptomycin. Considering these results, florfenicol and 
oxytetracycline seemed to be the most adequate to treat the fish as these are authorised 
antibiotics for use in aquaculture in Europe and the farms were consequently medicated. 
The isolation of the new strains emphasised the need for a suitable methodology to 
characterise them. Prior to this project researchers had limited their investigations to 
basic molecular identification i.e. PCR with universal eubacterial primers. Therefore in 
Chapter 2, the use of the Biolog GN2 plates to investigate the phenotypic and 
biochemical characteristics was proposed.  
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This was the first time that these plates were used with Fno, but the manufacture’s 
protocol had to be optimised to cope with the fastidious nature of the bacterium. This 
optimisation included the development of a gradient of inoculum densities and the 
selection of an optimal concentration. Having made these modifications to the protocol 
more than 20 new metabolic features of STIR-GUS-F2f7 and other strains from Central 
America and Asia were discovered.  
Additionally, to integrate a polyphasic approach a set of housekeeping genes was 
designed to genetically characterise the isolate STIR-GUS-F2f7. The selection of the 
genes was based on previous publications sequences from other Francisella spp. and they 
demonstrated a good level of resolution to classify the bacterium at the subspecies level. 
The primers to amplify and sequence the genes were originally designed based on the 
genome of F. philomiragia. While there were more than 30 fully sequenced genomes for 
other Francisella species, there were none from fish pathogenic strains at the beginning 
of this project.  
In Chapter 3, next generation sequencing i.e. Illumina Hi-Seq™ platform was used in 
collaboration with the Swedish Defence research agency to sequence and de novo 
assemble the complete genome of STIR-GUS-F2f7. A few weeks after the isolation of 
STIR-GUS-F2f7, Sridhar et al. (2012) released “Toba04” the first fully sequenced and 
assembled genomes from Francisella noatunensis orientalis. The primers for the house 
keeping genes were then redesigned using Toba04 as a backbone while STIR-GUS-F27 
was still being sequenced.  
The annotation of the genome presented in Chapter 3 represents an invaluable tool for 
future research on the metabolism and pathogenicity of Fno; not only could this be linked 
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to the phenotypic fingerprint obtained in Chapter 2, but it could also be useful to further 
investigate the OMVs-like structures observed in STIR-GUS-F2f7.  
True OMVs have been recently described by Brudal et.al (2014b) in Fnn grown in vitro 
and in vivo in zebrafish. In that study the structures contained virulence factors like iglC, 
PdpD, PdpA, FopA and GroEL proteins. Interestingly when the OMVs were used as a 
vaccine they reduced proliferation of the bacterium and protected zebrafish embryos 
during experimental infections. If the structures here described in STIR-GUS-F2f7 are 
OMVs with similar functions to those presented by Brudal et al. (2014b) for Fnn, the use 
of proteomics and the annotated genome could contribute to the develop a new approach 
for vaccine development against this disease in tilapia and cod. 
The genome sequence of STIR-GUS-F2f7 was also used in this study as a part of series 
of investigations that aimed to clarify its taxonomic status. In Chapter 4 sixteen Fno and 
sixteen Fnn strains (from a wide range of hosts and geographical regions) that had been 
collected and archived in different laboratories around the world during the last decade 
were phenotypically and genetically characterised to determine if the isolates belonging 
to the taxon Fno constitute an independent species.  
Although in the last decade some “new” concepts of prokaryotic species have been 
proposed e.g. ecological species (Cohan,  2002), recombination species (Dykhuizen, 
2005), phylo-phenetic species (Rosselló-Móra and Amann, 2001) and meta-population 
lineages (de Queiroz, 2005) no consensus has been reached yet to accept one or a group 
of them as the universal concept of “prokaryotic species”. Therefore, bacterial 
taxonomists continue to use the genomo-species concept (Wayne et al., 1987) which 
indicates that two (pure) isolates that show 70% or greater DNA-DNA association with 
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5°C or less difference in ∆Tm belong to the same species. Additionally the percent 
similarity in the 16S rRNA gene is also considered a standard species delineation. For 
this parameter the cut-off value is 98.65% and to use it the gene sequences must be 
complete i.e. ~1500bp.  
More recently, with the boom of next generation sequencing technologies, bacterial 
taxonomists have had access to thousands of complete genome sequences to correlate 
them with crude DNA-DNA values. This has allowed them to establish an average 
nucleotide identity (ANI) value of 95-96% in a set of at least five (the longer the sequence 
the better) conserved genes e.g. housekeeping or core genes as a third “new” gold 
standard.  
The use of the genomic sequence derived parameters from STIR-GUS-F2f7 and all the 
other sequenced strains indicated that according to the gold standards the Fno taxon does 
constitute a separate and independent species from F. noatunensis. Moreover, the 
endemic isolates from Chile represent a new true subspecies of Francisella noatunensis 
and one isolate from Ireland was classified as an “atypical strain” of the new Fnn 
subspecies. These results were supported by crude DNA-DNA values and other in silico 
analyses, which included phylogenetic networks and trees.  
Additionally, the biochemical and phenotypical characterisation performed with the 
Biolog GN2 plates as per the protocol proposed in Chapter 2 correlated with the genetic 
observations. The modification to the manufactures protocol helped to discover more 
positive reactions that allowed even the classification of the atypical Irish strain. In 2007, 
Huber et al. (2010) had used the plates with one Norwegian Fnn from cod, however since 
they used the protocol as per the manufactures instruction they presented only 6 positive 
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reactions and missed the other eleven “false negatives” that were unveiled in this 
research. The phenotypic information presented here was used to amend the description 
of F. noatunensis. 
While developing the gradient of densities a number of reactions appeared to be positive 
when OD600 over 1.0 were used to inoculate the plates in both, the cold water and warm 
water isolates. However, since the plates reached a point of saturation when this limit 
was passed, those reactions were not reported as positive. These carbon sources are for 
Fnn dextrin (A3), glycogen (A4), D-cellobiose (A12), glycyl-Lglutamic acid (F12), L-
threonine (G12), glycerol (H9) and D-L-α-glycerol phosphate (H10). And for Fno D-
cellobiose (A12), mono-methyl- succinate (C12), α-keto glutaric acid (E4), D,L-lactic 
acid (E6), succinic acid (E12), bromo succinic acid (F1), glycyl-Lglutamic acid (F12), 
L-ornithine (G4) and Thymidine (H4). 
It is emphasised that more research is required, either screening the genomes or 
developing individual tests for each of these metabolites, to rule out whether the fish 
pathogenic Francisella cells have or don’t have the ability to metabolise those carbon 
sources before considering them as a part of their phenotypic description. 
The nomenclature and taxonomic classification proposed here for the fish pathogenic 
Francisella strains is presented in Table 6.1. This is based on the phenotypic and genetic 
investigation performed in Chapter 4.  
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Table 6.1 Taxonomical rearrangement of fish pathogenic Francisella spp. proposed in 
this study and previous nomenclature 
 
With the correct nomenclature established, an autologous vaccine against F. orientalis 
(Fo) was developed in Chapter five of the present study to protect tilapia. This vaccine 
was formulated with a commercial oil adjuvant emulsified with formalin killed Fo STIR-
GUS-F2f7.  
This is the first time that this approach is used for francisellosis in tilapia. The only 
previously attempt to develop a vaccine against this disease was the live attenuated 
vaccine reported by (Hawke and Soto, 2012; Soto et al., 2011b). 
Prior to the formulation of the vaccine the susceptibility or LD50 of 3 genetic groups of 
tilapia to Fo STIR-GUS-F2f7 bacterium was investigated. The results obtained in these 
experiments clearly indicated a significant variation, with the red Nile tilapia appearing 
to be more susceptible than Mozambique tilapia and wild type Nile tilapia, while the 
latter was found to be the most resistant to francisellosis. Further research is required to 
determine if this can be attributed to the families tested or is indeed characteristic of the 
species/populations. The mortality curves of the red Nile tilapia were not stable and 
consistent with the sigmoidal curves normally observed in dose dependent experiments.  
There are no other reports in the literature where the susceptibility of different tilapia 
species against francisellosis had been compared, but the values obtained for Nile tilapia 
Genus Species Subspecies 
Francisella noatunensis F. philomiragia noatunensis F. piscicida
Francisella noatunensis chilense F. noatunensis noatunensis -
Francisella noatunensis noatunensis F. philomiragia noatunensis F. piscicida
Francisella orientalis - F. noatunensis orientalis F. asiatica ⱡ; F. victoria ⱡ
Previous names
ⱡ Never effectively or validly published
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wild type are in agreement with those reported by Soto et al. (2009b). In this sense the 
results presented here represent a starting point to look at resistance traits in different 
genetic groups of tilapia against francisellosis.  
On the basis of these results and the relevance that the red tilapia market has in several 
countries, the red Nile tilapia was selected as the candidate to test the vaccine. In order 
to determine the best dose to challenge the vaccinated fish a pre-challenge with 20 naïve 
red Nile tilapia fingerlings took place. The dose used in this experiment was selected 
from the results of the LD50 experiments and was expected to cause 60% mortalities by 
around day 30. Unexpectedly the dose killed the 20 fish in only 15 days and the decision 
was taken to reduce it by one log for the final challenge. The dose finally used caused 
63% of mortality in unvaccinated fish.  
All the fish were vaccinated 30 days prior to the challenge, and the production of specific 
antibodies against F. orientalis was constantly monitored during that period. The results 
of the ELISAs confirmed that specific antibodies were being produced and the peak of 
protection was reached around day 30 post-immunisation.  
These results are similar to those presented by Schrøder et al. (2009) who vaccinated cod 
with a whole cell inactivated vaccine but against Fnn. Soto et al. (2011b) also obtained 
a strong humoral response in adult tilapia and enhancement of antibodies production after 
intraperitoneal injection of the live attenuated vaccine. 
The formulation of the vaccine consisted of formalin killed inactivated cells of STIR-
GUS-F2f7 and the commercial oil adjuvant Montanide™ ISA763AVG. The inactivation 
of the bacteria was confirmed twice before emulsifying it with the adjuvant. Although 
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there were no reports of its use with Francisella it had been previously used with success 
in other fish pathogenic bacteria like Yersinia ruckeri, Aeromonas hydrophila and 
Lactococcus garvieae (Soltani et al., 2014).  
The adjuvant was considered adequate because the stability of the emulsion was 
maintained for weeks, no adherences were seen in the injected fish and no side effects 
were presented during the safety test experiments.  
The final results of the experiment indicated that the vaccine was 100% effective in 
protecting the fish against the experimental infection. In contrast a significantly lower 
relative percent survival (42%) was observed in the fish immunised only with the 
adjuvant and 63.3% of mortality was seen in the control group.  
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6.2 Final conclusions  
A new solid media (based on cysteine and tilapia blood) for the isolation and culture of 
fish pathogenic and other Francisella spp. was developed.  
A polyphasic approach for the characterisation of fish pathogenic Francisella spp. is 
presented and its use to phenotypically and genetically characterise Francisella spp. from 
other sources is proposed. 
This was the first documented report of the isolation and characterisation of Fno from 
tilapia in Europe. 
The complete genome of the Fno (Fo) strain STIR-GUS-F2f7 was fully sequenced using 
next generation sequencing (Illumina™ Hi-Seq platform) technology. 
The taxonomy of the genus Francisella was revised and the new bacterial species F. 
orientalis and the new subspecies F. noatunensis chilense are described. An emended 
description of F. noatunensis noatunensis is presented. 
The susceptibility of three different genetic groups of tilapia (two species and two 
varieties) to STIR-GUS-F2f7 was investigated. The families from the red Nile tilapia 
group were the most susceptible while the wild Nile tilapia were the most resistant. 
An inactivated (formalin killed/oil adjuvanted) vaccine against piscine francisellosis was 
developed. 
The vaccine was tested in red Nile tilapia and it proved to be capable to stimulate strong 
humoral immune response in the experimental fish and 100% effective.
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6.3 Recommendations for future research 
The results obtained in this thesis, open new avenues for research that could be explored 
in the near future. In this section some of these ideas and other suggestions to give 
continuity to this study are presented. 
- Control of piscine francisellosis by developing vaccines based on comparative 
proteomic analyses of several strains recovered from fish.  
- Application of the polyphasic approach to clarify the taxonomic status of several strains 
F. philomiragia and other Francisella spp. 
- Establishment of minimal standards for the description or delineation of species and 
subspecies within the genus Francisella. 
- Performance of comparative genomic analyses of all the Francisella species that are 
causative agents of disease in aquaculture. 
- Use the genomic information here obtained will contribute to develop highly sensitive, 
rapid detection methods for Francisella orientalis that could be used at the farm side 
such as loop-mediated isothermal amplification (LAMP) method.  
- The challenge models here established could facilitate the study of the effect of different 
probiotic bacteria and bioactive algal compounds to prevent and mitigate piscine 
francisellosis in tilapia. 
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